BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016;70:93-105. [PMID: 26935559 DOI: 10.1016/j.eururo.2016.02.029] [Cited by in Crossref: 1048] [Cited by in F6Publishing: 1040] [Article Influence: 174.7] [Reference Citation Analysis]
Number Citing Articles
1 Venditti M, Arcaniolo D, De Sio M, Minucci S. Preliminary Investigation on the Involvement of Cytoskeleton-Related Proteins, DAAM1 and PREP, in Human Testicular Disorders. Int J Mol Sci 2021;22:8094. [PMID: 34360857 DOI: 10.3390/ijms22158094] [Reference Citation Analysis]
2 Wang C, Hong T, Wang Y, Gan S, Wang Q, Li J, Zuo L, Cui X. Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients. Oncoimmunology 2020;9:1736793. [PMID: 32313718 DOI: 10.1080/2162402X.2020.1736793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Deuker M, Stolzenbach LF, Collà Ruvolo C, Nocera L, Tian Z, Roos FC, Becker A, Kluth LA, Tilki D, Shariat SF, Saad F, Chun FK, Karakiewicz PI. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma. Clinical Genitourinary Cancer 2021;19:117-24. [DOI: 10.1016/j.clgc.2020.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhang L, Wu B, Zha Z, Zhao H, Feng Y. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis. Cancer Manag Res 2018;10:1687-703. [PMID: 29970967 DOI: 10.2147/CMAR.S166710] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
5 Stang A, Rusner C, Trabert B, Oosterhuis JW, McGlynn KA, Heidinger O. Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013. Andrology 2019;7:402-7. [PMID: 30578617 DOI: 10.1111/andr.12565] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zhang Y, Hua X, Shi H, Zhang L, Xiao H, Liang C. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma. Cancer Cell Int 2021;21:680. [PMID: 34923969 DOI: 10.1186/s12935-021-02364-2] [Reference Citation Analysis]
7 Wang D, Zhang P, Liu Z, Xing' Y, Xiao Y. NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2. Cancers 2022;14:3782. [DOI: 10.3390/cancers14153782] [Reference Citation Analysis]
8 Büttner F, Winter S, Rausch S, Hennenlotter J, Kruck S, Stenzl A, Scharpf M, Fend F, Agaimy A, Hartmann A, Bedke J, Schwab M, Schaeffeler E. Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma. BMC Med 2018;16:108. [PMID: 29973214 DOI: 10.1186/s12916-018-1088-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Looijenga LHJ, Van der Kwast TH, Grignon D, Egevad L, Kristiansen G, Kao CS, Idrees MT. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors. Am J Surg Pathol 2020;44:e66-79. [PMID: 32205480 DOI: 10.1097/PAS.0000000000001465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Gao J, Xu Q, Fu Y, He K, Zhang C, Zhang Q, Shi J, Zhao X, Wang F, Guo H. Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 2021;48:561-9. [PMID: 32623502 DOI: 10.1007/s00259-020-04916-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Tamura K, Horikawa M, Sato S, Miyake H, Setou M. Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry. Oncotarget 2019;10:1688-703. [PMID: 30899441 DOI: 10.18632/oncotarget.26706] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
12 Tsili AC, Sofikitis N, Stiliara E, Argyropoulou MI. MRI of testicular malignancies. Abdom Radiol (NY) 2019;44:1070-82. [PMID: 30386879 DOI: 10.1007/s00261-018-1816-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
13 Trilla-Fuertes L, Miranda N, Castellano D, López-Vacas R, Farfán Tello CA, de Velasco G, Villacampa F, López-Camacho E, Prado-Vázquez G, Zapater-Moros A, Espinosa E, Fresno Vara JÁ, Pinto Á, Gámez-Pozo A. miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma. PLoS One 2020;15:e0229075. [PMID: 32109249 DOI: 10.1371/journal.pone.0229075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tanaka T, Kawashima A, Marukawa Y, Kitayama T, Masaoka Y, Kojima K, Iguchi T, Hiraki T, Kanazawa S. Imaging evaluation of hereditary renal tumors: a pictorial review. Jpn J Radiol 2021;39:619-32. [PMID: 33759057 DOI: 10.1007/s11604-021-01109-5] [Reference Citation Analysis]
15 Pederzoli F, Murati Amador B, Samarska I, Lombardo KA, Kates M, Bivalacqua TJ, Matoso A. Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical. Hum Pathol 2019;90:1-7. [PMID: 31071342 DOI: 10.1016/j.humpath.2019.04.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Yong C, Stewart GD, Frezza C. Immunohistochemistry as a tool for screening rare renal cancers. Ann Transl Med 2019;7:S314. [PMID: 31909051 DOI: 10.21037/atm.2019.10.18] [Reference Citation Analysis]
17 Alharbi H, Alkhateeb S, Murshid E, Alotaibi M, Abusamra A, Rabah D, Almansour M, Alghamdi A, Aljubran A, Eltigani A, Alkushi H, Ahmed I, Alsharm A, Bazarbashi S. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017. Urol Ann 2018;10:133-7. [PMID: 29719322 DOI: 10.4103/UA.UA_176_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Kim TM, Ahn H, Lee HJ, Kim MG, Cho JY, Hwang SI, Kim SY. Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristics. Abdom Radiol. [DOI: 10.1007/s00261-022-03571-9] [Reference Citation Analysis]
19 Yoo A, Tang C, Zucker M, Fitzgerald K, Dinatale RG, Rappold PM, Weiss K, Freeman B, Lee C, Schultz N, Motzer R, Russo P, Coleman J, Reuter VE, Chen Y, Carlo MI, Gill AJ, Kotecha RR, Ari Hakimi A, Reznik E. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas. European Urology Focus 2022. [DOI: 10.1016/j.euf.2021.12.002] [Reference Citation Analysis]
20 Chen Q, Cheng L, Li Q. The molecular characterization and therapeutic strategies of papillary renal cell carcinoma. Expert Rev Anticancer Ther 2019;19:169-75. [PMID: 30474436 DOI: 10.1080/14737140.2019.1548939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Gao J, Meng L, Xu Q, Zhao X, Deng Y, Fu Y, Guo S, He K, Shi J, Wang F, Zhang S, Guo H. 68Ga-PSMA-11 PET/CT Parameter Correlates with Pathological VEGFR-2/PDGFR-β Expression in Renal Cell Carcinoma Patients. Mol Imaging Biol 2022. [PMID: 35451707 DOI: 10.1007/s11307-022-01725-1] [Reference Citation Analysis]
22 Akitake M, Kiyoshima K, Yokomizo A, Shiga K, Koga H, Takeuchi A, Shiota M, Inokuchi J, Tatsugami K, Yamaguchi A, Eto M. A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases. Mol Clin Oncol 2018;8:785-90. [PMID: 29732157 DOI: 10.3892/mco.2018.1602] [Reference Citation Analysis]
23 Chieffi P. An up-date on epigenetic and molecular markers in testicular germ cell tumors. Intractable Rare Dis Res 2017;6:319-21. [PMID: 29259864 DOI: 10.5582/irdr.2017.01070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bardisi M, Khabaz MN, Al-Maghrabi JA. Large Cell Calcifying Sertoli Cell Tumor with Macrocalcification in a Partially Resected Testis. Case Rep Pathol 2020;2020:5279013. [PMID: 32257489 DOI: 10.1155/2020/5279013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kristiansen S, Bjartling C, Svensson Å, Forslund O, Torbrand C. Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium: a cross-sectional study of 351 circumcised men in Sweden. BJU Int 2021;127:428-34. [PMID: 32870593 DOI: 10.1111/bju.15221] [Reference Citation Analysis]
26 Jin F, Shahid M, Kim J. Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer. Adv Exp Med Biol 2021;1306:61-80. [PMID: 33959906 DOI: 10.1007/978-3-030-63908-2_5] [Reference Citation Analysis]
27 Panayotopoulos P, Bouvier A, Besnier L, Rousselet MC, Nedelcu C, Baize N, Beydon L, Aubé C, Azzouzi A, Bigot P. Laparoscopic partial nephrectomy following tumor embolization in a hybrid room. Feasibility and clinical outcomes. Surgical Oncology 2017;26:377-81. [DOI: 10.1016/j.suronc.2017.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Chen L, Hu B, Song X, Wang L, Ju M, Li Z, Zhou C, Zhang M, Wei Q, Guan Q, Jiang L, Chen T, Wei M, Zhao L. m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Front Oncol 2021;11:598017. [PMID: 33796449 DOI: 10.3389/fonc.2021.598017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Fontes-sousa M, Calvo E. First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features. Cancer Treatment Reviews 2022. [DOI: 10.1016/j.ctrv.2022.102374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Durand X, Fléchon A, Murez T, Rocher L, Camparo P, Morel-journel N, Savoie P, Ferretti L, Sèbe P, Méjean A. Recommandations en onco-urologie 2016-2018 du CCAFU : Tumeurs germinales testiculaires. Progrès en Urologie 2016;27:S147-65. [DOI: 10.1016/s1166-7087(16)30706-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
31 Bertolo R, Nicolas M, Garisto J, Magi-Galluzzi C, McKenney JK, Kaouk J. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence". Clin Genitourin Cancer 2019;17:209-215.e1. [PMID: 31000486 DOI: 10.1016/j.clgc.2019.03.004] [Reference Citation Analysis]
32 Yi X, Xiao Q, Zeng F, Yin H, Li Z, Qian C, Wang C, Lei G, Xu Q, Li C, Li M, Gong G, Zee C, Guan X, Liu L, Chen BT. Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma. Front Oncol 2020;10:570396. [PMID: 33585193 DOI: 10.3389/fonc.2020.570396] [Reference Citation Analysis]
33 Guo P, Wang Y, Han Y, Wei D, Zhao J, Li M, Jiang Y, Luo Y. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma. Urol Oncol 2021;39:835.e19-27. [PMID: 34620554 DOI: 10.1016/j.urolonc.2021.06.014] [Reference Citation Analysis]
34 Zhang X, Yadav PK, Niu Q, Cheng H, Xiao Y, Wang Y, Gui H, Wang H, Rodriguez R, Wang Z. Reevaluation of metanephric stromal tumor two decades after it was named: A narrative review. J Pediatr Urol 2020;16:822-9. [PMID: 32893164 DOI: 10.1016/j.jpurol.2020.08.011] [Reference Citation Analysis]
35 Abdessater M, Kanbar A, Comperat E, Dupont-Athenor A, Alechinsky L, Mouton M, Sebe P. Renal Oncocytoma: An Algorithm for Diagnosis and Management. Urology 2020;143:173-80. [PMID: 32512107 DOI: 10.1016/j.urology.2020.05.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Chovanec M, Cierna Z, Miskovska V, Machalekova K, Svetlovska D, Kalavska K, Rejlekova K, Spanik S, Kajo K, Babal P, Mardiak J, Mego M. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors. Oncotarget 2017;8:21794-805. [PMID: 28423520 DOI: 10.18632/oncotarget.15585] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
37 Correa AF, Ruth KJ, Al-Saleem T, Pei J, Dulaimi E, Kister D, Collins M, Abbosh PH, Slifker MJ, Ross E, Uzzo RG, Testa JR. Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma. Cancer Biol Ther 2020;21:424-31. [PMID: 32116106 DOI: 10.1080/15384047.2020.1721251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cozzi S, Bardoscia L, Najafi M, Botti A, Blandino G, Augugliaro M, Manicone M, Iori F, Giaccherini L, Sardaro A, Iotti C, Ciammella P. Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes. Current Oncology 2022;29:1866-76. [DOI: 10.3390/curroncol29030152] [Reference Citation Analysis]
39 Kubota S, Yoshida T, Kageyama S, Isono T, Yuasa T, Yonese J, Kushima R, Kawauchi A, Chano T. A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma. World J Surg Oncol 2020;18:270. [PMID: 33092599 DOI: 10.1186/s12957-020-02046-9] [Reference Citation Analysis]
40 Prisciandaro M, Ratta R, Massari F, Fornarini G, Caponnetto S, Iacovelli R, De Giorgi U, Facchini G, Scagliarini S, Sabbatini R, Caserta C, Peverelli G, Mennitto A, Verzoni E, Procopio G. Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program. Am J Clin Oncol 2019;42:42-5. [PMID: 30204614 DOI: 10.1097/COC.0000000000000478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Ding Y, Tan Q, Mao W, Dai C, Hu X, Hou J, Zeng M, Zhou J. Differentiating between malignant and benign renal tumors: do IVIM and diffusion kurtosis imaging perform better than DWI? Eur Radiol 2019;29:6930-9. [PMID: 31161315 DOI: 10.1007/s00330-019-06240-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
42 Xiao W, Xiong Z, Yuan C, Bao L, Liu D, Yang X, Li W, Tong J, Qu Y, Liu L, Xiao H, Yang H, Zhang X, Chen K. Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma. Oncotarget 2017;8:94819-33. [PMID: 29212269 DOI: 10.18632/oncotarget.21999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
43 Nikolovski I, Carlo MI, Chen YB, Vargas HA. Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study. Cancer Imaging 2021;21:24. [PMID: 33608050 DOI: 10.1186/s40644-021-00392-9] [Reference Citation Analysis]
44 Maughan BL. Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022. Curr Oncol Rep 2022. [PMID: 35438388 DOI: 10.1007/s11912-022-01269-1] [Reference Citation Analysis]
45 Fang L, Zhang Y, Zang Y, Chai R, Zhong G, Li Z, Duan Z, Ren J, Xu Z. HP-1 inhibits the progression of ccRCC and enhances sunitinib therapeutic effects by suppressing EMT. Carbohydr Polym 2019;223:115109. [PMID: 31427001 DOI: 10.1016/j.carbpol.2019.115109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
46 Xu Y, Wu G, Ma X, Li J, Ruan N, Zhang Z, Cao Y, Chen Y, Zhang Q, Xia Q. Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes. Int J Genomics 2020;2020:9493256. [PMID: 33381539 DOI: 10.1155/2020/9493256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Kobayashi K, Matsuyama H, Kawai T, Ikeda A, Miyake M, Nishimoto K, Matsushita Y, Komura K, Abe T, Kume H, Nishiyama H, Fujimoto K, Oyama M, Miyake H, Inoue K, Mitsui T, Kawakita M, Ohyama C, Mizokami A, Kuroiwa H. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study). Int J Urol 2022. [PMID: 35293022 DOI: 10.1111/iju.14854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Li J, Guo L, Chai L, Ai Z. Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma. Technol Cancer Res Treat 2019;18:1533033819830966. [PMID: 30852945 DOI: 10.1177/1533033819830966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Shehabeldin AN, Ro JY. Neuroendocrine tumors of genitourinary tract: Recent advances. Annals of Diagnostic Pathology 2019;42:48-58. [DOI: 10.1016/j.anndiagpath.2019.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Akgul M, Saeed O, Levy D, Mann SA, Cheng L, Grignon DJ, Eble JN, Idrees MT. Morphologic and Immunohistochemical Characteristics of Fluorescent In Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma: A Single Institutional Cohort. Am J Surg Pathol 2020;44:1450-8. [PMID: 32701515 DOI: 10.1097/PAS.0000000000001541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
51 Zinnall U, Weyerer V, Compérat E, Camparo P, Gaisa NT, Knuechel-clarke R, Perren A, Lugli A, Toma M, Baretton G, Kristiansen G, Wirtz RM, Cheng L, Wullich B, Stoehr R, Hartmann A, Bertz S. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype. Human Pathology 2018;80:55-64. [DOI: 10.1016/j.humpath.2018.05.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
52 Rupp NJ, Montironi R, Mischo A, Moch H. Clinical Trials for Specific Renal Cancer Subtypes—The Time Will Come! European Urology Supplements 2017;16:241-52. [DOI: 10.1016/j.eursup.2017.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
53 Franzen AM, Glitzky S, Moganti A, Lippek F, Coordes A. Metastases to Both Parotid Glands Six and Twelve Years after Resection of Renal Cell Carcinoma. Case Rep Med 2018;2018:7301727. [PMID: 29560015 DOI: 10.1155/2018/7301727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Calò B, Falagario U, Sanguedolce F, Veccia A, Chirico M, Carvalho-Diaz E, Mota P, Lima E, Autorino R, Carrieri G, Cormio L. Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin. World J Urol 2020;38:3161-7. [PMID: 32062805 DOI: 10.1007/s00345-020-03108-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Wang Q, Gan H, Chen C, Sun Y, Chen J, Xu M, Weng W, Cao L, Xu Q, Wang J. Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas. J Exp Clin Cancer Res 2017;36:176. [PMID: 29208006 DOI: 10.1186/s13046-017-0651-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
56 Sakhadeo U, Yadav SC, Bakshi GK, Prakash G, Katdare A, Menon S, Desai SB. Eosinophilic solid cystic renal cell carcinoma: A series of 3 cases elucidating the spectrum of morphological and clinical features of an emerging new entity. Indian J Urol 2021;37:350-4. [PMID: 34759528 DOI: 10.4103/iju.iju_217_21] [Reference Citation Analysis]
57 Su Y, Hong AL. Recent Advances in Renal Medullary Carcinoma. IJMS 2022;23:7097. [DOI: 10.3390/ijms23137097] [Reference Citation Analysis]
58 Marko J, Craig R, Nguyen A, Udager AM, Wolfman DJ. Chromophobe Renal Cell Carcinoma with Radiologic-Pathologic Correlation. Radiographics 2021;41:1408-19. [PMID: 34388049 DOI: 10.1148/rg.2021200206] [Reference Citation Analysis]
59 Gad S, Le Teuff G, Nguyen B, Verkarre V, Duchatelle V, Molinie V, Posseme K, Grandon B, Da Costa M, Job B, Meurice G, Droin N, Mejean A, Couve S, Renaud F, Gardie B, Teh BT, Richard S, Ferlicot S. Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway. Oncol Lett 2021;22:835. [PMID: 34712359 DOI: 10.3892/ol.2021.13096] [Reference Citation Analysis]
60 Choi Y, Keam B, Kim M, Yoon S, Kim D, Choi JG, Seo JY, Park I, Lee JL. Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients. Cancer Res Treat 2019;51:1549-56. [PMID: 30913859 DOI: 10.4143/crt.2019.086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
61 Kim J, Jin P, Yang W, Kim WJ. Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist. Investig Clin Urol 2020;61:539-54. [PMID: 33135400 DOI: 10.4111/icu.20200317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Bumbasirevic U, Bojanic N, Pljesa-Ercegovac M, Zivkovic M, Djukic T, Zekovic M, Milojevic B, Kajmakovic B, Janicic A, Simic T, Coric V. The Polymorphisms of Genes Encoding Catalytic Antioxidant Proteins Modulate the Susceptibility and Progression of Testicular Germ Cell Tumor. Cancers (Basel) 2022;14:1068. [PMID: 35205816 DOI: 10.3390/cancers14041068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sánchez-gastaldo A, Kempf E, González del Alba A, Duran I. Systemic treatment of renal cell cancer: A comprehensive review. Cancer Treatment Reviews 2017;60:77-89. [DOI: 10.1016/j.ctrv.2017.08.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 10.6] [Reference Citation Analysis]
64 Cai Y, Li F, Li Z, Li X, Li C, Xia Z, Du L, Wu R. Predictive value of contrast-enhanced ultrasound combined with conventional ultrasound in solid renal parenchymal lesions. Br J Radiol 2021;94:20210518. [PMID: 34319793 DOI: 10.1259/bjr.20210518] [Reference Citation Analysis]
65 Renshaw AA, Gould EW. Ancillary studies in fine needle aspiration of the kidney. Cancer Cytopathology 2018;126:711-23. [DOI: 10.1002/cncy.22029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
66 Zhu B, Poeta ML, Costantini M, Zhang T, Shi J, Sentinelli S, Zhao W, Pompeo V, Cardelli M, Alexandrov BS, Otlu B, Hua X, Jones K, Brodie S, Dabrowska ME, Toro JR, Yeager M, Wang M, Hicks B, Alexandrov LB, Brown KM, Wedge DC, Chanock S, Fazio VM, Gallucci M, Landi MT. The genomic and epigenomic evolutionary history of papillary renal cell carcinomas. Nat Commun 2020;11:3096. [PMID: 32555180 DOI: 10.1038/s41467-020-16546-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
67 Velez-torres J, Guido LP, Jorda M. Adult Renal Neoplasms. Surgical Pathology Clinics 2018;11:611-31. [DOI: 10.1016/j.path.2018.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Schmidtova S, Kalavska K, Gercakova K, Cierna Z, Miklikova S, Smolkova B, Buocikova V, Miskovska V, Durinikova E, Burikova M, Chovanec M, Matuskova M, Mego M, Kucerova L. Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells. Cancers (Basel) 2019;11:E1224. [PMID: 31443351 DOI: 10.3390/cancers11091224] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
69 Liu N, Chen Y, Yang L, Shi Q, Lu Y, Ma W, Han X, Guo H, Li D, Gan W. Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma. Clin Transl Med 2022;12:e797. [PMID: 35452181 DOI: 10.1002/ctm2.797] [Reference Citation Analysis]
70 Furubayashi N, Hori Y, Morokuma F, Tomoda T, Negishi T, Inoue T, Kumagai M, Kuroiwa K, Tokuda N, Nakamura M. Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma. Mol Clin Oncol 2021;14:91. [PMID: 33767860 DOI: 10.3892/mco.2021.2253] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 McFadden JD, Sesterhenn IA, Kern SQ. Unusual Suspect: A Case Report of Tubulocystic Renal Cell Carcinoma with Features of Cystic Renal Oncocytoma. Case Rep Urol 2019;2019:2919686. [PMID: 31467765 DOI: 10.1155/2019/2919686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Toguchi M, Takagi T, Ogawa Y, Morita S, Yoshida K, Kondo T, Iizuka J, Ishida H, Nagashima Y, Tanabe K. Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy using enhanced MDCT. Sci Rep 2021;11:2245. [PMID: 33500519 DOI: 10.1038/s41598-021-81922-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Fukuda H, Takagi T, Kondo T, Shimizu S, Tanabe K. Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy. Oncotarget 2018;9:14296-305. [PMID: 29581844 DOI: 10.18632/oncotarget.24507] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
74 Li H, Shukla S, Frappart L, Herrlich P, Ploubidou A. cd44 deletion suppresses atypia in the precancerous mouse testis. Mol Carcinog 2019;58:621-6. [PMID: 30582228 DOI: 10.1002/mc.22961] [Reference Citation Analysis]
75 Abdulfatah E, Kennedy JM, Hafez K, Davenport MS, Xiao H, Weizer AZ, Palapattu GS, Morgan TM, Mannan R, Wang XM, Dhanasekaran SM, Kaffenberger SD, Spratt DE, Kunju L, Wu A, Lew M, Udager AM, Chinnaiyan AM, Mehra R. Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature. Histopathology 2020;76:875-87. [PMID: 31872452 DOI: 10.1111/his.14051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Lee JB, Park HS, Park S, Lee HJ, Kwon KA, Choi YJ, Kim YJ, Nam CM, Cho NH, Kang B, Chung HC, Rha SY. Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma. Cancer Res Treat 2019;51:1578-88. [PMID: 30999721 DOI: 10.4143/crt.2018.671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Meng X, Shu J, Xia Y, Yang R. A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma. Biomed Res Int 2020;2020:7103647. [PMID: 32775436 DOI: 10.1155/2020/7103647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
78 Zhu G, Su H, Lu L, Guo H, Chen Z, Sun Z, Song R, Wang X, Li H, Wang Z. Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in Gansu province of China. Oncotarget 2016;7:31372-83. [PMID: 27153553 DOI: 10.18632/oncotarget.9146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
79 Compérat E, Babjuk M, Algaba F, Amin M, Brimo F, Grignon D, Hansel D, Hes O, Malavaud B, Reuter V, van der Kwast T. SIU-ICUD on bladder cancer: pathology. World J Urol 2019;37:41-50. [PMID: 30218308 DOI: 10.1007/s00345-018-2466-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
80 Manocha U, Kardos J, Selitsky S, Zhou M, Johnson SM, Breslauer C, Epstein JI, Kim WY, Wobker SE. RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype. Am J Pathol 2020;190:134-44. [PMID: 31610173 DOI: 10.1016/j.ajpath.2019.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
81 Shenhar C, Veredgorn Y, Bulis S, Aviv T, Darawsha AE, Gilad R, Baniel J, Ehrlich Y, Lifshitz D. Endoscopic Management of Low-Grade Upper Tract Urothelial Carcinoma: Characterizing the Long-term Burden of Care in Comparison to Radical Nephroureterectomy. Urology 2021:S0090-4295(21)00838-4. [PMID: 34536409 DOI: 10.1016/j.urology.2021.06.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Pivovarcikova K, Grossmann P, Hajkova V, Alaghehbandan R, Pitra T, Perez Montiel D, Sperga M, Rogala J, Slisarenko M, Bartos Vesela A, Svajdler P, Michalova K, Rotterova P, Hora M, Michal M, Hes O. Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: Molecular analysis of 39 difficult tumors to classify. Ann Diagn Pathol 2021;52:151734. [PMID: 33838490 DOI: 10.1016/j.anndiagpath.2021.151734] [Reference Citation Analysis]
83 Dieckmann KP, Richter-Simonsen H, Kulejewski M, Ikogho R, Zecha H, Anheuser P, Pichlmeier U, Isbarn H. Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation. Urol Int 2018;100:409-19. [PMID: 29649815 DOI: 10.1159/000488284] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
84 Gulati S, Philip E, Salgia S, Pal SK. Evolving treatment paradigm in metastatic non clear cell renal cell carcinoma. Cancer Treat Res Commun 2020;23:100172. [PMID: 32252014 DOI: 10.1016/j.ctarc.2020.100172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
85 Bode PK, Moch H. [Nephroblastomas: Almost exclusively in clinical trials!]. Pathologe 2016;37:166-71. [PMID: 26942729 DOI: 10.1007/s00292-016-0148-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 El Hanbuli HM, Ibrahim HA, Soliman SAM. Immunohistochemical Expression of CD200 in Renal Cell Carcinoma. J Microsc Ultrastruct 2021;9:136-40. [PMID: 34729355 DOI: 10.4103/JMAU.JMAU_29_20] [Reference Citation Analysis]
87 Amiri A, Chovanec M, Oliva V, Sedliak M, Mego M, Ukropec J, Ukropcová B. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise. Andrology 2021. [PMID: 34245663 DOI: 10.1111/andr.13078] [Reference Citation Analysis]
88 Chung JW, Park JY, Ha H, Park KB, Ha YS, Choi SH, Lee JN, Kim BS, Kim HT, Kim TH, Yoo ES, Chung SK, Yoon GS, Kwon TG. A rare pericytic tumor of the kidney: The first case in Korea. Int J Surg Case Rep 2020;66:178-81. [PMID: 31855704 DOI: 10.1016/j.ijscr.2019.11.009] [Reference Citation Analysis]
89 Dai H, Hu W, Zhang L, Jiang F, Mao X, Yang G, Li L. FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway. Cell Death Dis 2021;12:303. [PMID: 33753729 DOI: 10.1038/s41419-021-03588-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Rebuzzi SE, Perrone F, Bersanelli M, Bregni G, Milella M, Buti S. Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review. Expert Rev Mol Diagn 2020;20:169-85. [PMID: 31608727 DOI: 10.1080/14737159.2019.1680286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
91 Syed JS, Brito J, Pooli A, Boutros PC, Shuch B. Transcriptomics in RCC. Urol Oncol 2020;38:742-54. [PMID: 32222350 DOI: 10.1016/j.urolonc.2019.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Chakravarty D, Huang L, Kahn M, Tewari AK. Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options. Urol Clin North Am 2020;47:487-510. [PMID: 33008499 DOI: 10.1016/j.ucl.2020.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
93 Erlmeier F, Steffens S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Ivanyi P; (German Network Of Kidney Cancer). Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study. Clin Genitourin Cancer 2021;19:53-59.e1. [PMID: 32778505 DOI: 10.1016/j.clgc.2020.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Xu J, Liu Y, Liu J, Shou Y, Xiong Z, Xiong H, Xu T, Wang Q, Liu D, Liang H, Yang H, Yang X, Zhang X. Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma. Front Oncol 2021;11:659208. [PMID: 34249694 DOI: 10.3389/fonc.2021.659208] [Reference Citation Analysis]
95 Tsili AC, Argyropoulou MI, Dolciami M, Ercolani G, Catalano C, Manganaro L. When to ask for an MRI of the scrotum. Andrology 2021. [PMID: 33964115 DOI: 10.1111/andr.13032] [Reference Citation Analysis]
96 Liu HY, Chen YT, Huang SC, Wang HJ, Cheng YT, Kang CH, Lee WC, Su YL, Huang CC, Chang YL, Chuang YC, Luo HL, Chiang PH. The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis. Front Oncol 2021;11:613696. [PMID: 33718167 DOI: 10.3389/fonc.2021.613696] [Reference Citation Analysis]
97 Khatri G, Bhosale PR, Robbins JB, Akin EA, Ascher SM, Brook OR, Dassel M, Glanc P, Henrichsen TL, Learman LA, Sadowski EA, Saphier CJ, Wasnik AP, Maturen KE; Expert Panel on GYN and OB Imaging. ACR Appropriateness Criteria® Pelvic Floor Dysfunction in Females. J Am Coll Radiol 2022;19:S114-20. [PMID: 35550796 DOI: 10.1016/j.jacr.2022.02.018] [Reference Citation Analysis]
98 Buttmann-Schweiger N, Deleré Y, Klug SJ, Kraywinkel K. Cancer incidence in Germany attributable to human papillomavirus in 2013. BMC Cancer 2017;17:682. [PMID: 29037233 DOI: 10.1186/s12885-017-3678-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
99 Luchini C, Cheng L. Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy. Transl Androl Urol 2017;6:987-90. [PMID: 29184801 DOI: 10.21037/tau.2017.08.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Wu Z, Wen Z, Li Z, Yu M, Ye G. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer. Medicine (Baltimore) 2021;100:e23836. [PMID: 33545950 DOI: 10.1097/MD.0000000000023836] [Reference Citation Analysis]
101 David S, András F, Endre K, Balint K, Árpad K, Csaba P, Karoly S, Tamás T. More Cases of Benign Testicular Teratomas are Detected in Adults than in Children. A Clinicopathological Study of 543 Testicular Germ Cell Tumor Cases. Pathol Oncol Res 2017;23:513-7. [PMID: 27796764 DOI: 10.1007/s12253-016-0120-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
102 Furrer MA, Spycher SCJ, Büttiker SM, Gross T, Bosshard P, Thalmann GN, Schneider MP, Roth B. Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysis. Eur Urol Oncol 2020;3:464-73. [PMID: 31570270 DOI: 10.1016/j.euo.2019.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
103 Mu Z, Dong D, Sun M, Li L, Wei N, Hu B. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma. Front Oncol 2020;10:1566. [PMID: 33102202 DOI: 10.3389/fonc.2020.01566] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Bremmer F, Bohnenberger H, Küffer S, Oellerich T, Serve H, Urlaub H, Strauss A, Maatoug Y, Behnes CL, Oing C, Radzun HJ, Ströbel P, Balabanov S, Honecker F. Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines. Dis Markers 2019;2019:8298524. [PMID: 31565104 DOI: 10.1155/2019/8298524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
105 Di Pierro G, Mini E, Roviello G. Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now? Ann Transl Med 2019;7:S229. [PMID: 31656808 DOI: 10.21037/atm.2019.07.70] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Lu Z, Zhou J, Yang C, Zhang L, Tai S, Xiang R, Liang C. Endoscopic robot‐assisted simple enucleation of renal tumours: Impact of learning curve and tumour complexity on trifecta outcomes. Int J Med Robotics Comput Assist Surg 2019;15. [DOI: 10.1002/rcs.2000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Guimerà N, Alemany L, Halec G, Pawlita M, Wain GV, Vailén JSS, Azike JE, Jenkins D, de Sanjosé S, Quint W, Bosch FX. Human papillomavirus 16 is an aetiological factor of scrotal cancer. Br J Cancer 2017;116:1218-22. [PMID: 28376081 DOI: 10.1038/bjc.2017.74] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
108 Smirnova EA, Bezhanova SD, Kozlov NA, Bukaeva IA, Raikhlin NT, Stroganova AM, Senderovich AI. [Renal cell carcinoma associated with Xp11 translocation involving the gene]. Arkh Patol 2018;80:58-62. [PMID: 29460896 DOI: 10.17116/patol201880158-62] [Reference Citation Analysis]
109 Hsieh JJ, Le V, Cao D, Cheng EH, Creighton CJ. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision. J Pathol. 2018;244:525-537. [PMID: 29266437 DOI: 10.1002/path.5022] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 14.3] [Reference Citation Analysis]
110 Giunchi F, Franceschini T, Gruppioni E, Altimari A, Capizzi E, Massari F, Schiavina R, Brunelli M, Martignoni G, Fiorentino M. Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis. Diagnostics (Basel) 2020;10:E123. [PMID: 32102250 DOI: 10.3390/diagnostics10020123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Santoni M, Aurilio G, Massari F, Grande E, Matrana MR, Rizzo M, De Giorgi U, Incorvaia L, Martignetti A, Molina-cerrillo J, Zabalza IO, Mollica V, Rizzo A, Battelli N, Porta C. Nivolumab versus Cabozantinib as second-line therapy in patients with advanced Renal Cell Carcinoma: a real-world comparison. Clinical Genitourinary Cancer 2022. [DOI: 10.1016/j.clgc.2022.02.003] [Reference Citation Analysis]
112 Tao Z, Zhang E, Li L, Zheng J, Zhao Y, Chen X. A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients. Bioengineered 2021;12:4259-77. [PMID: 34304692 DOI: 10.1080/21655979.2021.1955558] [Reference Citation Analysis]
113 Huang Y, Zhang Y, Jia L, Liu C, Xu F. Circular RNA ABCB10 promotes tumor progression and correlates with pejorative prognosis in clear cell renal cell carcinoma. Int J Biol Markers 2019;34:176-83. [PMID: 31106654 DOI: 10.1177/1724600819842279] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
114 de Angelis C, Galdiero M, Pivonello C, Garifalos F, Menafra D, Cariati F, Salzano C, Galdiero G, Piscopo M, Vece A, Colao A, Pivonello R. The role of vitamin D in male fertility: A focus on the testis. Rev Endocr Metab Disord 2017;18:285-305. [PMID: 28667465 DOI: 10.1007/s11154-017-9425-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 9.8] [Reference Citation Analysis]
115 Sondermann M, Günther M, Enzmann T. Das Ductus-Bellini-Karzinom. Urologe. [DOI: 10.1007/s00120-022-01830-7] [Reference Citation Analysis]
116 Østbye KM, Pedersen MK, Sauer T. Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method. Cytojournal 2019;16:26. [PMID: 31897084 DOI: 10.4103/cytojournal.cytojournal_9_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
117 Ged Y, Chen YB, Knezevic A, Casuscelli J, Redzematovic A, DiNatale RG, Carlo MI, Lee CH, Feldman DR, Patil S, Hakimi AA, Russo P, Motzer RJ, Voss MH. Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes. Clin Genitourin Cancer 2019;17:e678-88. [PMID: 31036466 DOI: 10.1016/j.clgc.2019.03.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
118 Nicolau C, Antunes N, Paño B, Sebastia C. Imaging Characterization of Renal Masses. Medicina (Kaunas) 2021;57:51. [PMID: 33435540 DOI: 10.3390/medicina57010051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Cochetti G, Rossi de Vermandois JA, Maulà V, Cari L, Cagnani R, Suvieri C, Balducci PM, Paladini A, Del Zingaro M, Nocentini G, Mearini E. Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial. Urol Oncol 2021:S1078-1439(21)00483-X. [PMID: 34911649 DOI: 10.1016/j.urolonc.2021.11.001] [Reference Citation Analysis]
120 Loveday C, Litchfield K, Proszek PZ, Cornish AJ, Santo F, Levy M, Macintyre G, Holryod A, Broderick P, Dudakia D, Benton B, Bakir MA, Hiley C, Grist E, Swanton C, Huddart R, Powles T, Chowdhury S, Shipley J, O'Connor S, Brenton JD, Reid A, de Castro DG, Houlston RS, Turnbull C. Genomic landscape of platinum resistant and sensitive testicular cancers. Nat Commun 2020;11:2189. [PMID: 32366847 DOI: 10.1038/s41467-020-15768-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
121 Ogorevc M, Strikic A, Tomas SZ. Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method. Biomed Rep 2021;15:79. [PMID: 34429965 DOI: 10.3892/br.2021.1455] [Reference Citation Analysis]
122 Williamson SR, Gill AJ, Argani P, Chen YB, Egevad L, Kristiansen G, Grignon DJ, Hes O. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. Am J Surg Pathol 2020;44:e47-65. [PMID: 32251007 DOI: 10.1097/PAS.0000000000001476] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 9.5] [Reference Citation Analysis]
123 Lopes Vendrami C, McCarthy RJ, Villavicencio CP, Miller FH. Predicting common solid renal tumors using machine learning models of classification of radiologist-assessed magnetic resonance characteristics. Abdom Radiol (NY) 2020;45:2797-809. [PMID: 32666233 DOI: 10.1007/s00261-020-02637-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
124 Bai X, Sun SM, Xu W, Kang HH, Li L, Jin YQ, Gong QG, Liang GC, Liu HY, Liu LL, Chen SL, Wang QR, Wu P, Guo AT, Huang QB, Zhang XJ, Ye HY, Wang HY. MRI-based Bosniak Classification of Cystic Renal Masses, Version 2019: Interobserver Agreement, Impact of Readers' Experience, and Diagnostic Performance. Radiology 2020;297:597-605. [PMID: 32960726 DOI: 10.1148/radiol.2020200478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
125 Morais M, Dias F, Nogueira I, Leão A, Gonçalves N, Araújo L, Granja S, Baltazar F, Teixeira AL, Medeiros R. Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186. Cancers (Basel) 2021;13:1733. [PMID: 33917405 DOI: 10.3390/cancers13071733] [Reference Citation Analysis]
126 Tronik-Le Roux D, Renard J, Vérine J, Renault V, Tubacher E, LeMaoult J, Rouas-Freiss N, Deleuze JF, Desgrandschamps F, Carosella ED. Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients. Mol Oncol 2017;11:1561-78. [PMID: 28815885 DOI: 10.1002/1878-0261.12119] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
127 Ekmekci S, Küçük Ü, Kaya Ö, Yörükoğlu K. The association between the histopathological features and microsatellite instability in young patients with urothelial carcinoma of the bladder. Rev Assoc Med Bras (1992) 2021;67:64-70. [PMID: 34161481 DOI: 10.1590/1806-9282.67.01.20200297] [Reference Citation Analysis]
128 Cancel M, Fromont G, Blonz C, Chevreau C, Rioux-Leclercq N, Laguerre B, Oudard S, Gross-Goupil M, Gravis G, Goldwasser F, Rolland F, Delva R, Moise L, Emambux S, Vassal C, Zanetta S, Penel N, Fléchon A, Barthélémy P, Saldana C, Lefort F, Escudier B, Linassier C, Albiges L. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales). Eur J Cancer 2021;158:1-11. [PMID: 34619467 DOI: 10.1016/j.ejca.2021.08.046] [Reference Citation Analysis]
129 Stitzlein L, Rao P, Dudley R. Emerging oral VEGF inhibitors for the treatment of renal cell carcinoma. Expert Opinion on Investigational Drugs 2018;28:121-30. [DOI: 10.1080/13543784.2019.1559296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
130 Qing ZM, Shuping WM, Bin YM, Xiaoqin QM. Differences Between Type I and Type II Papillary Renal Cell Carcinoma on Ultrasound. Advanced Ultrasound in Diagnosis and Therapy 2019;3:187. [DOI: 10.37015/audt.2019.191220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
131 Murez T, Fléchon A, Savoie PH, Rocher L, Camparo P, Morel-Journel N, Ferretti L, Sèbe P, Méjean A. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs germinales du testicule French ccAFU guidelines — Update 2018—2020: Testicular germ cell tumors. Prog Urol 2018;28:S147-64. [PMID: 30472999 DOI: 10.1016/j.purol.2018.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
132 Compérat E, Amin MB, Epstein JI, Hansel DE, Paner G, Al-Ahmadie H, True L, Baydar D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo C, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, McKenney J, Netto GJ, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat SF, Trpkov K, Weyerer V, Zhou M, Reuter V. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol 2021;28:196-208. [PMID: 34128484 DOI: 10.1097/PAP.0000000000000309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
133 Shahait M, Jackman S, Landman J, Lechevallier E, Billiet I, Fossion L, Aslan Y, Laguna MP. Utilization and Operative Influence of Renal Mass Biopsy in the Small Renal Mass: Analysis from the Clinical Research Office of the Endourological Society Small Renal Mass registry. J Endourol 2020;34:99-106. [PMID: 31559847 DOI: 10.1089/end.2019.0297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Naito S, Ichiyanagi O, Ito H, Kabasawa T, Kanno H, Narisawa T, Fukuhara H, Yagi M, Kurota Y, Yamagishi A, Sakurai T, Nishida H, Kawazoe H, Yamanobe T, Kato T, Makhov P, Kolenko VM, Yamakawa M, Tsuchiya N. Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma. Oncol Lett 2019;17:3910-8. [PMID: 30881508 DOI: 10.3892/ol.2019.10033] [Reference Citation Analysis]
135 Cierna Z, Miskovska V, Roska J, Jurkovicova D, Pulzova LB, Sestakova Z, Hurbanova L, Machalekova K, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Kajo K, Babal P, Mardiak J, Ward TA, Mego M, Chovanec M. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours. BMC Cancer 2020;20:17. [PMID: 31906898 DOI: 10.1186/s12885-019-6496-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
136 Park JS, Lee ME, Jang WS, Kim J, Park SM, Ham WS. Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers. Biomedicines 2022;10:321. [DOI: 10.3390/biomedicines10020321] [Reference Citation Analysis]
137 Patel ZT, Hogg JP, Plata A. Nasal congestion and nasal obstruction: An unusual presentation of renal cell carcinoma. Radiol Case Rep 2020;15:970-4. [PMID: 32419897 DOI: 10.1016/j.radcr.2020.04.020] [Reference Citation Analysis]
138 Kopp RP, Stratton KL, Glogowski E, Schrader KA, Rau-murthy R, Russo P, Coleman JA, Offit K. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma: Pathology Reports Identify HLRCC Cases. Cancer 2017;123:2452-8. [DOI: 10.1002/cncr.30605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
139 Liu G, Lu Y, Li L, Jiang T, Chu S, Hou P, Bai J, Chen M. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma. Invest New Drugs 2020;38:1730-42. [PMID: 32533288 DOI: 10.1007/s10637-020-00961-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
140 Dizman N, Arslan ZE, Feng M, Pal SK. Sequencing Therapies for Metastatic Renal Cell Carcinoma. Urol Clin North Am 2020;47:305-18. [PMID: 32600533 DOI: 10.1016/j.ucl.2020.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Dong Y, Liu D, Zhou H, Gao Y, Nueraihemaiti Y, Xu Y. A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints. Front Genet 2022;13:912190. [PMID: 35685438 DOI: 10.3389/fgene.2022.912190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Abu-Ghanem Y, Powles T, Capitanio U, Beisland C, Järvinen P, Stewart GD, Gudmundsson E, Lam TBL, Marconi L, Fernandéz-Pello S, Nisen H, Meijer RP, Volpe A, Ljungberg B, Klatte T, Bensalah K, Dabestani S, Bex A. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy? BJU Int 2021;128:386-94. [PMID: 33794055 DOI: 10.1111/bju.15415] [Reference Citation Analysis]
143 Liu T, Zhao Z, Feng B, Wang X, Li T, Xie S, Zhu W, Li X, Guo H, Yang R. Robotic-assisted laparoscopic tumor enucleation is a feasible technique for renal hilar tumors: A retrospective study. J Surg Oncol 2021;124:135-42. [PMID: 33836093 DOI: 10.1002/jso.26479] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
144 Thakur S, Kakkar A, Jana M, Das P, Agarwala SP, Iyer VK. Pediatric Primary Yolk Sac Tumour of the Kidney: Recommendations for Pretreatment Diagnosis. Fetal Pediatr Pathol 2022;:1-8. [PMID: 35188860 DOI: 10.1080/15513815.2022.2042631] [Reference Citation Analysis]
145 Bianchi L, Schiavina R, Borghesi M, Chessa F, Casablanca C, Angiolini A, Ercolino A, Pultrone CV, Mineo Bianchi F, Barbaresi U, Piazza P, Manferrari F, Bertaccini A, Fiorentino M, Ferro M, Porreca A, Marcelli E, Brunocilla E. Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique. Minerva Urol Nefrol. 2020;72:339-349. [PMID: 31619030 DOI: 10.23736/s0393-2249.19.03485-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
146 van Oostenbrugge TJ, Runneboom W, Bekers E, Heidkamp J, Langenhuijsen JF, Veltien A, Maat A, Mulders PFA, Hulsbergen-van de Kaa CA, Fütterer JJ. MRI as a tool to assess surgical margins and pseudocapsule features directly following partial nephrectomy for small renal masses. Eur Radiol 2019;29:509-16. [PMID: 30043161 DOI: 10.1007/s00330-018-5630-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
147 Sokolakis I, Kalogirou C, Frey L, Oelschläger M, Krebs M, Riedmiller H, Kübler H, Vergho D. Mucin-Poor Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Presented with Multiple Metastases Two Years after Nephrectomy: An Atypical Behaviour of a Rare, Indolent Tumour. Case Rep Urol 2017;2017:6597592. [PMID: 29348963 DOI: 10.1155/2017/6597592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
148 Furubayashi N, Negishi T, Miura A, Nakamura N, Nakamura M. Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma. Res Rep Urol 2020;12:455-61. [PMID: 33117745 DOI: 10.2147/RRU.S270495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
149 Chiu IJ, Hsu YH, Chang JS, Yang JC, Chiu HW, Lin YF. Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2020;12:E847. [PMID: 32244557 DOI: 10.3390/cancers12040847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
150 Ren Q, Wang L, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ, Tickoo SK, Reuter VE, Chen YB. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features. Am J Surg Pathol 2018;42:767-77. [PMID: 29462091 DOI: 10.1097/PAS.0000000000001038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
151 Kim KM, Hussein UK, Bae JS, Park SH, Kwon KS, Ha SH, Park HS, Lee H, Chung MJ, Moon WS, Kang MJ, Jang KY. The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients. Front Oncol 2019;9:14. [PMID: 30723706 DOI: 10.3389/fonc.2019.00014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
152 Anheuser P, Kranz J, Stolle E, Höflmayer D, Büscheck F, Mühlstädt S, Lock G, Dieckmann KP. Testicular epidermoid cysts: a reevaluation. BMC Urol 2019;19:52. [PMID: 31185974 DOI: 10.1186/s12894-019-0477-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
153 Zhang C, Zheng Y, Li X, Hu X, Qi F, Luo J. Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma. Ann Transl Med 2019;7:427. [PMID: 31700863 DOI: 10.21037/atm.2019.08.113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
154 Courcier J, de la Taille A, Nourieh M, Leguerney I, Lassau N, Ingels A. Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management. Int J Mol Sci 2020;21:E7146. [PMID: 32998233 DOI: 10.3390/ijms21197146] [Reference Citation Analysis]
155 Seisen T, Mari A, Campi R, Peyronnet B, Bensalah K, Rioux-Leclercq N, Pfister C, Gobet F, De La Taille A, Allory Y, Xylinas E, Neuzillet Y, Radulescu C, Descotes JL, Saada-Sebag G, Irani J, Delpech-Debiais C, Bigot P, Eymerit C, Crouzet S, Mege-Lechevallier F, Ruffion A, Decaussin-Petrucci M, Droupy S, Roger P, Durand X, Camparo P, Cussenot O, Compérat E, Rouprêt M. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review. Eur Urol Focus 2020:S2405-4569(20)30288-1. [PMID: 33463527 DOI: 10.1016/j.euf.2020.10.004] [Reference Citation Analysis]
156 Mondorf Y, Mikuteit M, Ivanyi P, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief CG, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F. The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma. Urol Int 2022;:1-9. [PMID: 35654002 DOI: 10.1159/000525016] [Reference Citation Analysis]
157 Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol 2019;75:799-810. [PMID: 30803729 DOI: 10.1016/j.eururo.2019.02.011] [Cited by in Crossref: 383] [Cited by in F6Publishing: 370] [Article Influence: 127.7] [Reference Citation Analysis]
158 Cabanillas G, Montoya-Cerrillo D, Kryvenko ON, Pal SK, Arias-Stella JA 3rd. "Collecting duct carcinoma of the kidney: diagnosis and implications for management". Urol Oncol 2021:S1078-1439(21)00204-0. [PMID: 34116936 DOI: 10.1016/j.urolonc.2021.04.041] [Reference Citation Analysis]
159 Flaig TW, Kamat AM, Hansel D, Ingersoll MA, Barton Grossman H, Mendelsohn C, DeGraff D, Liao JC, Taylor JA 3rd. Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium. Bladder Cancer 2017;3:211-23. [PMID: 28824949 DOI: 10.3233/BLC-170111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
160 Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler M. Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2019;11:E1580. [PMID: 31627266 DOI: 10.3390/cancers11101580] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
161 Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, Rohan SM, Cost NG, Khanna G, Mullen EA, Dome JS, Fernandez CV, Perlman EJ. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer 2018;124:3381-9. [PMID: 29905933 DOI: 10.1002/cncr.31578] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
162 Paludo AO, Knijnik P, Brum P, Cachoeira E, Gorgen A, Burttet L, Cabral R, Puliatti S, Rosito T, Berger M, Neto BS. Urology Residents Simulation Training Improves Clinical Outcomes in Laparoscopic Partial Nephrectomy. J Surg Educ 2021;78:1725-34. [PMID: 33849788 DOI: 10.1016/j.jsurg.2021.03.012] [Reference Citation Analysis]
163 Soares A, Monteiro FSM, Maluf FC, Bastos DA, Jardim DL, Sasse AD, Gonçalves E Silva A, Fay AP, da Rosa DAR, Wierman E, Kater F, Schutz FA, de Oliveira FNG, Morbeck IAP, Rinck JA Jr, da Trindade KM, Maia MC, Souza VC, da Silva Neto DCV, de Almeida E Paula F, Korkes F, Carvalhal GF, Nogueira L, de Carvalho Fernandes R, Dos Reis RB, Matheus WE, Busato WFS Jr, da Costa WH, de Cássio Zequi S. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG). J Cancer Res Clin Oncol 2020;146:1829-45. [PMID: 32410064 DOI: 10.1007/s00432-020-03236-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Wisniewski AB, Batista RL, Costa EMF, Finlayson C, Sircili MHP, Dénes FT, Domenice S, Mendonca BB. Management of 46,XY Differences/Disorders of Sex Development (DSD) Throughout Life. Endocr Rev 2019;40:1547-72. [PMID: 31365064 DOI: 10.1210/er.2019-00049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
165 Siev M, Renson A, Tan HJ, Rose TL, Kang SK, Huang WC, Bjurlin MA. Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers. Kidney Cancer 2020;4:49-58. [PMID: 34084980 DOI: 10.3233/kca-190072] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Seo JY, Ahn JY, Keam B, Kim M, Yoon S, Lee JL, Park K, Park I. Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients. Ann Lab Med 2021;41:207-13. [PMID: 33063682 DOI: 10.3343/alm.2021.41.2.207] [Reference Citation Analysis]
167 Canvasser NE, Kay FU, Xi Y, Pinho DF, Costa D, de Leon AD, Khatri G, Leyendecker JR, Yokoo T, Lay A, Kavoussi N, Koseoglu E, Cadeddu JA, Pedrosa I. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses. J Urol 2017;198:780-6. [PMID: 28457802 DOI: 10.1016/j.juro.2017.04.089] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
168 Boguslawska J, Kryst P, Poletajew S, Piekielko-Witkowska A. TGF-β and microRNA Interplay in Genitourinary Cancers. Cells 2019;8:E1619. [PMID: 31842336 DOI: 10.3390/cells8121619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
169 Webster BR, Rompre-Brodeur A, Daneshvar M, Pahwa R, Srinivasan R. Kidney cancer: from genes to therapy. Curr Probl Cancer 2021;45:100773. [PMID: 34261604 DOI: 10.1016/j.currproblcancer.2021.100773] [Reference Citation Analysis]
170 Walter M. Tumor Microenvironment in Penile Cancer. Adv Exp Med Biol 2020;1296:291-307. [PMID: 34185300 DOI: 10.1007/978-3-030-59038-3_18] [Reference Citation Analysis]
171 Fichtner A, Richter A, Filmar S, Gaisa NT, Schweyer S, Reis H, Nettersheim D, Oing C, Gayer FA, Leha A, Küffer S, Ströbel P, Kaulfuß S, Bremmer F. The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real-time polymerase chain reaction. Histopathology 2021;78:593-606. [PMID: 32970854 DOI: 10.1111/his.14258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Zhang J, Li X, Lin J, Liu Z, Tian Y, Wang Q. Modified cancer TNM classification for localized renal cell carcinoma based on the prognostic analysis of 3748 cases from a single center. Can J Physiol Pharmacol 2021;:1-7. [PMID: 34779659 DOI: 10.1139/cjpp-2021-0291] [Reference Citation Analysis]
173 Tabourin T, Pinar U, Parra J, Vaessen C, Bensalah CK, Audenet F, Bigot P, Champy C, Olivier J, Bruyere F, Doumerc N, Paparel P, Parier B, Nouhaud FX, Durand X, Lang H, Branger N, Long JA, Durand M, Waeckel T, Charles T, Cussenot O, Xylinas E, Boissier R, Tambwe R, Patard JJ, Bernhard JC, Roupret M. Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82). Ann Surg Oncol 2022. [PMID: 35780452 DOI: 10.1245/s10434-022-12052-8] [Reference Citation Analysis]
174 Yuan Y, Wang Y, Zhang N, Mao X, Huang Y, Huang J, Ji N. Influence of American Society of Anesthesiologists Score on Oncologic Outcomes in Patients With Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Large-Sample Study in Two Institutions. Front Oncol 2021;11:723669. [PMID: 34671552 DOI: 10.3389/fonc.2021.723669] [Reference Citation Analysis]
175 Murez T, Fléchon A, Savoie PH, Rocher L, Camparo P, Morel-Journel N, Ferretti L, Méjean A. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors]. Prog Urol 2020;30:S280-313. [PMID: 33349427 DOI: 10.1016/S1166-7087(20)30754-5] [Reference Citation Analysis]
176 Elias R, Tcheuyap VT, Kaushik AK, Singla N, Gao M, Reig Torras O, Christie A, Mulgaonkar A, Woolford L, Stevens C, Kettimuthu KP, Pavia-Jimenez A, Boroughs LK, Joyce A, Dakanali M, Notgrass H, Margulis V, Cadeddu JA, Pedrosa I, Williams NS, Sun X, DeBerardinis RJ, Öz OK, Zhong H, Seshagiri S, Modrusan Z, Cantarel BL, Kapur P, Brugarolas J. A renal cell carcinoma tumorgraft platform to advance precision medicine. Cell Rep 2021;37:110055. [PMID: 34818533 DOI: 10.1016/j.celrep.2021.110055] [Reference Citation Analysis]
177 Mancini M, Righetto M, Baggio G. Gender-Related Approach to Kidney Cancer Management: Moving Forward. Int J Mol Sci 2020;21:E3378. [PMID: 32397685 DOI: 10.3390/ijms21093378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
178 Phan TDA, To NT, Pham DTN. Malignant Pigmented Epithelioid Angiomyolipoma of the Kidney in a Child with Tuberous Sclerosis Complex. Fetal Pediatr Pathol 2022;:1-6. [PMID: 35735187 DOI: 10.1080/15513815.2022.2088911] [Reference Citation Analysis]
179 Zhou J, Zhao L, Yang Z, Chen Y, Wu X, Xue W. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas. BMC Urol 2022;22:109. [PMID: 35850864 DOI: 10.1186/s12894-022-01060-1] [Reference Citation Analysis]
180 Zhang J, Zhang Q, Shi Y, Wang P, Gong Y, He S, Li Z, Feng N, Wang Y, Jiang P, Ci W, Li X, Zhou L. Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma. Front Mol Biosci 2022;9:837145. [DOI: 10.3389/fmolb.2022.837145] [Reference Citation Analysis]
181 Webster NJ, Maywald RL, Benton SM, Dawson EP, Murillo OD, LaPlante EL, Milosavljevic A, Lanza DG, Heaney JD. Testicular germ cell tumors arise in the absence of sex-specific differentiation. Development 2021;148:dev197111. [PMID: 33912935 DOI: 10.1242/dev.197111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Takagi T, Yoshida K, Wada A, Kondo T, Fukuda H, Ishihara H, Kobayashi H, Iizuka J, Okumi M, Ishida H, Nagashima Y, Tanabe K. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution. Int J Clin Oncol 2020;25:892-8. [PMID: 32048086 DOI: 10.1007/s10147-020-01632-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
183 Fang A, Ferguson J. Penile Sparing Techniques For Penile Cancer. Postgrad Med 2020;132:42-51. [PMID: 32907436 DOI: 10.1080/00325481.2020.1822052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Yuan C, Xiong Z, Shi J, Peng J, Meng X, Wang C, Hu W, Ru Z, Xie K, Yang H, Chen K, Zhang X. Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition. J Cancer 2020;11:1151-61. [PMID: 31956361 DOI: 10.7150/jca.36477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
185 Al-Obaidy KI, Williamson SR, Shelman N, Idrees MT, Ulbright TM. Hepatoid Teratoma, Hepatoid Yolk Sac Tumor, and Hepatocellular Carcinoma: A Morphologic and Immunohistochemical Study of 30 Cases. Am J Surg Pathol 2021;45:127-36. [PMID: 32991342 DOI: 10.1097/PAS.0000000000001588] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Tse JR, Shen J, Yoon L, Kamaya A. Bosniak Classification Version 2019 of Cystic Renal Masses Assessed With MRI. AJR Am J Roentgenol 2020;215:413-9. [PMID: 32515608 DOI: 10.2214/AJR.19.22740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
187 Ferreira MJ, Pires-Luís AS, Vieira-Coimbra M, Costa-Pinheiro P, Antunes L, Dias PC, Lobo F, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization. Epigenetics 2017;12:1057-64. [PMID: 29099276 DOI: 10.1080/15592294.2017.1385685] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
188 Reinholdt K, Thomsen LT, Munk C, Dehlendorff C, Carstensen B, Jørgensen ME, Kjaer SK. Incidence of HPV-related Anogenital Intraepithelial Neoplasia and Cancer in Men With Diabetes Compared With the General Population. Epidemiology 2021;32:705-11. [PMID: 34039899 DOI: 10.1097/EDE.0000000000001375] [Reference Citation Analysis]
189 Stang A, McMaster ML, Sesterhenn IA, Rapley E, Huddart R, Heimdal K, McGlynn KA, Oosterhuis JW, Greene MH. Histological Features of Sporadic and Familial Testicular Germ Cell Tumors Compared and Analysis of Age-Related Changes of Histology. Cancers (Basel) 2021;13:1652. [PMID: 33916078 DOI: 10.3390/cancers13071652] [Reference Citation Analysis]
190 Berkenblit R, Ricci Z, Kanmaniraja D, Sarungbam J. CT features of acquired cystic kidney disease-associated renal cell carcinoma. Clin Imaging 2022;83:83-6. [PMID: 35007888 DOI: 10.1016/j.clinimag.2021.12.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Ornstein MC, Hutson TE. Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches. Cancer J 2020;26:441-7. [PMID: 32947312 DOI: 10.1097/PPO.0000000000000474] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Moschini M, D'andrea D, Korn S, Irmak Y, Soria F, Compérat E, Shariat SF. Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol 2017;14:651-68. [DOI: 10.1038/nrurol.2017.125] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 16.2] [Reference Citation Analysis]
193 Santoni M, Massari F, Bracarda S, Grande E, Matrana MR, Rizzo M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Molina-cerrillo J, Mollica V, Rizzo A, Battelli N. Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors. European Urology Focus 2022. [DOI: 10.1016/j.euf.2022.02.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Gao S, Ruan H, Liu J, Liu Y, Liu D, Tong J, Shi J, Yang H, Xu T, Zhang X. A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma. Front Oncol 2021;11:678694. [PMID: 34367965 DOI: 10.3389/fonc.2021.678694] [Reference Citation Analysis]
195 Costanzo M, Touzon MS, Marino R, Guercio G, Ramirez P, Mattone MC, Pérez Garrido N, Bailez MM, Vaiani E, Ciaccio M, Galluzzo Mutti ML, Belgorosky A, Berensztein E. Gonadal tumor development in 46,XX disorders of gonadal development. Eur J Endocrinol 2022;187:451-62. [PMID: 35900314 DOI: 10.1530/EJE-22-0283] [Reference Citation Analysis]
196 Wong KJ, Shusterman M, Goel S, Negassa A, Lin J, Gartrell BA. Racial Diversity Among Histology of Renal Cell Carcinoma at an Urban Medical Center. Clin Genitourin Cancer 2021;19:e166-70. [PMID: 33602582 DOI: 10.1016/j.clgc.2020.12.010] [Reference Citation Analysis]
197 Al-danakh A, Safi M, Al-radhi M, Zhu X, Yang D. Surgery improve overall and cancer-specific survival of rare urinary cancers; population - Based study. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101807] [Reference Citation Analysis]
198 Wu SC, Li XY, Liao BJ, Xie K, Chen WM. Thyroid follicular renal cell carcinoma excluding thyroid metastases: A case report . World J Clin Cases 2022; 10(18): 6307-6313 [DOI: 10.12998/wjcc.v10.i18.6307] [Reference Citation Analysis]
199 Xu C, Liang H, Zhou J, Wang Y, Liu S, Wang X, Su L, Kang X. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway. Mol Med Rep 2020;22:3677-86. [PMID: 32901847 DOI: 10.3892/mmr.2020.11490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Dolzhansky OV, Paltseva EM, Bukaeva AA, Zaklyazminskaya EV, Pominalnaya VM. [The morphological and molecular genetic characteristics of nephroblastomas in immature ovarian teratoma in adult patients]. Arkh Patol 2019;81:80-8. [PMID: 31626209 DOI: 10.17116/patol20198105180] [Reference Citation Analysis]
201 Sestakova Z, Kalavska K, Smolkova B, Miskovska V, Rejlekova K, Sycova-Mila Z, Palacka P, Obertova J, Holickova A, Hurbanova L, Jurkovicova D, Roska J, Goffa E, Svetlovska D, Chovanec M, Mardiak J, Mego M, Chovanec M. DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients. Mutat Res 2020;854-855:503200. [PMID: 32660824 DOI: 10.1016/j.mrgentox.2020.503200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Wang T, Huang Y, Huang X, Lv Z, Tian S, Ma X, Zhang X. Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report. Front Oncol 2021;11:735077. [PMID: 34722283 DOI: 10.3389/fonc.2021.735077] [Reference Citation Analysis]
203 Parker WP, Cheville JC, Frank I, Zaid HB, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. Eur Urol 2017;71:665-73. [PMID: 27287995 DOI: 10.1016/j.eururo.2016.05.034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
204 Gudapati P, Abouamara M. Clear cell renal cell carcinoma with stage IV cavoatrial tumour thrombus extension and rapid metastatic reoccurrence postsurgical treatment with review of current treatment strategies. BMJ Case Rep 2022;15:e248156. [PMID: 35296494 DOI: 10.1136/bcr-2021-248156] [Reference Citation Analysis]
205 Cantisani V, Di Leo N, Bertolotto M, Fresilli D, Granata A, Polti G, Polito E, Pacini P, Guiban O, Del Gaudio G, Dolcetti V, DʼAndrea V, Di Pierro GB, Verrengia M, Drudi FM, Catalano C. Role of multiparametric ultrasound in testicular focal lesions and diffuse pathology evaluation, with particular regard to elastography: Review of literature. Andrology 2021. [PMID: 34114745 DOI: 10.1111/andr.13067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Muselaers S, Erdem S, Bertolo R, Ingels A, Kara Ö, Pavan N, Roussel E, Pecoraro A, Marchioni M, Carbonara U, Marandino L, Amparore D, Campi R; on behalf of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature. JCM 2022;11:1829. [DOI: 10.3390/jcm11071829] [Reference Citation Analysis]
207 Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S, Zimmermann EF, Edison E, Jefferies M, Nambiar A, Mannas MP, Lee T, Marra G, Lillaz B, Gómez Rivas J, Olivier J, Assmus MA, Uçar T, Claps F, Boltri M, Burnhope T, Nkwam N, Tanasescu G, Boxall NE, Downey AP, Lal AA, Antón-Juanilla M, Clarke H, Lau DHW, Gillams K, Crockett M, Nielsen M, Takwoingi Y, Chuchu N, O'Rourke J, MacLennan G, McGrath JS, Kasivisvanathan V; IDENTIFY Study group. The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study. BJU Int 2021. [PMID: 33991045 DOI: 10.1111/bju.15483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Lobo J, Rodrigues Â, Guimarães R, Cantante M, Lopes P, Maurício J, Oliveira J, Jerónimo C, Henrique R. Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers. Cancers (Basel) 2019;11:E1535. [PMID: 31614500 DOI: 10.3390/cancers11101535] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
209 Bernard A, Teddy J, Asad H, Zarouhie B, Fatme G, Michel J. Oncocytic Papillary Renal Cell Carcinoma in an 11-year-old girl. Urology 2021:S0090-4295(21)00337-X. [PMID: 33891928 DOI: 10.1016/j.urology.2021.04.009] [Reference Citation Analysis]
210 Liu K, Liu X, Sun Q, Tang Z, Wang G, Xu Z. Construction of an individualized clinical prognostic index based on ubiquitination-associated lncRNA in clear cell renal cell carcinoma patients. World J Surg Oncol 2022;20:148. [PMID: 35538487 DOI: 10.1186/s12957-022-02618-x] [Reference Citation Analysis]
211 Simonaggio A, Ambrosetti D, Verkarre V, Auvray M, Oudard S, Vano Y. MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights. IJMS 2022;23:7649. [DOI: 10.3390/ijms23147649] [Reference Citation Analysis]
212 Fan C, Zhao C, Wang F, Li S, Wang J. Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma. Front Oncol 2019;9:357. [PMID: 31139560 DOI: 10.3389/fonc.2019.00357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
213 Safaei S, Sajed R, Saeednejad Zanjani L, Rahimi M, Fattahi F, Ensieh Kazemi-sefat G, Razmi M, Dorafshan S, Eini L, Madjd Z, Ghods R. Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma. CBM 2022. [DOI: 10.3233/cbm-210514] [Reference Citation Analysis]
214 Xiao R, Qin Y, Liu L, Chen Z, Yang B, Xu C, He W, Liu C, Ma L. Development and validation of nomogram based on a novel platelet index score to predict prognosis in patients with renal cell carcinoma. J Cancer 2021;12:6301-9. [PMID: 34659520 DOI: 10.7150/jca.60268] [Reference Citation Analysis]
215 Ni J, Cui N, Wang Y, Liu J. Case Report: Bilateral Renal Cell Carcinoma With Different Histological and Morphological Features, Clear Cell and Cystic Thyroid-Like Follicular Subtype. Front Oncol 2021;11:659706. [PMID: 33981609 DOI: 10.3389/fonc.2021.659706] [Reference Citation Analysis]
216 Pinto MT, Cárcano FM, Vieira AGS, Cabral ERM, Lopes LF. Molecular Biology of Pediatric and Adult Male Germ Cell Tumors. Cancers (Basel) 2021;13:2349. [PMID: 34068019 DOI: 10.3390/cancers13102349] [Reference Citation Analysis]
217 Martínez Chanzá N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Lancet Oncol 2019;20:581-90. [PMID: 30827746 DOI: 10.1016/S1470-2045(18)30907-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 19.7] [Reference Citation Analysis]
218 Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K. Association between tumor contact surface area and parenchymal volume change in robot‐assisted laparoscopic partial nephrectomy carried out using the enucleation technique. Int J Urol 2019;26:745-51. [DOI: 10.1111/iju.14004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Himmelman JG, Merrimen J, Matheson K, Theriault C, Wood LA. Accuracy of kidney cancer diagnosis and histological subtype within Canadian cancer registry data. Can Urol Assoc J 2017;11:E326-9. [PMID: 29382453 DOI: 10.5489/cuaj.4269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Aurilio G, Verri E, Frassoni S, Bagnardi V, Cossu Rocca M, Cullurà D, Milani M, Mascia R, Curigliano G, Orsi F, Jereczek-Fossa BA, Musi G, Omodeo Salè E, De Cobelli O, Nolè F. Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center. Am J Clin Oncol 2020;43:381-7. [PMID: 32079853 DOI: 10.1097/COC.0000000000000679] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 Lyndaker AM, Pierpont TM, Loehr AR, Weiss RS. A Genetically Engineered Mouse Model of Malignant Testicular Germ Cell Tumors. Methods Mol Biol 2021;2195:147-65. [PMID: 32852763 DOI: 10.1007/978-1-0716-0860-9_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Li D, Liu S, Xu J, Chen L, Xu C, Chen F, Xu Z, Zhang Y, Xia S, Shao Y, Wang Y. Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma. J Cell Mol Med 2021;25:3610-21. [PMID: 33728749 DOI: 10.1111/jcmm.16458] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Erlmeier F. [Chromophobe renal cell carcinoma-diagnosis and prognosis]. Pathologe 2019;40:252-8. [PMID: 31712889 DOI: 10.1007/s00292-019-00696-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
224 Lu S, Li S. Association between preoperative serum Cystatin-C levels and postsurgical oncological prognosis in patients with PRCC: A retrospective cohort study. Cancer Med 2022. [PMID: 35384340 DOI: 10.1002/cam4.4731] [Reference Citation Analysis]
225 Wu J, Xu WH, Wei Y, Qu YY, Zhang HL, Ye DW. An Integrated Score and Nomogram Combining Clinical and Immunohistochemistry Factors to Predict High ISUP Grade Clear Cell Renal Cell Carcinoma. Front Oncol 2018;8:634. [PMID: 30619768 DOI: 10.3389/fonc.2018.00634] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
226 Michael J, Velazquez N, Renson A, Tan HJ, Rose TL, Osterman C, Milowsky M, Raynor M, Kang SK, Huang WC, Bjurlin MA. Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology. Clin Genitourin Cancer 2021;19:280-7. [PMID: 33582101 DOI: 10.1016/j.clgc.2020.12.006] [Reference Citation Analysis]
227 Zhu D, Zhu L, Wu J, Wu L, Li J, Luo H, Yang K, Liu G, Quo X, Dong F, Xu J. Metanephric adenoma: association between the imaging features of contrast-enhanced ultrasound and clinicopathological characteristics. Gland Surg 2021;10:2490-9. [PMID: 34527561 DOI: 10.21037/gs-21-437] [Reference Citation Analysis]
228 Kashofer K, Winter E, Halbwedl I, Thueringer A, Kreiner M, Sauer S, Regauer S. HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common. Mod Pathol 2017;30:1013-20. [PMID: 28387325 DOI: 10.1038/modpathol.2017.26] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
229 Ciccarese C, Di Nunno V, Montironi R, Fiorentino M, Brunelli M, Tortora G, Ardizzoni A, Massari F. The role of precision medicine for the treatment of metastatic renal cell carcinoma. Expert Review of Precision Medicine and Drug Development 2016;1:369-77. [DOI: 10.1080/23808993.2016.1214057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
230 Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol 2019;37:941-6. [PMID: 31540830 DOI: 10.1016/j.urolonc.2019.07.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
231 Hu X, Yang ZQ, Dou WC, Shao YX, Wang YH, Lia T, Li X. Validation of the Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Surgically Treated Non-Metastatic Renal Cell Carcinoma. Onco Targets Ther 2020;13:8287-97. [PMID: 32903862 DOI: 10.2147/OTT.S264217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Mooney KL, Kao CS. A Contemporary Review of Common Adult Non-germ Cell Tumors of the Testis and Paratestis. Surg Pathol Clin 2018;11:739-58. [PMID: 30447839 DOI: 10.1016/j.path.2018.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
233 Tanaka T, Ueda T, Yokoyama T, Harada S, Hatakeyama K, Yoshimura A. Pseudosarcomatous myofibroblastic proliferation of the appendix with an abdominal abscess due to diverticulum perforation: a case report. Surg Case Rep 2020;6:144. [PMID: 32572649 DOI: 10.1186/s40792-020-00901-1] [Reference Citation Analysis]
234 D'souza A, Van Veldhuizen P, Fung C. Surviving Testicular Cancer: The Role of the Contralateral Testicle. J Clin Oncol 2021;39:265-8. [PMID: 33503392 DOI: 10.1200/JCO.20.03333] [Reference Citation Analysis]
235 Poprach A, Rumanova K, Lakomý R, Chloupková R, Stanik M, Pokrivcak T, Kiss I, Slaby O, Studentova H, Melichar B, Juracek J, Fiala O, Kopecky J, Kopeckova K, Zemanova M, Buchler T. Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database. Urologic Oncology: Seminars and Original Investigations 2019;37:294.e1-8. [DOI: 10.1016/j.urolonc.2018.12.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
236 Faure Conter C, Brindusa Gorduza D, Mure PY, Pracros JP, Mouriquand P, Bouvattier C, Siffroi JP, Plotton I, Gay CL, Cools M, Dijoud F. [Atypical genital development and tumor risk]. Bull Cancer 2019;106:461-7. [PMID: 30910228 DOI: 10.1016/j.bulcan.2019.01.018] [Reference Citation Analysis]
237 Feng R, Tao Y, Chen Y, Xu W, Zhang G, Wang H. Renal cancer associated with Xp11.2 translocation/TFE3 gene fusion: Clinicopathological analysis of 13 cases. Annals of Diagnostic Pathology 2022. [DOI: 10.1016/j.anndiagpath.2022.151908] [Reference Citation Analysis]
238 dos Reis AFP, Simão D, Odeny T, Rodrigues C, Fontes-sousa M, Luz RD, Chowdry RP, Welsh SJ, Paller C, Barata PC. A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer. KCA 2022. [DOI: 10.3233/kca-210012] [Reference Citation Analysis]
239 Kudryavtsev GY, Kudryavtseva LV, Mikhaleva LM, Solovieva NA, Babichenko II. [Immunohistochemical study of Ki-67, p53 and Notch1 expressions in prostate cancer of different grades]. Arkh Patol 2020;82:42-9. [PMID: 33054031 DOI: 10.17116/patol20208205142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Chang Y, Wang X, Xu Y, Yang L, Qian Q, Ju S, Chen Y, Chen S, Qin N, Ma Z, Dai J, Ma H, Jin G, Zhang E, Wang C, Hu Z. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor. Cancer Med 2019;8:3511-9. [PMID: 31070303 DOI: 10.1002/cam4.2223] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
241 Rafael TS, Rotman J, Brouwer OR, van der Poel HG, Mom CH, Kenter GG, de Gruijl TD, Jordanova ES. Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis. JCM 2022;11:1101. [DOI: 10.3390/jcm11041101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Zito Marino F, Brunelli M, Rossi G, Calabrese G, Caliò A, Nardiello P, Martignoni G, Squire JA, Cheng L, Massi D, Franco R. Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors. Expert Rev Mol Diagn 2021;21:161-73. [PMID: 33593207 DOI: 10.1080/14737159.2021.1887733] [Reference Citation Analysis]
243 Olesen TB, Sand FL, Aalborg GL, Munk C, Kjaer SK. Incidence of penile intraepithelial neoplasia and incidence and survival of penile cancer in Denmark, 1997 to 2018. Cancer Causes Control 2021. [PMID: 34698994 DOI: 10.1007/s10552-021-01510-5] [Reference Citation Analysis]
244 Buss JH, Begnini KR, Bender CB, Pohlmann AR, Guterres SS, Collares T, Seixas FK. Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer. Front Pharmacol 2017;8:977. [PMID: 29379438 DOI: 10.3389/fphar.2017.00977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
245 Win ML, Kaur D, Oyibo SO, Rajkanna J, Sagi SV. Bilateral Testicular Epidermoid Cysts in a Man with Klinefelter Syndrome: A Case Report. Cureus 2020;12:e11834. [PMID: 33274173 DOI: 10.7759/cureus.11834] [Reference Citation Analysis]
246 Milionis V, Goutas D, Vlachodimitropoulos D, Katsoulas N, Kyriazis ID, Liatsikos EN, Marinakis N, Joanne TS, Lazaris AC, Goutas N. SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation. Clin Case Rep 2021;9:e04605. [PMID: 34703596 DOI: 10.1002/ccr3.4605] [Reference Citation Analysis]
247 Yang L, Chen Y, Liu N, Lu Y, Li X, Ma W, Gan W, Li D. 5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma. Biomark Res 2022;10:54. [PMID: 35897085 DOI: 10.1186/s40364-022-00402-3] [Reference Citation Analysis]
248 Martin FC, Conduit C, Loveland KL, Thomas B, Lewin J, Tran B. Genetics of testicular cancer: a review. Curr Opin Urol 2022. [PMID: 35855571 DOI: 10.1097/MOU.0000000000001017] [Reference Citation Analysis]
249 Udare A, Walker D, Krishna S, Chatelain R, McInnes MD, Flood TA, Schieda N. Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging. Eur Radiol 2020;30:2091-102. [PMID: 31858204 DOI: 10.1007/s00330-019-06590-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
250 Rupp N, Moch H. [FH-deficient renal cell carcinoma expands the spectrum of renal papillary tumors]. Pathologe 2021;42:560-4. [PMID: 34448900 DOI: 10.1007/s00292-021-00977-y] [Reference Citation Analysis]
251 Bai Y, Wang H, Wu X, Weng M, Han Q, Xu L, Zhang H, Chang C, Jin C, Chen M, Luo K, Teng X. Study on Molecular Information Intelligent Diagnosis and Treatment of Bladder Cancer on Pathological Tissue Image. Front Med 2022;9:838182. [DOI: 10.3389/fmed.2022.838182] [Reference Citation Analysis]
252 Kaushik A, Bhartiya D. Testicular cancer in mice: interplay between stem cells and endocrine insults. Stem Cell Res Ther 2022;13:243. [PMID: 35676718 DOI: 10.1186/s13287-022-02784-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Salz HK, Dawson EP, Heaney JD. Germ cell tumors: Insights from the Drosophila ovary and the mouse testis. Mol Reprod Dev 2017;84:200-11. [PMID: 28079292 DOI: 10.1002/mrd.22779] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
254 Brodziak A, Sobczuk P, Bartnik E, Fiedorowicz M, Porta C, Szczylik C, Czarnecka AM. Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities. Nat Rev Urol 2019;16:655-73. [PMID: 31602010 DOI: 10.1038/s41585-019-0233-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
255 Defidio L, Antonucci M, De Dominicis M, Fuchs G, Patel A. Thulium-Holmium:YAG Duo Laser in Conservative Upper Tract Urothelial Cancer Treatment: 13 Years Experience from a Tertiary National Referral Center. J Endourol 2019;33:902-8. [PMID: 31422699 DOI: 10.1089/end.2019.0308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
256 Tsili AC, Andriotis E, Gkeli MG, Krokidis M, Stasinopoulou M, Varkarakis IM, Moulopoulos LA; Oncologic Imaging Subcommittee Working Group of the Hellenic Radiological Society. The role of imaging in the management of renal masses. Eur J Radiol 2021;141:109777. [PMID: 34020173 DOI: 10.1016/j.ejrad.2021.109777] [Reference Citation Analysis]
257 Dalakoti P, Pujary K, Ramaswamy B. Sinonasal Metastatic Renal Cell Carcinoma: A Report of Two Cases with Varied Presentation and a Review of Literature. Indian J Otolaryngol Head Neck Surg 2019;71:2072-7. [PMID: 31763296 DOI: 10.1007/s12070-018-1475-4] [Reference Citation Analysis]
258 Roška J, Wachsmannová L, Hurbanová L, Šestáková Z, Mueller T, Jurkovičová D, Chovanec M. Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines. Oncotarget 2020;11:4735-53. [PMID: 33473258 DOI: 10.18632/oncotarget.27844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
259 Pohl L, Friedhoff J, Jurcic C, Teroerde M, Schindler I, Strepi K, Schneider F, Kaczorowski A, Hohenfellner M, Duensing A, Duensing S. Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities. Front Oncol 2022;12:889686. [PMID: 35619925 DOI: 10.3389/fonc.2022.889686] [Reference Citation Analysis]
260 Skala SL, Xiao H, Udager AM, Dhanasekaran SM, Shukla S, Zhang Y, Landau C, Shao L, Roulston D, Wang L, Siddiqui J, Cao X, Magi-galluzzi C, Zhang M, Osunkoya AO, Smith SC, Mckenney JK, Betz BL, Myers JL, Chinnaiyan AM, Tomlins SA, Mehra R. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod Pathol 2018;31:179-97. [DOI: 10.1038/modpathol.2017.99] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
261 Tsimafeyeu I. Management of non–clear cell renal cell carcinoma: Current approaches. Urologic Oncology: Seminars and Original Investigations 2017;35:5-13. [DOI: 10.1016/j.urolonc.2016.07.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
262 Griffin BB, Lin X. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features. Cancer Cytopathol 2021;129:192-203. [PMID: 33036062 DOI: 10.1002/cncy.22355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
263 Ward RD, Remer EM. Cystic renal masses: An imaging update. European Journal of Radiology 2018;99:103-10. [DOI: 10.1016/j.ejrad.2017.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
264 Chen Y, Yang L, Lu Y, Liu N, Ma W, Fan H, Hu Q, Han X, Gan W, Li D. Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma. Cancer Lett 2022;:215689. [PMID: 35447281 DOI: 10.1016/j.canlet.2022.215689] [Reference Citation Analysis]
265 Sarkany B, Kovacs G, Banyai D. Ureteric Bud-derivatives in Wilms Tumor and Nephrogenic Rest. In Vivo 2021;35:2159-62. [PMID: 34182492 DOI: 10.21873/invivo.12486] [Reference Citation Analysis]
266 Costa AL, Lobo J, Jerónimo C, Henrique R. The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers. Epigenomics 2017;9:155-69. [PMID: 28097877 DOI: 10.2217/epi-2016-0081] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
267 Morais M, Dias F, Teixeira AL, Medeiros R. Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney. Cancer Manag Res 2020;12:1669-79. [PMID: 32184670 DOI: 10.2147/CMAR.S211225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
268 Liu Z, Wan Y, Yang M, Qi X, Dong Z, Huang J, Xu J. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas. Cancer Cell Int 2020;20:235. [PMID: 32536823 DOI: 10.1186/s12935-020-01331-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
269 Sanguedolce F, Calò B, Chirico M, Falagario U, Busetto GM, Zanelli M, Bisagni A, Zizzo M, Ascani S, Carrieri G, Cormio L. Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern. J Pathol Transl Med 2021;55:239-46. [PMID: 34111910 DOI: 10.4132/jptm.2021.04.20] [Reference Citation Analysis]
270 Santoni M, Massari F, Grande E, Procopio G, Matrana MR, Rizzo M, De Giorgi U, Basso U, Milella M, Iacovelli R, Aurilio G, Incorvaia L, Buti S, Caffo O, Fornarini G, Carrozza F, Mollica V, Rizzo A, Farag F, Molina-Cerrillo J, Battelli N. Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study. Target Oncol 2021. [PMID: 34338966 DOI: 10.1007/s11523-021-00828-z] [Reference Citation Analysis]
271 Choi TS, Lee DG, Won KY, Min GE. Tubulocystic Renal Cell Carcinoma Is Not an Indolent Tumor: A Case Report of Recurrences in the Retroperitoneum and Contralateral Kidney. Medicina (Kaunas) 2021;57:851. [PMID: 34441057 DOI: 10.3390/medicina57080851] [Reference Citation Analysis]
272 Krishna S, Schieda N, Pedrosa I, Hindman N, Baroni RH, Silverman SG, Davenport MS. Update on MRI of Cystic Renal Masses Including Bosniak Version 2019. J Magn Reson Imaging 2021;54:341-56. [PMID: 33009722 DOI: 10.1002/jmri.27364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
273 Friedrich M, Stoehr C, Jasinski-Bergner S, Hartmann A, Wach S, Wullich B, Steven A, Seliger B. Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. J Transl Med 2020;18:371. [PMID: 32993793 DOI: 10.1186/s12967-020-02544-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
274 Park I, Shim YS, Go H, Hong BS, Lee JL. Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. BMC Urol 2019;19:51. [PMID: 31182090 DOI: 10.1186/s12894-019-0484-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
275 Mollica V, Franceschini T, Gruppioni E, Rizzo A, Ricci C, Schiavina R, Brunocilla E, Ardizzoni A, Fiorentino M, Giunchi F, Massari F. Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing. Pathol Res Pract 2021;219:153350. [PMID: 33556910 DOI: 10.1016/j.prp.2021.153350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
276 Raszewski Ł, Chyrek AJ, Marciniak M, Burchardt WM, Biele da GM, Chicheł A. High-dose-rate surface brachytherapy as a treatment option for renal cell carcinoma cutaneous metastases. J Contemp Brachytherapy 2021;13:331-7. [PMID: 34122574 DOI: 10.5114/jcb.2021.105947] [Reference Citation Analysis]
277 Gansler T, Fedewa S, Amin MB, Lin CC, Jemal A. Trends in reporting histological subtyping of renal cell carcinoma: association with cancer center type. Hum Pathol 2018;74:99-108. [PMID: 29339177 DOI: 10.1016/j.humpath.2018.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
278 Shi SN, Qin X, Wang S, Wang WF, Zhu YF, Lin Y, Zhou ZL, Shi BK, Liu XG. Identification of potential novel differentially-expressed genes and their role in invasion and migration in renal cell carcinoma. Aging (Albany NY) 2020;12:9205-23. [PMID: 32420905 DOI: 10.18632/aging.103192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
279 Jiang T, Li W, Lin D, Wang J, Liu F, Ding Z. Imaging features of metanephric adenoma and their pathological correlation. Clin Radiol 2019;74:408.e9-408.e17. [PMID: 30803811 DOI: 10.1016/j.crad.2019.01.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
280 Zhu P, Duan Y, Ao Q, Wang G. Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review. Cancer Res Treat 2018;50:1452-7. [PMID: 29169232 DOI: 10.4143/crt.2017.414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
281 Lebacle C, Pooli A, Bessede T, Irani J, Pantuck AJ, Drakaki A. Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art. World J Urol 2019;37:115-23. [PMID: 29858701 DOI: 10.1007/s00345-018-2355-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
282 Robila V, Kraft AO, Smith SC. New entities, new technologies, new findings: A review of the cytologic features of recently established subtypes of renal cell carcinoma. Cancer Cytopathol 2019;127:79-97. [PMID: 30690877 DOI: 10.1002/cncy.22093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
283 Wen YC, Lin YW, Chu CY, Yang YC, Yang SF, Liu YF, Hsiao M, Lee WJ, Chien MH. Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma. J Pineal Res 2020;69:e12668. [PMID: 32408377 DOI: 10.1111/jpi.12668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
284 Wu CY, Li L, Chen SL, Yang X, Zhang CZ, Cao Y. A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma. Cell Death Dis 2021;12:319. [PMID: 33767130 DOI: 10.1038/s41419-021-03617-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 van der Beek JN, Hol JA, Coulomb-l'Hermine A, Graf N, van Tinteren H, Pritchard-Jones K, Houwing ME, de Krijger RR, Vujanic GM, Dzhuma K, Schenk JP, Littooij AS, Ramírez-Villar GL, Murphy D, Ray S, Al-Saadi R, Gessler M, Godzinski J, Ruebe C, Collini P, Verschuur AC, Frisk T, Vokuhl C, Hulsbergen-van de Kaa CA, de Camargo B, Sandstedt B, Selle B, Tytgat GAM, van den Heuvel-Eibrink MM. Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study Group. Int J Cancer 2021;148:2724-35. [PMID: 33460450 DOI: 10.1002/ijc.33476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
286 Xu H, Li Z, Cui F, Zhang Y, Yan D, Zhang Y. Imaging features of eosinophilic solid and cystic renal cell carcinoma: An additional case report of a novel tumor entity. Urology Case Reports 2022;42:102042. [DOI: 10.1016/j.eucr.2022.102042] [Reference Citation Analysis]
287 Hanusek K, Poletajew S, Kryst P, Piekiełko-witkowska A, Bogusławska J. piRNAs and PIWI Proteins as Diagnostic and Prognostic Markers of Genitourinary Cancers. Biomolecules 2022;12:186. [DOI: 10.3390/biom12020186] [Reference Citation Analysis]
288 Zhao Y, Chen H, Xie Y, Zhang C, Hou Y, Jin M. Clinicopathologic features and prognostic factors in patients with renal cell carcinoma with sarcomatoid differentiation. APMIS 2020;128:378-86. [PMID: 32048364 DOI: 10.1111/apm.13035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
289 Saeednejad Zanjani L, Madjd Z, Abolhasani M, Rasti A, Shariftabrizi A, Mehrazma M, Fodstad Ø, Asgari M. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma. Pathology 2019;51:21-31. [PMID: 30466948 DOI: 10.1016/j.pathol.2018.08.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
290 Marchetti A, Rosellini M, Rizzo A, Mollica V, Battelli N, Massari F, Santoni M. An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma. Expert Opin Pharmacother 2021;22:2323-36. [PMID: 34405738 DOI: 10.1080/14656566.2021.1959548] [Reference Citation Analysis]
291 Lian B, Zhang W, Wang T, Yang Q, Jia Z, Chen H, Wang L, Xu J, Wang W, Cao K, Gao X, Sun Y, Shao C, Liu Z, Li J. Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory Testicular Tumors. Oncologist 2019;24:e1437-42. [PMID: 31492770 DOI: 10.1634/theoncologist.2019-0295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
292 Wang H, Fan Y, Chen W, Lv Z, Wu S, Xuan Y, Wang C, Lu Y, Guo T, Shen D, Zhang F, Huang Q, Gao Y, Li H, Ma X, Wang B, Huang Y, Zhang X. Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity. Oncoimmunology 2022;11:2011673. [PMID: 35024247 DOI: 10.1080/2162402X.2021.2011673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
293 Hwang C. Genitourinary Pathology Reporting Parameters Most Relevant to the Medical Oncologist. Surg Pathol Clin 2018;11:877-91. [PMID: 30447846 DOI: 10.1016/j.path.2018.07.009] [Reference Citation Analysis]
294 Furubayashi N, Negishi T, Sakamoto N, Shimokawa H, Morokuma F, Song Y, Hori Y, Tomoda T, Tokuda N, Seki N, Kuroiwa K, Nakamura M. Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy. Onco Targets Ther 2021;14:1981-8. [PMID: 33776447 DOI: 10.2147/OTT.S299724] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Kooij CD, Hulsker CC, Kranendonk ME, Zsiros J, Littooij AS, Looijenga LH, Klijn AJ, Mavinkurve-groothuis AM. Evaluation of an Algorithm for Testis-Sparing Surgery in Boys with Testicular Tumors: A Retrospective Cohort Study. Surgeries 2021;2:9-19. [DOI: 10.3390/surgeries2010002] [Reference Citation Analysis]
296 Shigeta K, Matsumoto K, Abe T, Komatsuda A, Takeda T, Mizuno R, Kikuchi E, Asanuma H, Arita Y, Akita H, Jinzaki M, Miyajima A, Oya M. The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm. Asian J Surg 2020;43:668-75. [PMID: 31629637 DOI: 10.1016/j.asjsur.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
297 Massari F, Nunno VD, Mollica V, Montironi R, Cheng L, Cimadamore A, Blanca A, Lopez-Beltran A. Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice. Immunotherapy 2019;11:1507-21. [PMID: 31663411 DOI: 10.2217/imt-2019-0115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
298 Verkarre V, Morini A, Denize T, Ferlicot S, Richard S. [Hereditary kidney cancers: The pathologist's view in 2020]. Ann Pathol 2020;40:148-67. [PMID: 32197858 DOI: 10.1016/j.annpat.2020.02.022] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Li X, Song D, Liu H, Wang Z, Ma G, Yu M, Zhang Y, Zeng Y. Expression levels of VEGF-C and VEGFR-3 in renal cell carcinoma and their association with lymph node metastasis. Exp Ther Med 2021;21:554. [PMID: 33850526 DOI: 10.3892/etm.2021.9986] [Reference Citation Analysis]
300 Hou G, Zhao D, Jiang Y, Zhu Z, Huo L, Li F, Cheng W. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma. Cancer Imaging 2021;21:25. [PMID: 33632314 DOI: 10.1186/s40644-021-00393-8] [Reference Citation Analysis]
301 Takagi T, Yoshida K, Kondo T, Fukuda H, Ishihara H, Kobayashi H, Iizuka J, Ishida H, Tanabe K. Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy. Jpn J Clin Oncol 2021:hyab141. [PMID: 34487184 DOI: 10.1093/jjco/hyab141] [Reference Citation Analysis]
302 Straub Hogan MM, Spieker AJ, Orejudos M, Gheit T, Herfs M, Tommasino M, Sanchez DF, Fernandez-Nestosa MJ, Pena MDCR, Gordetsky JB, Epstein JI, Canete-Portillo S, Gellert LL, Prieto Granada CN, Magi-Galluzzi C, Cubilla AL, Giannico GA. Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series. Mod Pathol 2022. [PMID: 35190664 DOI: 10.1038/s41379-022-01020-y] [Reference Citation Analysis]
303 Genco IS, Ratzon F, Glickman L, Santagada E, Unger P. Intratubular Teratoma: A Rare Form of Testicular Germ Cell Neoplasia. Int J Surg Pathol 2019;27:556-60. [PMID: 30907201 DOI: 10.1177/1066896919836491] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Dai C, Huang J, Li Y, Zhang S, Tan Q, Hou J, Tang Q, Hu X, Guo J, Zeng M, Wang H, Zhou J. Tumor contour irregularity on preoperative imaging: a practical and useful prognostic parameter for papillary renal cell carcinoma. Eur Radiol 2021;31:3745-53. [PMID: 33211144 DOI: 10.1007/s00330-020-07456-7] [Reference Citation Analysis]
305 Mehra R, Vats P, Cao X, Su F, Lee ND, Lonigro R, Premkumar K, Trpkov K, McKenney JK, Dhanasekaran SM, Chinnaiyan AM. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. Eur Urol 2018;74:483-6. [PMID: 29941307 DOI: 10.1016/j.eururo.2018.06.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
306 Huang C, Yuan N, Wu L, Wang X, Dai J, Song P, Li F, Xu C, Zhao X. An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma. Onco Targets Ther 2017;10:4037-50. [PMID: 28860812 DOI: 10.2147/OTT.S141951] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
307 Francolini G, Trodella LE, Marvaso G, Matrone F, Nicosia L, Timon G, Ognibene L, Vinciguerra A, Franzese C, Borghetti P, Arcangeli S. Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario. Int J Clin Oncol 2021. [PMID: 34273014 DOI: 10.1007/s10147-021-01989-7] [Reference Citation Analysis]
308 Shu J, Wen D, Xi Y, Xia Y, Cai Z, Xu W, Meng X, Liu B, Yin H. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade. Eur J Radiol 2019;121:108738. [PMID: 31756634 DOI: 10.1016/j.ejrad.2019.108738] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
309 Li Q, Mou Z, Yang K, Jiang H. A first case report of primary epithelial myoepithelial carcinoma-like renal tumor showing a perivascular pseudorosette-like pattern: Description of morphologic, immunohistochemical, and genetic features. Medicine (Baltimore) 2019;98:e17245. [PMID: 31574838 DOI: 10.1097/MD.0000000000017245] [Reference Citation Analysis]
310 Wang R, Hu Z, Shen X, Wang Q, Zhang L, Wang M, Feng Z, Chen F. Computed Tomography-Based Radiomics Model for Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Preoperatively: A Multicenter Study. Front Oncol 2021;11:543854. [PMID: 33718124 DOI: 10.3389/fonc.2021.543854] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 Zhu H, Lu J, Zhao H, Chen Z, Cui Q, Lin Z, Wang X, Wang J, Dong H, Wang S, Tan J. Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network. Med Sci Monit 2018;24:8250-63. [PMID: 30444862 DOI: 10.12659/MSM.910773] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
312 Honda Y, Nakamura Y, Goto K, Terada H, Sentani K, Yasui W, Sekino Y, Hayashi T, Teishima J, Matsubara A, Akagi M, Fuji T, Baba Y, Iida M, Awai K. Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis. Abdom Radiol (NY) 2018;43:1540-5. [PMID: 29796844 DOI: 10.1007/s00261-018-1643-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
313 He Z, Sun M, Ke Y, Lin R, Xiao Y, Zhou S, Zhao H, Wang Y, Zhou F, Zhou Y. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis. Oncotarget 2017;8:27904-14. [PMID: 28427189 DOI: 10.18632/oncotarget.15842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
314 Xu P, Zhang S, Cao B, Li Y, Huang J, Lin W, Cheng J, Li H, Chen W, Zhu Y, Jiang S, Hu X, Wu J, Wu Z, Zhou J, Guo J, Wang H. Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study. Urol Oncol 2022;40:199.e1-8. [PMID: 35365414 DOI: 10.1016/j.urolonc.2022.02.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Li G, Zhu D, Gao H, Chen H, Li Y, Niu Y. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma. Clin Transl Oncol 2019;21:760-5. [PMID: 30443869 DOI: 10.1007/s12094-018-1984-3] [Reference Citation Analysis]
316 Pham QT, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, Sakamoto N, Sentani K, Oue N, Yasui W. Clinicopathologic features of TDO2 overexpression in renal cell carcinoma. BMC Cancer 2021;21:737. [PMID: 34174844 DOI: 10.1186/s12885-021-08477-1] [Reference Citation Analysis]
317 Wolf MM, Kimryn Rathmell W, Beckermann KE. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene 2020;39:3413-26. [PMID: 32123314 DOI: 10.1038/s41388-020-1234-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
318 Hrudka J, Eis V, Šach J, Klézl P, Schilling S, Bandke D. [Two synchronous malignancies in a single nephrectomy specimen]. Pathologe 2018;39:65-70. [PMID: 29209798 DOI: 10.1007/s00292-017-0401-y] [Reference Citation Analysis]
319 Neumann JM, Niehaus K, Neumann N, Knobloch HC, Bremmer F, Krafft U, Kellner U, Nyirády P, Szarvas T, Bednarz H, Reis H. A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer. Lab Invest 2021;101:1281-8. [PMID: 34021261 DOI: 10.1038/s41374-021-00612-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Yang C, Shuch B, Kluger H, Humphrey PA, Adeniran AJ. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis. Am J Surg Pathol 2020;44:582-93. [PMID: 32101890 DOI: 10.1097/PAS.0000000000001455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
321 Inamura K. Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification. Oncotarget 2018;9:14723-37. [PMID: 29581876 DOI: 10.18632/oncotarget.24515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
322 Agnello F, Albano D, Micci G, Di Buono G, Agrusa A, Salvaggio G, Pardo S, Sparacia G, Bartolotta TV, Midiri M, Lagalla R, Galia M. CT and MR imaging of cystic renal lesions. Insights Imaging 2020;11:5. [PMID: 31900669 DOI: 10.1186/s13244-019-0826-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
323 Ged Y, Chen YB, Knezevic A, Donoghue MTA, Carlo MI, Lee CH, Feldman DR, Patil S, Hakimi AA, Russo P, Voss MH, Motzer RJ. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes. Clin Genitourin Cancer 2019;17:268-274.e1. [PMID: 31151928 DOI: 10.1016/j.clgc.2019.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
324 Liu K, Li Z, Ruan D, Wang H, Wang W, Zhang G. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma. Front Genet 2022;13:890641. [DOI: 10.3389/fgene.2022.890641] [Reference Citation Analysis]
325 Yang W, Li L, Zhang K, Ma K, Gong Y, Zhou J, Gong K. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma. Epigenomics 2021;13:31-45. [PMID: 33203244 DOI: 10.2217/epi-2020-0256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
326 Cimadamore A, Cheng L, Scarpelli M, Massari F, Mollica V, Santoni M, Lopez-Beltran A, Montironi R, Moch H. Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review. Transl Androl Urol 2021;10:1506-20. [PMID: 33850785 DOI: 10.21037/tau-20-1150] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
327 Hu D, Meng N, Lou X, Li Z, Teng Y, Tu B, Zou Y, Wang F. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis. Int J Gen Med 2021;14:3593-609. [PMID: 34295182 DOI: 10.2147/IJGM.S321585] [Reference Citation Analysis]
328 Ma W, Zhang F, Huang H, Wang W, Zhu Y, Lu Y, Guo H, Gan W. Contrast-Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma: Differential Diagnosis With Three Main Renal Cell Carcinoma Subtypes. J Ultrasound Med 2022. [PMID: 35103338 DOI: 10.1002/jum.15951] [Reference Citation Analysis]
329 Beserra AO, Estevan EC, Bezerra SM, Torrezan GT, Ikegami A, Dellê H, Cunha IW, Meira IT, Carraro DM, Lara PN, Zequi SC, Martins VR, Santos TG. Patient-Derived Renal Cell Carcinoma Xenografts Capture Tumor Genetic Profiles and Aggressive Behaviors. KCA 2022. [DOI: 10.3233/kca-210011] [Reference Citation Analysis]
330 Kremer L, von Brandenstein M, Wittersheim M, Koeditz B, Paffenholz P, Hellmich M, Pfister D, Heidenreich A, Nestler T. The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens. Transl Androl Urol 2021;10:1647-55. [PMID: 33968653 DOI: 10.21037/tau-20-1349] [Reference Citation Analysis]
331 Masuo Y, Taniguchi H, Matsuzaki T, Kinoshita H, Miyasaka C, Ohe C, Matsuda T. Robot-assisted laparoscopic vesicule prostatectomy for mixed epithelial-stromal tumor of seminal vesicle. IJU Case Rep 2020;3:103-7. [PMID: 32743484 DOI: 10.1002/iju5.12157] [Reference Citation Analysis]
332 Le X, Wang XB, Zhao H, Chen RF, Ge P. Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma. BMC Urol 2020;20:148. [PMID: 32933514 DOI: 10.1186/s12894-020-00716-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
333 Mouallem NE, Smith SC, Paul AK. Sarcomatoid renal cell carcinoma: Biology and treatment advances. Urol Oncol 2018;36:265-71. [PMID: 29306556 DOI: 10.1016/j.urolonc.2017.12.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
334 Adami BS, Diz FM, Oliveira Gonçalves GP, Reghelin CK, Scherer M, Dutra AP, Papaléo RM, de Oliveira JR, Morrone FB, Wieck A, Xavier LL. Morphological and mechanical changes induced by quercetin in human T24 bladder cancer cells. Micron 2021;151:103152. [PMID: 34607251 DOI: 10.1016/j.micron.2021.103152] [Reference Citation Analysis]
335 Calò B, Chirico M, Fortunato F, Sanguedolce F, Carvalho-Dias E, Autorino R, Carrieri G, Cormio L. Is Repeat Transurethral Resection Always Needed in High-Grade T1 Bladder Cancer? Front Oncol 2019;9:465. [PMID: 31214506 DOI: 10.3389/fonc.2019.00465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
336 Fu G, Xu Z, Chen X, Pan H, Wang Y, Jin B. CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation. J Cancer 2020;11:2408-20. [PMID: 32201512 DOI: 10.7150/jca.35372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
337 Xie Z, Yadav S, Lohse CM, Cheville JC, Pagliaro LC, Shah PH, Boorjian SA, Thompson H, Leibovich BC, Costello BA. Collecting duct carcinoma: A single-institution retrospective study. Urol Oncol 2021:S1078-1439(21)00446-4. [PMID: 34750052 DOI: 10.1016/j.urolonc.2021.09.019] [Reference Citation Analysis]
338 Casey RT, Warren AY, Martin JE, Challis BG, Rattenberry E, Whitworth J, Andrews KA, Roberts T, Clark GR, West H, Smith PS, Docquier FM, Rodger F, Murray V, Simpson HL, Wallis Y, Giger O, Tran M, Tomkins S, Stewart GD, Park SM, Woodward ER, Maher ER. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review. J Clin Endocrinol Metab 2017;102:4013-22. [PMID: 28973655 DOI: 10.1210/jc.2017-00562] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
339 Hatayama T, Sekino Y, Shikuma H, Mukai S, Muto M, Miyamoto S, Sadahide K, Fukuoka K, Fuji S, Goto K, Shinmei S, Hieda K, Inoue S, Hayashi T, Teishima J, Kuroda N, Sentani K, Yasui W, Matsubara A. Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade. IJU Case Rep 2019;2:193-6. [PMID: 32743410 DOI: 10.1002/iju5.12075] [Reference Citation Analysis]
340 Wang X, Song G, Jiang H, Zheng L, Pang P, Xu J. Can texture analysis based on single unenhanced CT accurately predict the WHO/ISUP grading of localized clear cell renal cell carcinoma? Abdom Radiol (NY) 2021;46:4289-300. [PMID: 33909090 DOI: 10.1007/s00261-021-03090-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
341 Marchetti A, Rosellini M, Mollica V, Rizzo A, Tassinari E, Nuvola G, Cimadamore A, Santoni M, Fiorentino M, Montironi R, Massari F. The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? Int J Mol Sci 2021;22:6237. [PMID: 34207825 DOI: 10.3390/ijms22126237] [Reference Citation Analysis]
342 Behera P, Ahuja A, Bhardwaj M. Pure yolk sac tumor of testis with lung metastasis in an adult patient - case report. Med Pharm Rep 2021;94:252-5. [PMID: 34013198 DOI: 10.15386/mpr-1470] [Reference Citation Analysis]
343 Lian BJ, Zhang K, Fang XD, Li F, Dai Z, Chen WY, Qi XP. Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review. Front Oncol 2022;12:927250. [PMID: 35875073 DOI: 10.3389/fonc.2022.927250] [Reference Citation Analysis]
344 Ciarimboli G, Theil G, Bialek J, Edemir B. Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32772272 DOI: 10.1007/112_2020_34] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
345 Ma Y, Hao J, Yin H, Zhu M, Guan B, Zhu C, Dong B, Zhao S, He Z, Yang T. A laparoscopic radical inguinal lymphadenectomy approach partly preserving great saphenous vein branches can benefit for patients with penile carcinoma. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01582-3] [Reference Citation Analysis]
346 Hasan A, Abozied H, Youssef A, Fayad S, Ismail A. A rare case of collecting duct carcinoma with first presentation of respiratory symptoms. Urol Case Rep 2020;33:101367. [PMID: 33102066 DOI: 10.1016/j.eucr.2020.101367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
347 Duan C, Li N, Niu L, Wang G, Zhao J, Liu F, Liu X, Ren Y, Zhou X. CT texture analysis for the differentiation of papillary renal cell carcinoma subtypes. Abdom Radiol (NY) 2020;45:3860-8. [PMID: 32444891 DOI: 10.1007/s00261-020-02588-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
348 Brito HO, Calixto JRR, Medeiros R, da Costa RMG. Comment on DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells. Transl Oncol 2022;16:101326. [PMID: 34974279 DOI: 10.1016/j.tranon.2021.101326] [Reference Citation Analysis]
349 Peng Y, Greenland NY, Lang UE, Stohr BA. LZTS2, a Novel and Independent Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153831] [Reference Citation Analysis]
350 Sobottka B, Lorch A, Silina K, van den Broek M, Moch H. Renal cell carcinoma pathology in 2021: 'new need for renal cancer immune profiling'. Curr Opin Urol 2021;31:228-35. [PMID: 33742986 DOI: 10.1097/MOU.0000000000000864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Chong WC, Cain JE. Lessons learned from the developmental origins of childhood renal cancer. Anat Rec 2020;303:2561-77. [DOI: 10.1002/ar.24315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
352 Nicolai N, Catanzaro M, Zazzara M. The role of surgery in metastatic squamous cell carcinoma of the penis. Current Opinion in Urology 2016;26:596-601. [DOI: 10.1097/mou.0000000000000328] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
353 Gu YY, Chen G, Lin P, Cheng JW, Huang ZG, Luo J, Zhai GQ, Wang YL, Yan HB, Li SH. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma. Cancer Biomark 2020;27:265-75. [PMID: 31929144 DOI: 10.3233/CBM-191017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
354 Zou X, Guo B, Ling Q, Mo Z. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation. Front Mol Biosci 2022;9:832238. [DOI: 10.3389/fmolb.2022.832238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
355 Canto LM, da Silva JM, Castelo-branco PV, da Silva IM, Nogueira L, Fonseca-alves CE, Khayat A, Birbrair A, Pereira SR. Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients. Cancers 2022;14:3514. [DOI: 10.3390/cancers14143514] [Reference Citation Analysis]
356 Dauendorffer JN, Renaud-Vilmer C, Cavelier Balloy B, Meria P, Desgrandchamps F, Bagot M. [Penile intra-epithelial neoplasia]. Prog Urol 2018;28:466-74. [PMID: 29937064 DOI: 10.1016/j.purol.2018.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
357 Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilligan T, Looijenga LHJ. Testicular cancer. Nat Rev Dis Primers 2018;4:29. [PMID: 30291251 DOI: 10.1038/s41572-018-0029-0] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 30.0] [Reference Citation Analysis]
358 Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Tamura S, Kuroiwa K, Seki N, Fujimoto N, Nakamura M. The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab. Cancer Manag Res 2021;13:8049-56. [PMID: 34729023 DOI: 10.2147/CMAR.S333823] [Reference Citation Analysis]
359 Zou J, Huang R, Chen Y, Huang X, Li H, Liang P, Chen S. Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial-Mesenchymal Transition. Front Cell Dev Biol 2021;9:641432. [PMID: 34295887 DOI: 10.3389/fcell.2021.641432] [Reference Citation Analysis]
360 Lobo J, Costa AL, Cantante M, Guimarães R, Lopes P, Antunes L, Braga I, Oliveira J, Pelizzola M, Henrique R, Jerónimo C. m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance. J Transl Med 2019;17:79. [PMID: 30866959 DOI: 10.1186/s12967-019-1837-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
361 Shu J, Tang Y, Cui J, Yang R, Meng X, Cai Z, Zhang J, Xu W, Wen D, Yin H. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade. Eur J Radiol 2018;109:8-12. [PMID: 30527316 DOI: 10.1016/j.ejrad.2018.10.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 12.5] [Reference Citation Analysis]
362 Monteiro-Reis S, Lobo J, Henrique R, Jerónimo C. Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer. Int J Mol Sci 2019;20:E297. [PMID: 30642115 DOI: 10.3390/ijms20020297] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
363 Xing Z, Guo G, Pan X, Xu L, Guo C, An R. The Association Between hMLH1 and hMSH2 Polymorphisms and Renal Tumors in Northeastern China. Genet Test Mol Biomarkers 2019;23:573-9. [PMID: 31373852 DOI: 10.1089/gtmb.2019.0011] [Reference Citation Analysis]
364 Khochikar M. Newly Proposed Prognostic Grade Group System for Prostate Cancer: Genesis, Utility and its Implications in Clinical Practice. Curr Urol Rep 2016;17:80. [PMID: 27659696 DOI: 10.1007/s11934-016-0635-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Ciccarese C, Iacovelli R, Brunelli M, Massari F, Bimbatti D, Fantinel E, De Marco V, Porcaro AB, Martignoni G, Artibani W, Tortora G. Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies. Eur J Cancer 2017;83:237-46. [PMID: 28756136 DOI: 10.1016/j.ejca.2017.06.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
366 Zhang C, Li L, Zhang Y, Zeng C. Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment. Front Oncol 2021;11:686556. [PMID: 34113573 DOI: 10.3389/fonc.2021.686556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
367 Bryce AH, Egan JB, Smadbeck JB, Johnson SH, Murphy SJ, Harris FR, Halling GC, Terra SBSP, Cheville J, Pagliaro L, Leibovich B, Costello BA, Vasmatzis G. Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Sci Rep 2019;9:3586. [PMID: 30837548 DOI: 10.1038/s41598-019-39956-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
368 Kalarakis G, Brehmer K, Svensson A, Axelsson R, Brismar TB, Tzortzakakis A. Combining contrast-enhanced ultrasound, CT perfusion and 99mTc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour. BJR Case Rep 2021;7:20200115. [PMID: 33614118 DOI: 10.1259/bjrcr.20200115] [Reference Citation Analysis]
369 Liu YJ, Houldsworth J, Emmadi R, Dyer L, Wolff DJ. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet 2020;244:40-54. [PMID: 32434132 DOI: 10.1016/j.cancergen.2020.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
370 Kim SH, Park WS, Chung J. SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investig Clin Urol 2019;60:148-55. [PMID: 31098421 DOI: 10.4111/icu.2019.60.3.148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
371 Xie Y, Shangguan W, Chen Z, Zheng Z, Chen Y, Zhong Q, Zhang Y, Yang J, Zhu D, Xie W. Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways. DDDT 2021;Volume 15:5061-74. [DOI: 10.2147/dddt.s343718] [Reference Citation Analysis]
372 Alkhouli MA, Bazargan S, Pilon-Thomas S, Poch M, Chahoud J. Current State of Cell Therapies for Genitourinary Malignancies. Cancer J 2022;28:294-300. [PMID: 35880939 DOI: 10.1097/PPO.0000000000000604] [Reference Citation Analysis]
373 Debien V, Thouvenin J, Lindner V, Barthélémy P, Lang H, Flippot R, Malouf GG. Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities. Cancers (Basel) 2019;12:E99. [PMID: 31906050 DOI: 10.3390/cancers12010099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
374 Sharma A, Nagalli S, Varughese AT, Ayvazian AM. A Review of the Diagnostic Use of Fine-needle Aspiration Cytology for Tuberculosis Epididymo-orchitis: To Do or Not to Do. Cureus 2020;12:e6532. [PMID: 32038890 DOI: 10.7759/cureus.6532] [Reference Citation Analysis]
375 Casuscelli J, Becerra MF, Seier K, Manley BJ, Benfante N, Redzematovic A, Stief CG, Hsieh JJ, Tickoo SK, Reuter VE, Coleman JA, Russo P, Ostrovnaya I, Hakimi AA. Chromophobe renal cell carcinoma: results from a large single-institution series. Clin Genitourin Cancer 2019; 17: 373-379. e4. [PMID: 31326335 DOI: 10.1016/j.clgc.2019.06.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
376 Cieri M, Contieri R, De Carlo C, Lughezzani G, Maffei D, Colombo P. Delayed Diagnosis of a Testicular Mass During COVID-19 Pandemic in Lombardy: A Case Report. Res Rep Urol 2021;13:41-4. [PMID: 33537246 DOI: 10.2147/RRU.S297880] [Reference Citation Analysis]
377 Lawrence MG, Porter LH, Clouston D, Murphy DG, Frydenberg M, Taylor RA, Risbridger GP. Knowing what's growing: Why ductal and intraductal prostate cancer matter. Sci Transl Med 2020;12:eaaz0152. [PMID: 32132214 DOI: 10.1126/scitranslmed.aaz0152] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
378 Whooley PD, Flores JP, Fotoohi M, Lin BS. Palliative TACE for hepatic metastases of chromophobe renal cell carcinoma. BMJ Case Rep 2019;12:e229207. [PMID: 31308185 DOI: 10.1136/bcr-2019-229207] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
379 Singh NP, Vinod PK. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. Mol Genet Genomics 2020;295:807-24. [PMID: 32185457 DOI: 10.1007/s00438-020-01664-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
380 Cheng J, Han Z, Mehra R, Shao W, Cheng M, Feng Q, Ni D, Huang K, Cheng L, Zhang J. Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma. Nat Commun 2020;11:1778. [PMID: 32286325 DOI: 10.1038/s41467-020-15671-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
381 Nogueira I, Dias F, Morais M, Teixeira AL, Medeiros R. Everolimus resistance in clear cell renal cell carcinoma: miRNA-101 and HIF-2α as molecular triggers? Future Oncol 2019;15:2361-70. [PMID: 31267758 DOI: 10.2217/fon-2019-0067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
382 Lee KS, Choe G, Yun S, Lee K, Moon S, Lee S, Hong SK, Byun SS, Lee SE. Comparative analysis of programmed cell death ligand 1 assays in renal cell carcinoma. Histopathology 2020;77:67-78. [PMID: 31872892 DOI: 10.1111/his.14054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
383 Wu Y, Wei X, Feng H, Hu B, Liu B, Luan Y, Ruan Y, Liu X, Liu Z, Wang S, Liu J, Wang T. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma. Aging (Albany NY) 2020;12:23165-86. [PMID: 33221754 DOI: 10.18632/aging.104088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
384 Zucca LE, Morini Matushita MA, da Silva Oliveira RJ, Scapulatempo-Neto C, de Lima MA, Ribeiro GG, Viana CR, Cárcano FM, Reis RM. Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib. Urol Oncol 2018;36:11.e13-21. [PMID: 28986088 DOI: 10.1016/j.urolonc.2017.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
385 Wang JY, Gao MZ, Yu DX, Xie DD, Wang Y, Bi LK, Zhang T, Ding DM. Histological subtype is a significant predictor for inguinal lymph node metastasis in patients with penile squamous cell carcinoma. Asian J Androl 2018;20:265-9. [PMID: 29286007 DOI: 10.4103/aja.aja_60_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
386 Gasparrini S, Cimadamore A, Scarpelli M, Massari F, Doria A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montironi R. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians. Asian J Androl 2017. [PMID: 28782737 DOI: 10.4103/aja.aja_24_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
387 Nini A, Larcher A, Cianflone F, Trevisani F, Terrone C, Volpe A, Regis F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U. The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma. Front Surg 2018;5:26. [PMID: 29740587 DOI: 10.3389/fsurg.2018.00026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
388 Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A; German Network Of Kidney Cancer. High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. Hum Pathol 2019;83:212-23. [PMID: 30121370 DOI: 10.1016/j.humpath.2018.08.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
389 Khella HWZ, Daniel N, Youssef L, Scorilas A, Nofech-Mozes R, Mirham L, Krylov SN, Liandeau E, Krizova A, Finelli A, Cheng Y, Yousef GM. miR-10b is a prognostic marker in clear cell renal cell carcinoma. J Clin Pathol 2017;70:854-9. [PMID: 28360191 DOI: 10.1136/jclinpath-2017-204341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
390 Ma Y, Guan Z, Liang H, Cao H. Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Through CT-Based Tumoral and Peritumoral Radiomics. Front Oncol 2022;12:831112. [PMID: 35237524 DOI: 10.3389/fonc.2022.831112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Evrimler S, Ali Gedik M, Ahmet Serel T, Ertunc O, Alperen Ozturk S, Soyupek S. Bladder Urothelial Carcinoma: Machine Learning-based Computed Tomography Radiomics for Prediction of Histological Variant. Acad Radiol 2022:S1076-6332(22)00116-7. [PMID: 35351362 DOI: 10.1016/j.acra.2022.02.007] [Reference Citation Analysis]
392 Thouvenin J, Barthélémy P, Ladoire S. Les cancers du rein non à cellules claires : caractéristiques clinico-biologiques et prise en charge thérapeutique hors chirurgie. Bulletin du Cancer 2020;107:S56-65. [DOI: 10.1016/s0007-4551(20)30279-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
393 Pavan H, Garcia TS, Torres FS, Gazzoni FF, Folador L, Ghezzi CLA. Focal incidental upper abdominal findings on unenhanced chest computed tomography that do not require further imaging: a roadmap for the thoracic radiologist. Radiol Bras. [DOI: 10.1590/0100-3984.2021.0106] [Reference Citation Analysis]
394 Kotecha RR, Motzer RJ, Voss MH. Towards individualized therapy for metastatic renal cell carcinoma. Nat Rev Clin Oncol 2019;16:621-33. [PMID: 30992569 DOI: 10.1038/s41571-019-0209-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
395 Brobeil A, Wagenlehner F, Gattenlöhner S. Expression of terminal deoxynucleotidyl transferase (TdT) in classical seminoma: a potential diagnostic pitfall. Virchows Arch 2018;472:433-40. [PMID: 29455318 DOI: 10.1007/s00428-018-2313-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
396 Xu T, Ruan H, Song Z, Cao Q, Wang K, Bao L, Liu D, Tong J, Yang H, Chen K, Zhang X. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Biomed Pharmacother 2019;118:109264. [PMID: 31390578 DOI: 10.1016/j.biopha.2019.109264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
397 Pires-Luís AS, Costa-Pinheiro P, Ferreira MJ, Antunes L, Lobo F, Oliveira J, Henrique R, Jerónimo C. Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel. J Transl Med 2017;15:149. [PMID: 28662726 DOI: 10.1186/s12967-017-1248-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
398 Al Nasibi K, Pickovsky JS, Eldehimi F, Flood TA, Lavallee LT, Tsampalieros AK, Schieda N. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear-Cell Renal Cell Carcinoma Among Small (≤4 cm) Solid Renal Masses. AJR Am J Roentgenol 2022. [PMID: 35766532 DOI: 10.2214/AJR.22.27971] [Reference Citation Analysis]
399 de Araújo LA, De Paula AAP, de Paula HDSC, Ramos JEP, de Oliveira BR, De Carvalho KPA, Guimarães RA, de Alencar RCG, Duarte ECB, Rabelo Santos SH, Saddi VA, Carneiro MADS. Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors. PLoS One 2018;13:e0199557. [PMID: 29949632 DOI: 10.1371/journal.pone.0199557] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
400 Tolkach Y, Kristiansen G. The Heterogeneity of Prostate Cancer: A Practical Approach. Pathobiology 2018;85:108-16. [PMID: 29393241 DOI: 10.1159/000477852] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
401 Khadirnaikar S, Kumar P, Pandi SN, Malik R, Dhanasekaran SM, Shukla SK. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma. Mol Carcinog 2019;58:544-53. [PMID: 30520148 DOI: 10.1002/mc.22949] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
402 Chen XY, Zhang Y, Chen YX, Huang ZQ, Xia XY, Yan YX, Xu MP, Chen W, Wang XL, Chen QL. MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier. Front Oncol 2021;11:708655. [PMID: 34660276 DOI: 10.3389/fonc.2021.708655] [Reference Citation Analysis]
403 Rouprêt M, Xylinas E, Colin P, Houédé N, Compérat E, Audenet F, Larré S, Masson-Lecomte A, Pignot G, Brunelle S, Roumiguié M, Neuzillet Y, Méjean A. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la voie excrétrice supérieure French ccAFU guidelines — Update 2018—2020: Upper tract urothelial carcinoma. Prog Urol 2018;28:S32-45. [PMID: 30318333 DOI: 10.1016/j.purol.2018.07.284] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
404 Alderson M, Grivas P, Milowsky MI, Wobker SE. Histologic Variants of Urothelial Carcinoma: Morphology, Molecular Features and Clinical Implications. BLC 2020;6:107-22. [DOI: 10.3233/blc-190257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
405 Ogawa Y, Morita S, Takagi T, Yoshida K, Tanabe K, Nagashima Y, Nishina Y, Sakai S. Early dark cortical band sign on CT for differentiating clear cell renal cell carcinoma from fat poor angiomyolipoma and detecting peritumoral pseudocapsule. Eur Radiol 2021;31:5990-7. [PMID: 33559699 DOI: 10.1007/s00330-021-07717-z] [Reference Citation Analysis]
406 Daubisse-Marliac L, Colonna M, Trétarre B, Defossez G, Molinié F, Jéhannin-Ligier K, Marrer E, Grosclaude P; FRANCIM network. Long-term trends in incidence and survival of penile cancer in France. Cancer Epidemiol 2017;50:125-31. [PMID: 28898817 DOI: 10.1016/j.canep.2017.08.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
407 Drljevic-Nielsen A, Mains JR, Thorup K, Andersen MB, Rasmussen F, Donskov F. Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma. Eur Radiol 2022. [PMID: 35511260 DOI: 10.1007/s00330-022-08793-5] [Reference Citation Analysis]
408 Barrachina F, de la Iglesia A, Jodar M, Soler-Ventura A, Mallofré C, Rodriguez-Carunchio L, Goudarzi A, Corral JM, Ballescà JL, Castillo J, Oliva R. Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours. Hum Reprod 2022:deac130. [PMID: 35678707 DOI: 10.1093/humrep/deac130] [Reference Citation Analysis]
409 Xing S, Liu A, Yang X, Chen L, Xu D. Tubulocystic renal cell carcinoma: Two-case report and literature review. Int J Immunopathol Pharmacol 2021;35:20587384211002966. [PMID: 33726547 DOI: 10.1177/20587384211002966] [Reference Citation Analysis]
410 Hofmann AL, Behr J, Singer J, Kuipers J, Beisel C, Schraml P, Moch H, Beerenwinkel N. Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers. BMC Bioinformatics 2017;18:8. [PMID: 28049408 DOI: 10.1186/s12859-016-1417-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
411 Yang G, Gong A, Nie P, Yan L, Miao W, Zhao Y, Wu J, Cui J, Jia Y, Wang Z. Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal Angiomyolipoma From Chromophobe Renal Cell Carcinoma. Mol Imaging 2019;18:1536012119883161. [PMID: 31625454 DOI: 10.1177/1536012119883161] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
412 Calabrò D, Telo S, Ambrosini V. PET imaging in testicular tumours. Curr Opin Urol 2020;30:665-71. [PMID: 32732623 DOI: 10.1097/MOU.0000000000000796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
413 Manoharan D, Netaji A, Diwan K, Sharma S. Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT. AJR Am J Roentgenol 2020;215:1389-97. [PMID: 33052738 DOI: 10.2214/AJR.19.22612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Baboudjian M, Moser D, Yanagisawa T, Gondran-tellier B, Compérat EM, Ambrosetti D, Daniel L, Bastide C, Shariat SF, Lechevallier E, Diana P, Breda A, Pradere B, Boissier R. Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis. European Urology Open Science 2022;41:8-15. [DOI: 10.1016/j.euros.2022.04.009] [Reference Citation Analysis]
415 Mao C, Gao Y, Wan M, Xu N. Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer. Funct Integr Genomics 2022. [PMID: 35420332 DOI: 10.1007/s10142-022-00845-9] [Reference Citation Analysis]
416 Ge YZ, Xu LW, Zhou CC, Lu TZ, Yao WT, Wu R, Zhao YC, Xu X, Hu ZK, Wang M, Yang XB, Zhou LH, Zhong B, Xu Z, Li WC, Zhu JG, Jia RP. A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1. J Cancer 2017;8:2643-52. [PMID: 28900502 DOI: 10.7150/jca.20234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
417 de Vries-Brilland M, McDermott DF, Suárez C, Powles T, Gross-Goupil M, Ravaud A, Flippot R, Escudier B, Albigès L. Checkpoint inhibitors in metastatic papillary renal cell carcinoma. Cancer Treat Rev 2021;99:102228. [PMID: 34111642 DOI: 10.1016/j.ctrv.2021.102228] [Reference Citation Analysis]
418 Buljubašić R, Buljubašić M, Bojanac AK, Ulamec M, Vlahović M, Ježek D, Bulić-Jakuš F, Sinčić N. Epigenetics and testicular germ cell tumors. Gene 2018;661:22-33. [PMID: 29605605 DOI: 10.1016/j.gene.2018.03.072] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
419 Nguyen AH, O'Leary MP, De Andrade JP, Ituarte PHG, Kessler J, Li D, Singh G, Chang S. Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name? Front Endocrinol (Lausanne) 2020;11:624251. [PMID: 33613455 DOI: 10.3389/fendo.2020.624251] [Reference Citation Analysis]
420 Yamamoto S, Kato M, Takeyama Y, Yukimatsu N, Hirayama Y, Otoshi T, Yamasaki T, Kuratsukuri K, Uchida J. A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma. Urol Oncol 2021:S1078-1439(21)00481-6. [PMID: 34852939 DOI: 10.1016/j.urolonc.2021.10.013] [Reference Citation Analysis]
421 Moguelet P, Compérat EM. [Penile intraepithelial neoplasia]. Ann Pathol 2021:S0242-6498(21)00120-6. [PMID: 34865881 DOI: 10.1016/j.annpat.2021.04.005] [Reference Citation Analysis]
422 Harb OA, Elfeky MA, El Shafaay BS, Taha HF, Osman G, Harera IS, Gertallah LM, Abdelmonem DM, Embaby A. SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance. Pathophysiology 2018;25:335-45. [PMID: 29801752 DOI: 10.1016/j.pathophys.2018.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
423 Nizioł J, Bonifay V, Ossoliński K, Ossoliński T, Ossolińska A, Sunner J, Beech I, Arendowski A, Ruman T. Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA. Anal Bioanal Chem 2018;410:3859-69. [PMID: 29658093 DOI: 10.1007/s00216-018-1059-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
424 Mollica V, Santoni M, Di Nunno V, Cimadamore A, Cheng L, Lopez-Beltran A, Battelli N, Montironi R, Massari F. Immunotherapy and Radiation Therapy in Renal Cell Carcinoma. Curr Drug Targets 2020;21:1463-75. [PMID: 32160846 DOI: 10.2174/1389450121666200311121540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
425 Pudova EA, Krasnov GS, Nyushko KM, Kobelyatskaya AA, Savvateeva MV, Poloznikov AA, Dolotkazin DR, Klimina KM, Guvatova ZG, Simanovsky SA, Gladysh NS, Tokarev AT, Melnikova NV, Dmitriev AA, Alekseev BY, Kaprin AD, Kiseleva MV, Snezhkina AV, Kudryavtseva AV. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer. BMC Med Genomics 2020;13:129. [PMID: 32948204 DOI: 10.1186/s12920-020-00788-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
426 Matsuda K, Kawasaki T, Akazawa Y, Hasegawa Y, Kondo H, Suzuki K, Iseki M, Nakashima M. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma. Sci Rep 2018;8:15477. [PMID: 30341375 DOI: 10.1038/s41598-018-33761-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
427 Liu X, Zhang W, Wang H, Zhu L, Xu K. Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. Front Oncol 2021;11:762629. [PMID: 35096573 DOI: 10.3389/fonc.2021.762629] [Reference Citation Analysis]
428 Santos VE, da Costa WH, Bezerra SM, da Cunha IW, Nobre JQC, Brazão ES Jr, Meduna RR, Rocha MM, Fornazieri L, Zequi SC. Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer 2021;19:339-45. [PMID: 33839039 DOI: 10.1016/j.clgc.2021.03.003] [Reference Citation Analysis]
429 Kurose N, Takenaka M, Yamashita M, Shimaguchi C, Nakano M, Britni B, Guo X, Futatsuya C, Shioya A, Yamada S. A case report of infantile cystic nephroblastoma. Diagn Pathol 2018;13:84. [PMID: 30368245 DOI: 10.1186/s13000-018-0761-5] [Reference Citation Analysis]
430 Gayer FA, Fichtner A, Legler TJ, Reichardt HM. A Coculture Model Mimicking the Tumor Microenvironment Unveils Mutual Interactions between Immune Cell Subtypes and the Human Seminoma Cell Line TCam-2. Cells 2022;11:885. [DOI: 10.3390/cells11050885] [Reference Citation Analysis]
431 Kaur R, Juneja M, Mandal AK. An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions. Med Biol Eng Comput 2020;58:1-24. [DOI: 10.1007/s11517-019-02049-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Foix MP, Dunatov A, Martinek P, Mundó EC, Suster S, Sperga M, Lopez JI, Ulamec M, Bulimbasic S, Montiel DP, Alaghehbandan R, Peckova K, Pivovarcikova K, Ondrej D, Rotterova P, Skenderi F, Prochazkova K, Dusek M, Hora M, Michal M, Hes O. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. Virchows Arch 2016;469:669-78. [PMID: 27631338 DOI: 10.1007/s00428-016-2022-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
433 Yao JX, Chen X, Xi W, Zhu YJ, Wang H, Hu XY, Guo JM. Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors. J Cancer 2018;9:4099-107. [PMID: 30519309 DOI: 10.7150/jca.27408] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
434 Wang Q, Zhang Y, Zhang B, Fu Y, Zhao X, Zhang J, Zuo K, Xing Y, Jiang S, Qin Z, Li E, Guo H, Liu Z, Yang J. Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma. Nat Commun 2022;13:31. [PMID: 35013217 DOI: 10.1038/s41467-021-27660-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
435 Kriegsmann M, Casadonte R, Maurer N, Stoehr C, Erlmeier F, Moch H, Junker K, Zgorzelski C, Weichert W, Schwamborn K, Deininger SO, Gaida M, Mechtersheimer G, Stenzinger A, Schirmacher P, Hartmann A, Kriegsmann J, Kriegsmann K. Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy. J Cancer 2020;11:6081-9. [PMID: 32922548 DOI: 10.7150/jca.47698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
436 Elmore SA, Aeffner F, Bangari DS, Crabbs TA, Fossey S, Gad SC, Haschek WM, Hoane JS, Janardhan K, Kovi RC, Pearse G, Wancket LM, Quist EM. Proceedings of the 2017 National Toxicology Program Satellite Symposium. Toxicol Pathol 2017;45:799-833. [PMID: 29113559 DOI: 10.1177/0192623317733924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
437 Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study. J Clin Oncol 2021;39:308-18. [PMID: 33356420 DOI: 10.1200/JCO.20.02713] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Ding Y, Miyamoto H, Rothberg PG. Is Tubulocystic Renal Cell Carcinoma Real?: Genomic Analysis Confirms the World Health Organization Classification. J Mol Diagn 2018;20:28-30. [PMID: 29155049 DOI: 10.1016/j.jmoldx.2017.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
439 Guan Y, Xu F, Tian J, Gao K, Wan Z, Wang Y, Gao M, Wang Z, Chong T. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma. BMC Cancer 2021;21:826. [PMID: 34271857 DOI: 10.1186/s12885-021-08463-7] [Reference Citation Analysis]
440 Talluri S, Goedde MA, Coventry S, Rosenberg E, Canalichio KL, Peppas D, White JT. Case Report: Rare Presentation of Mixed Germ Cell Tumor in an Infant. Front Pediatr 2021;9:729917. [PMID: 34557461 DOI: 10.3389/fped.2021.729917] [Reference Citation Analysis]
441 Alevizakos M, Gaitanidis A, Nasioudis D, Msaouel P, Appleman LJ. Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients. Clin Genitourin Cancer 2019;17:e447-53. [PMID: 30799129 DOI: 10.1016/j.clgc.2019.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
442 Guo X, Li R, Bai Q, Jiang S, Wang H. TFE3-PD-L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma. J Cell Mol Med 2020;24:14441-52. [PMID: 33145941 DOI: 10.1111/jcmm.16066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
443 Atkins MB, Tannir NM. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat Rev 2018;70:127-37. [PMID: 30173085 DOI: 10.1016/j.ctrv.2018.07.009] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 23.8] [Reference Citation Analysis]
444 Deng Y, Soule E, Samuel A, Shah S, Cui E, Asare-Sawiri M, Sundaram C, Lall C, Sandrasegaran K. CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade. Eur Radiol 2019;29:6922-9. [PMID: 31127316 DOI: 10.1007/s00330-019-06260-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
445 Jeong H, Oh HE, Kim H, Lee JH, Lee ES, Kim YS, Choi JW. Upregulation of Fatty Acid Transporters is Associated With Tumor Progression in Non-Muscle-Invasive Bladder Cancer. Pathol Oncol Res 2021;27:594705. [PMID: 34257543 DOI: 10.3389/pore.2021.594705] [Reference Citation Analysis]
446 Lin H, Zhang H, Cheng Y, Zhang C. Solitary Metastasis in the Mediastinal Lymph Node After Radical Nephrectomy for Clear Cell Renal Cell Carcinoma: A Case Report and Literature Review. Front Oncol 2020;10:593142. [PMID: 33392088 DOI: 10.3389/fonc.2020.593142] [Reference Citation Analysis]
447 Sugrue DD, Ryan J, Harris J, Cheema I. Visible haematuria-an unusual presentation of metastatic testicular mixed germ cell tumour. BMJ Case Rep 2021;14:e241056. [PMID: 33692071 DOI: 10.1136/bcr-2020-241056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
448 Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, Hu JC. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol Oncol 2017;35:673.e9-673.e14. [PMID: 28919182 DOI: 10.1016/j.urolonc.2017.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
449 Adashek JJ, Zhang Y, Skelton WP 4th, Bilotta A, Chahoud J, Zemp L, Li J, Dhillon J, Manley B, Spiess PE. Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation? Front Oncol 2020;10:627025. [PMID: 33643921 DOI: 10.3389/fonc.2020.627025] [Reference Citation Analysis]
450 Vecchio SJD, Ellis RJ. Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma. J Kidney Cancer VHL 2018;5:1-5. [PMID: 30319937 DOI: 10.15586/jkcvhl.2018.109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
451 Joshi VB, Spiess PE, Necchi A, Pettaway CA, Chahoud J. Immune-based therapies in penile cancer. Nat Rev Urol. [DOI: 10.1038/s41585-022-00617-x] [Reference Citation Analysis]
452 Dorantes-Heredia R, Motola-Kuba D, Murphy-Sanchez C, Izquierdo-Tolosa CD, Ruiz-Morales JM. Spontaneous regression as a 'burned-out' non-seminomatous testicular germ cell tumor: a case report and literature review. J Surg Case Rep 2019;2019:rjy358. [PMID: 30647899 DOI: 10.1093/jscr/rjy358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
453 Yotani T, Yamada Y, Arai E, Tian Y, Gotoh M, Komiyama M, Fujimoto H, Sakamoto M, Kanai Y. Novel method for DNA methylation analysis using high-performance liquid chromatography and its clinical application. Cancer Sci 2018;109:1690-700. [PMID: 29520901 DOI: 10.1111/cas.13566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
454 Matuszczak M, Salagierski M. Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers. Int J Mol Sci 2020;21:E3360. [PMID: 32397531 DOI: 10.3390/ijms21093360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
455 Medeiros-Fonseca B, Cubilla A, Brito H, Martins T, Medeiros R, Oliveira P, Gil da Costa RM. Experimental Models for Studying HPV-Positive and HPV-Negative Penile Cancer: New Tools for An Old Disease. Cancers (Basel) 2021;13:460. [PMID: 33530343 DOI: 10.3390/cancers13030460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 King KG. Use of Contrast Ultrasound for Renal Mass Evaluation. Radiol Clin North Am 2020;58:935-49. [PMID: 32792125 DOI: 10.1016/j.rcl.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
457 Sharbidre KG, Morani AC, Zahid M, Bhosale P, Lall C, Francis IR, Verma S. Imaging of neuroendocrine neoplasms of the male GU tract. Abdom Radiol (NY) 2022. [PMID: 35412112 DOI: 10.1007/s00261-022-03510-8] [Reference Citation Analysis]
458 Chieffi P, De Martino M, Esposito F. Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets. Expert Rev Anticancer Ther 2020;20:189-95. [PMID: 32164473 DOI: 10.1080/14737140.2020.1736566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
459 Al-obaidy KI, Trevino KE, Idrees MT. Clinicopathologic Characterization of Bilateral Testicular Germ Cell Tumors With Immunohistochemical Evaluation of Mismatch Repair and BRAF (V600E) Genes Mutations. Int J Surg Pathol 2019;27:619-23. [DOI: 10.1177/1066896919842939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
460 Ljungberg B, Albiges L, Abu-ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. European Urology 2022. [DOI: 10.1016/j.eururo.2022.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
461 Gupta R, Ornstein MC, Li H, Allman KD, Wood LS, Gilligan T, Garcia JA, Merveldt DV, Hammers HJ, Rini BI. Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer 2020;18:429-35. [PMID: 32800717 DOI: 10.1016/j.clgc.2019.11.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
462 Tretiakova MS, Wang W, Wu Y, Tykodi SS, True L, Liu YJ. Gene fusion analysis in renal cell carcinoma by FusionPlex RNA‐sequencing and correlations of molecular findings with clinicopathological features. Genes Chromosomes Cancer 2019;59:40-9. [DOI: 10.1002/gcc.22798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
463 Al-Obaidy KI, Alruwaii FI, Ulbright TM, Idrees MT. Appendageal tumors and tumor-like lesions of the testis and paratestis: a 32-year experience at a single institution. Hum Pathol 2020;103:25-33. [PMID: 32619438 DOI: 10.1016/j.humpath.2020.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
464 Ballard DH, De Alba L, Migliaro M, Previgliano CH, Sangster GP. CT imaging spectrum of infiltrative renal diseases. Abdom Radiol (NY) 2017;42:2700-9. [PMID: 28580537 DOI: 10.1007/s00261-017-1193-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
465 Dauendorffer JN, Cavelier Balloy B, Bagot M, Renaud-Vilmer C. [Differentiated penile intra-epithelial neoplasia]. Ann Dermatol Venereol 2017;144:649-51. [PMID: 28690079 DOI: 10.1016/j.annder.2017.05.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
466 Massari F, Di Nunno V, Comito F, Cubelli M, Ciccarese C, Iacovelli R, Fiorentino M, Montironi R, Ardizzoni A. Circulating tumor cells in genitourinary tumors. Ther Adv Urol 2018;10:65-77. [PMID: 29434674 DOI: 10.1177/1756287217742564] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
467 Gopee-Ramanan P, Chin SS, Lim C, Shanbhogue KP, Schieda N, Krishna S. Renal Neoplasms in Young Adults. Radiographics 2022;42:433-50. [PMID: 35230920 DOI: 10.1148/rg.210138] [Reference Citation Analysis]
468 Guo J, Ma J, Sun Y, Qin S, Ye D, Zhou F, He Z, Sheng X, Bi F, Cao D, Chen Y, Huang Y, Liang H, Liang J, Liu J, Liu W, Pan Y, Shu Y, Song X, Wang W, Wang X, Wu X, Xie X, Yao X, Yu S, Zhang Y, Zhou A; written; CSCO Renal Cell Carcinoma Committee. Chinese guidelines on the management of renal cell carcinoma (2015 edition). Ann Transl Med. 2015;3:279. [PMID: 26697439 DOI: 10.3978/j.issn.2305-5839.2015.11.21] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
469 Luo Y, Chen L, Wang G, Xiao Y, Ju L, Wang X. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. J Cell Biochem 2019;120:13751-64. [PMID: 30957284 DOI: 10.1002/jcb.28648] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
470 Xu T, Gao S, Ruan H, Liu J, Liu Y, Liu D, Tong J, Shi J, Yang H, Chen K, Zhang X. METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma. Front Genet 2021;12:609174. [PMID: 34122497 DOI: 10.3389/fgene.2021.609174] [Reference Citation Analysis]
471 Anglickis M, Stulpinas R, Anglickienė G, Gabrilevičius J, Jaškevičius A. Case Report of Misleading Features of a Rare Sertoli Cell Testicular Tumor. Medicina (Kaunas) 2019;55:E170. [PMID: 31137577 DOI: 10.3390/medicina55050170] [Reference Citation Analysis]
472 Boga MS, Ates M. Retroperitoneal robot-assisted laparoscopic partial nephrectomy for posterior located renal tumours: Technique and early term outcomes. Int J Clin Pract 2021;75:e13851. [PMID: 33237611 DOI: 10.1111/ijcp.13851] [Reference Citation Analysis]
473 Abdelzaher Ahmed E, Abdel Bary Abdel-Latif A, Fahmy AM, Elzarrouk Mania I. Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas. J Histotechnol 2021;:1-10. [PMID: 34378492 DOI: 10.1080/01478885.2021.1924971] [Reference Citation Analysis]
474 La Rosa S, Uccella S. Classification of neuroendocrine neoplasms: lights and shadows. Rev Endocr Metab Disord 2021;22:527-38. [PMID: 33169199 DOI: 10.1007/s11154-020-09612-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
475 Campedel L, Kossaï M, Blanc-Durand P, Rouprêt M, Seisen T, Compérat E, Spano JP, Malouf G. [Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions]. Bull Cancer 2017;104:789-99. [PMID: 28673439 DOI: 10.1016/j.bulcan.2017.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
476 Wyvekens N, Rechsteiner M, Fritz C, Wagner U, Tchinda J, Wenzel C, Kuithan F, Horn LC, Moch H. Histological and molecular characterization of TFEB-rearranged renal cell carcinomas. Virchows Arch 2019;474:625-31. [PMID: 30706129 DOI: 10.1007/s00428-019-02526-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
477 McKay RR, Bossé D, Xie W, Wankowicz SAM, Flaifel A, Brandao R, Lalani AA, Martini DJ, Wei XX, Braun DA, Van Allen E, Castellano D, De Velasco G, Wells JC, Heng DY, Fay AP, Schutz FA, Hsu J, Pal SK, Lee JL, Hsieh JJ, Harshman LC, Signoretti S, Motzer RJ, Feldman D, Choueiri TK. The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma. Cancer Immunol Res 2018;6:758-65. [PMID: 29748390 DOI: 10.1158/2326-6066.CIR-17-0475] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
478 Solano C, Thapa S, Chisti MM. Adult Xp11.2 translocation renal cell carcinoma managed effectively with pazopanib. BMJ Case Rep 2021;14:e243058. [PMID: 34172479 DOI: 10.1136/bcr-2021-243058] [Reference Citation Analysis]
479 Liu Z, Sun T, Piao C, Zhang Z, Kong C. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. J Transl Med 2021;19:209. [PMID: 33985542 DOI: 10.1186/s12967-021-02879-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Chen S, Zhang E, Jiang L, Wang T, Guo T, Gao F, Zhang N, Wang X, Zheng J. Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm. Front Immunol 2022;13:798471. [DOI: 10.3389/fimmu.2022.798471] [Reference Citation Analysis]
481 Alharbi H, Alkhateeb S, Murshid E, Alotaibi M, Abusamra A, Rabah D, Almansour M, Alghamdi A, Aljubran A, Eltigani A, Alkushi H, Ahmed I, Alsharm A, Bazarbashi S. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017. Urol Ann 2018;10:133-7. [PMID: 29719322 DOI: 10.4103/UA.UA_176_17] [Reference Citation Analysis]
482 Mo L, Yu Z, Lv Y, Cheng J, Yan H, Lu W, Su C, Ling Q, Mo Z. Single-Cell RNA Sequencing of Metastatic Testicular Seminoma Reveals the Cellular and Molecular Characteristics of Metastatic Cell Lineage. Front Oncol 2022;12:871489. [PMID: 35494058 DOI: 10.3389/fonc.2022.871489] [Reference Citation Analysis]
483 Graham J, Dudani S, Heng DYC. Prognostication in Kidney Cancer: Recent Advances and Future Directions. J Clin Oncol. 2018;JCO2018790147. [PMID: 30372388 DOI: 10.1200/jco.2018.79.0147] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
484 Simon AG, Esser LK, Ellinger J, Ritter M, Kristiansen G, Muders MH, Mayr T, Toma MI. RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma. Front Oncol 2022;12:883195. [PMID: 35646693 DOI: 10.3389/fonc.2022.883195] [Reference Citation Analysis]
485 Compérat E, Varinot J. Classification of Adult Renal Tumors: An Update. Semin Ultrasound CT MR 2017;38:2-9. [PMID: 28237277 DOI: 10.1053/j.sult.2016.08.004] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
486 Outeiro-Pinho G, Barros-Silva D, Correia MP, Henrique R, Jerónimo C. Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs. Cancers (Basel) 2020;12:E2214. [PMID: 32784737 DOI: 10.3390/cancers12082214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
487 Pal SK, Tangen C, Thompson IM, Balzer-haas N, George DJ, Heng DYC, Shuch B, Stein M, Tretiakova M, Humphrey P, Adeniran A, Narayan V, Bjarnason GA, Vaishampayan U, Alva A, Zhang T, Cole S, Plets M, Wright J, Lara PN. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. The Lancet 2021;397:695-703. [DOI: 10.1016/s0140-6736(21)00152-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 20.0] [Reference Citation Analysis]
488 Haake SM, Rathmell WK. Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making? Cancer 2017;123:200-9. [PMID: 27861752 DOI: 10.1002/cncr.30314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
489 Cao W, Kang R, Xiang Y, Hong J. Human Endogenous Retroviruses in Clear Cell Renal Cell Carcinoma: Biological Functions and Clinical Values. Onco Targets Ther 2020;13:7877-85. [PMID: 32821127 DOI: 10.2147/OTT.S259534] [Reference Citation Analysis]
490 Stoehr R, Wendler O, Giedl J, Gaisa NT, Richter G, Campean V, Burger M, Wullich B, Bertz S, Hartmann A. Risk of penile tumor development in Caucasian individuals is independent of the coding variant rs7208422 in the TMC8 (EVER2) gene. Mol Clin Oncol 2021;15:267. [PMID: 34790351 DOI: 10.3892/mco.2021.2429] [Reference Citation Analysis]
491 ElKhaldi M, Radi R, Al-Hussaini M. Choriocarcinoma metastatic to the skin: A rare occurrence associated with dismal outcome. Rare Tumors 2021;13:20363613211039724. [PMID: 34434536 DOI: 10.1177/20363613211039724] [Reference Citation Analysis]
492 Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, Desgrandchamps F, Mongiat-artus P, Feugeas J. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems. American Journal of Surgical Pathology 2018;42:423-41. [DOI: 10.1097/pas.0000000000001025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
493 Avogbe PH, Manel A, Vian E, Durand G, Forey N, Voegele C, Zvereva M, Hosen MI, Meziani S, De Tilly B, Polo G, Lole O, Francois P, Delhomme TM, Carreira C, Monteiro-Reis S, Henrique R, Abedi-Ardekani B, Byrnes G, Foll M, Weiderpass E, McKay J, Jeronimo C, Scelo G, Le Calvez-Kelm F. Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer. EBioMedicine 2019;44:431-8. [PMID: 31122840 DOI: 10.1016/j.ebiom.2019.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
494 Furubayashi N, Negishi T, Sakamoto N, Tamura S, Morokuma F, Song Y, Hori Y, Tomoda T, Seki N, Kuroiwa K, Nakamura M. Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy. In Vivo 2021;35:2869-74. [PMID: 34410980 DOI: 10.21873/invivo.12575] [Reference Citation Analysis]
495 Zhang XL, Xu G, Zhou Y, Yan JJ. MicroRNA-183 promotes the proliferation and metastasis of renal cell carcinoma through targeting Dickkopf-related protein 3. Oncol Lett 2018;15:6003-8. [PMID: 29552228 DOI: 10.3892/ol.2018.7998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
496 Christensen MB, Wadt K, Jensen UB, Lautrup CK, Bojesen A, Krogh LN, Overeem Hansen TV, Gerdes AM. Exploring the hereditary background of renal cancer in Denmark. PLoS One 2019;14:e0215725. [PMID: 31034483 DOI: 10.1371/journal.pone.0215725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
497 Furubayashi N, Kuroiwa K, Tokuda N, Tomoda T, Morokuma F, Hori Y, Negishi T, Inoue T, Kumagai M, Nakamura M. Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice. J Clin Med Res 2020;12:300-6. [PMID: 32489505 DOI: 10.14740/jocmr4162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
498 Al-Maghrabi JA. Overexpression of SIRT1 in urothelial carcinoma of the urinary bladder is associated with local recurrence and poor survival. Saudi Med J 2019;40:541-7. [PMID: 31219487 DOI: 10.15537/smj.2019.6.24248] [Reference Citation Analysis]
499 Xiang M, Huang Y, Dai C, Zou G. MiR-340 regulates the growth and metabolism of renal cell carcinoma cells by targeting frizzled class receptor 3. Arch Pharm Res 2021;44:219-29. [PMID: 33609235 DOI: 10.1007/s12272-021-01310-0] [Reference Citation Analysis]
500 Raos D, Krasic J, Masic S, Abramovic I, Coric M, Kruslin B, Katusic Bojanac A, Bulic-Jakus F, Jezek D, Ulamec M, Sincic N. In Search of TGCT Biomarkers: A Comprehensive In Silico and Histopathological Analysis. Dis Markers 2020;2020:8841880. [PMID: 33224314 DOI: 10.1155/2020/8841880] [Reference Citation Analysis]
501 De Bree E, Stamatiou D, Chryssou E, Michelakis D, Tzardi M. Late local, peritoneal and systemic recurrence of renal angiomyolipoma: A case report. Mol Clin Oncol 2019;10:43-8. [PMID: 30655976 DOI: 10.3892/mco.2018.1755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
502 Shao Y, Wu B, Jia W, Zhang Z, Chen Q, Wang D. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. BMC Urol 2020;20:90. [PMID: 32631294 DOI: 10.1186/s12894-020-00665-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
503 Nunno VD, Nuvola G, Mosca M, Maggio I, Gatto L, Tosoni A, Lodi R, Franceschi E, Brandes AA. Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases. Immunotherapy 2021;13:419-32. [PMID: 33472433 DOI: 10.2217/imt-2020-0208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
504 Fonseca-Alves CE, Kobayashi PE, Rivera Calderón LG, Felisbino SL, Rinaldi JC, Drigo SA, Rogatto SR, Laufer-Amorim R. Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression. PLoS One 2018;13:e0199173. [PMID: 29894516 DOI: 10.1371/journal.pone.0199173] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
505 Zhu X, Tan J, Liang Z, Zhou M. Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer. Medicine (Baltimore) 2019;98:e16672. [PMID: 31348324 DOI: 10.1097/MD.0000000000016672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
506 Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. European Urology 2018;73:772-80. [DOI: 10.1016/j.eururo.2018.01.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
507 Liu Z, Wang H, Zhang L, Li S, Fan Y, Meng Y, Hu S, Zhang Q, He Z, Zhou L, Han W, Yu W, Jin J. Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma. Transl Androl Urol 2019;8:507-18. [PMID: 31807427 DOI: 10.21037/tau.2019.10.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
508 Barchi M, Innocenzi E, Giannattasio T, Dolci S, Rossi P, Grimaldi P. Cannabinoid Receptors Signaling in the Development, Epigenetics, and Tumours of Male Germ Cells. Int J Mol Sci 2019;21:E25. [PMID: 31861494 DOI: 10.3390/ijms21010025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
509 Krawczyk KM, Nilsson H, Allaoui R, Lindgren D, Arvidsson M, Leandersson K, Johansson ME. Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages. Lab Invest 2017;97:1296-305. [PMID: 28759013 DOI: 10.1038/labinvest.2017.78] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
510 Matos-Perdomo E, Machín F. Nucleolar and Ribosomal DNA Structure under Stress: Yeast Lessons for Aging and Cancer. Cells 2019;8:E779. [PMID: 31357498 DOI: 10.3390/cells8080779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
511 Zhu Z, Xu C, Lin L, Lv T, Cai T, Lin J. Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma. Onco Targets Ther 2020;13:9135-45. [PMID: 32982302 DOI: 10.2147/OTT.S266846] [Reference Citation Analysis]
512 Dugas SG, Müller DC, Le Magnen C, Federer‐gsponer J, Seifert H, Ruiz C, Savic Prince S, Vlajnic T, Zellweger T, Mertz KD, Bacon JVW, Wyatt AW, Rentsch CA, Bubendorf L. Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer. Cancer Cytopathology 2019;127:578-85. [DOI: 10.1002/cncy.22167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
513 Luo L, Zhou H, Su H. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis. BMC Cancer 2021;21:553. [PMID: 33993869 DOI: 10.1186/s12885-021-08319-0] [Reference Citation Analysis]
514 Zhang C, Huang R, Xi X. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Papillary Renal Cell Carcinoma. Front Mol Biosci 2022;9:871602. [DOI: 10.3389/fmolb.2022.871602] [Reference Citation Analysis]
515 Vendrami CL, Velichko YS, Miller FH, Chatterjee A, Villavicencio CP, Yaghmai V, McCarthy RJ. Differentiation of Papillary Renal Cell Carcinoma Subtypes on MRI: Qualitative and Texture Analysis. AJR Am J Roentgenol 2018;211:1234-45. [PMID: 30240294 DOI: 10.2214/AJR.17.19213] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
516 Hong B, Zhang Z, Zhou J, Ma K, Zhang J, Cai L, Zhang N, Gong K. Distinctive clinicopathological features of Von Hippel-Lindau-associated hereditary renal cell carcinoma: A single-institution study. Oncol Lett 2019;17:4600-6. [PMID: 30944649 DOI: 10.3892/ol.2019.10091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
517 Xu Y, Wu G, Zhang J, Li J, Ruan N, Zhang J, Zhang Z, Chen Y, Zhang Q, Xia Q. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro. BioMed Research International 2020;2020:1-18. [DOI: 10.1155/2020/8409239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
518 Delhorme J, Fontana A, Levy A, Terrier P, Fiore M, Tzanis D, Callegaro D, Dratwa C, Gronchi A, Bonvalot S. Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions. European Journal of Surgical Oncology (EJSO) 2017;43:831-6. [DOI: 10.1016/j.ejso.2016.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
519 Narwal A, Kaushal S, Nakra T, Sharma MC, Kumar M. Atrophic Kidney Like Lesion: A Provisional Entity With Brief Review of Literature. Int J Surg Pathol 2022;:10668969211070482. [PMID: 35037508 DOI: 10.1177/10668969211070482] [Reference Citation Analysis]
520 Lema BE, Patricio GM, Kreimann EL. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma. Acta Histochem 2021;123:151717. [PMID: 33965858 DOI: 10.1016/j.acthis.2021.151717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
521 Ranjan SK, Mittal A, Kumar S, Kishore S, Narain TA, Mammen KJ. Papillary Renal Cell Carcinoma with Sarcomatoid Differentiation in a Native Kidney of Transplant Recipient: A Case Report and Review of Literature. Indian J Nephrol 2021;31:386-9. [PMID: 34584356 DOI: 10.4103/ijn.IJN_239_20] [Reference Citation Analysis]
522 Rupp NJ, Moch H. [Characterization of different renal cell carcinoma entities]. Urologe A 2020;59:135-41. [PMID: 31974661 DOI: 10.1007/s00120-019-01108-5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
523 Bross SP, Mongelluzzo GJ, Conger AR, Patel MA, Vadakara J, Grant M, Gatson NTN. Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain Injury. World Neurosurg 2020;139:483-7. [PMID: 32360731 DOI: 10.1016/j.wneu.2020.04.177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Dias F, Teixeira AL, Nogueira I, Morais M, Maia J, Bodo C, Ferreira M, Silva A, Vilhena M, Lobo J, Sequeira JP, Maurício J, Oliveira J, Kok K, Costa-Silva B, Medeiros R. Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease. Cancers (Basel) 2020;12:E1450. [PMID: 32498409 DOI: 10.3390/cancers12061450] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
525 Gadot M, Gal M, Dobosz P, Dotan Z, Ramon J, Berger R, Avni D, Fridman E, Leibowitz R. Associations between T cell infiltration, T cell receptor clonality, histology and recurrence in renal cell carcinoma. Clin Exp Immunol 2021;205:160-8. [PMID: 33899933 DOI: 10.1111/cei.13608] [Reference Citation Analysis]
526 Cathro HP. Iatrogenic Disease of the Genitourinary Tract. Adv Anat Pathol 2019;26:171-85. [PMID: 30720471 DOI: 10.1097/PAP.0000000000000226] [Reference Citation Analysis]
527 Ocal O, Baydar DE, Idilman IS, Dogan HS, Tekgul S, Ozmen M. Sonographic diagnosis of large-cell calcifying Sertoli cell tumor. J Ultrason 2019;19:161-4. [PMID: 31355590 DOI: 10.15557/JoU.2019.0024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Deacon MJ, Harvey H, Shah C, Khan A. A Rare Case of a Large Primary Renal Neuroendocrine Tumour: A Case Report and Brief Review of Literature. Cureus 2021;13:e19743. [PMID: 34812336 DOI: 10.7759/cureus.19743] [Reference Citation Analysis]
529 Ren X, Liang S, Li Y, Ji Y, Li L, Qin C, Fang K. ENAM gene associated with T classification and inhibits proliferation in renal clear cell carcinoma. Aging (Albany NY) 2021;13:7035-51. [PMID: 33539322 DOI: 10.18632/aging.202558] [Reference Citation Analysis]
530 Papathomas T, Tzortzakakis A, Sun N, Erlmeier F, Feuchtinger A, Trpkov K, Bazarova A, Arvanitis A, Wang W, Bozoky B, Kokaraki G, Axelsson R, Walch A. In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination. Eur Urol Open Sci 2020;22:88-96. [PMID: 34337482 DOI: 10.1016/j.euros.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Suciu MD, Marica NA, Oniu T, Tomuta AI, Badea R. Embryonal carcinoma of an intraabdominal testicular tumor on an undescended testicle: a case report. Med Pharm Rep 2020;93:213-8. [PMID: 32478330 DOI: 10.15386/mpr-1293] [Reference Citation Analysis]
532 Deleuze A, Saout J, Dugay F, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Crouzet L, Laguerre B, Belaud-Rotureau MA, Rioux-Leclercq N, Kammerer-Jacquet SF. Immunotherapy in Renal Cell Carcinoma: The Future Is Now. Int J Mol Sci 2020;21:E2532. [PMID: 32260578 DOI: 10.3390/ijms21072532] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
533 Bártů M, Hojný J, Hájková N, Michálková R, Krkavcová E, Hadravský L, Kleissnerová L, Bui QH, Stružinská I, Němejcová K, Čapoun O, Šlemendová M, Dundr P. Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours. Sci Rep 2020;10:17151. [PMID: 33051485 DOI: 10.1038/s41598-020-74059-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Rao H, Li X, Liu M, Liu J, Li X, Xu J, Li L, Gao WQ. Di-Ras2 promotes renal cell carcinoma formation by activating the mitogen-activated protein kinase pathway in the absence of von Hippel-Lindau protein. Oncogene 2020;39:3853-66. [PMID: 32161311 DOI: 10.1038/s41388-020-1247-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
535 Escudier B, Porta C, Schmidinger M, Rioux-leclercq N, Bex A, Khoo V, Grünwald V, Gillessen S, Horwich A. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2019;30:706-20. [DOI: 10.1093/annonc/mdz056] [Cited by in Crossref: 253] [Cited by in F6Publishing: 233] [Article Influence: 84.3] [Reference Citation Analysis]
536 Ujfaludi Z, Kuthi L, Pankotai-Bodó G, Bankó S, Sükösd F, Pankotai T. Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC. Pathol Oncol Res 2022;28:1610345. [PMID: 35586183 DOI: 10.3389/pore.2022.1610345] [Reference Citation Analysis]
537 Tabár L, Dean PB, Lee Tucker F, Yen AM, Chen SL, Jen GHH, Wang JW, Smith RA, Duffy SW, Chen TH. A new approach to breast cancer terminology based on the anatomic site of tumour origin: The importance of radiologic imaging biomarkers. European Journal of Radiology 2022;149:110189. [DOI: 10.1016/j.ejrad.2022.110189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
538 M A, B H, O B. Prostate adenocarcinoma of secretory type with wide expression of p63 and negativity of the basal marker Ck5/6: Rare subtype of adenocarcinoma of secretory origin and to be differentiated from basal cell carcinoma. Review of literature. Rare Tumors 2020;12:2036361320971948. [PMID: 33312493 DOI: 10.1177/2036361320971948] [Reference Citation Analysis]
539 Woldu SL, Bagrodia A, Lotan Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int 2017;119:371-80. [PMID: 28058776 DOI: 10.1111/bju.13760] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 20.8] [Reference Citation Analysis]
540 González-Serrano A, Cortez-Betancourt R, Alías-Melgar A, Botello-Gómez PJ, Ramírez-Garduño E, Trujillo-Vázquez EI, Torres-Santos Y, Mata-Martínez JA, Carreño-de la Rosa F. Multilocular Cystic Renal Cell Carcinoma or Cystic Nephroma? Case Rep Urol 2016;2016:5304324. [PMID: 28074169 DOI: 10.1155/2016/5304324] [Reference Citation Analysis]
541 Xv Y, Lv F, Guo H, Liu Z, Luo D, Liu J, Gou X, He W, Xiao M, Zheng Y. A CT-Based Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperatively Predicting WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma. Front Oncol 2021;11:712554. [PMID: 34926241 DOI: 10.3389/fonc.2021.712554] [Reference Citation Analysis]
542 Subramanian H, Parepalli D, Srinivas BH, Gochhait D, Ks S. Primary Renal Angiosarcoma With Lymph Node Metastasis- A Rare Intriguing Malignancy With a Grim Outcome. Urology 2021;153:14-6. [PMID: 33621584 DOI: 10.1016/j.urology.2021.02.016] [Reference Citation Analysis]
543 Carter P, Schnell U, Chaney C, Tong B, Pan X, Ye J, Mernaugh G, Cotton JL, Margulis V, Mao J, Zent R, Evers BM, Kapur P, Carroll TJ. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest 2021;131:144108. [PMID: 34060480 DOI: 10.1172/JCI144108] [Reference Citation Analysis]
544 Zabihollahy F, Schieda N, Krishna S, Ukwatta E. Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion. Eur Radiol 2020;30:5183-90. [PMID: 32350661 DOI: 10.1007/s00330-020-06787-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
545 Lastraioli E, Pillozzi S, Mari A, Tellini R, Duranti C, Baldazzi V, Venturini S, Minervini A, Lapini A, Nesi G, Carini M, Arcangeli A. hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma. Eur J Surg Oncol 2020;46:209-15. [PMID: 31679954 DOI: 10.1016/j.ejso.2019.10.031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
546 Franceschini T, Giunchi F, Mollica V, Altimari A, Capizzi E, Banfi M, Schiavina R, Fiorentino M, Massari F. Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study. Diagnostics (Basel) 2021;11:184. [PMID: 33525402 DOI: 10.3390/diagnostics11020184] [Reference Citation Analysis]
547 Sarami I, Shi J, Lin B, Liu H, Monroe R, Lin F. Evaluation of Human Kidney Injury Molecule 1 (hKIM-1) Expression in Tumors From Various Organs by Messenger RNA In Situ Hybridization. Am J Clin Pathol 2021;156:288-99. [PMID: 33608720 DOI: 10.1093/ajcp/aqaa236] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Testa U, Pelosi E, Castelli G. Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets. Medicines (Basel) 2020;7:E44. [PMID: 32751108 DOI: 10.3390/medicines7080044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
549 Cimadamore A, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Liquid biopsies in renal cell carcinoma with focus on epigenome analysis. Ann Transl Med 2019;7:S194. [PMID: 31656773 DOI: 10.21037/atm.2019.07.30] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
550 Tao Z, Zhao Y, Chen X. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers. PeerJ 2020;8:e9589. [PMID: 32765970 DOI: 10.7717/peerj.9589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
551 Moch H. WHO-ISUP-Graduierungssystem für Nierenkarzinome. Pathologe 2016;37:355-60. [DOI: 10.1007/s00292-016-0171-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
552 Polifka I, Agaimy A, Moch H, Hartmann A. [Histological subtypes of renal cell carcinoma : Overview and new developments]. Pathologe 2021;42:294-304. [PMID: 33825093 DOI: 10.1007/s00292-021-00937-6] [Reference Citation Analysis]
553 Zhang L, Hobeika CS, Khabibullin D, Yu D, Filippakis H, Alchoueiry M, Tang Y, Lam HC, Tsvetkov P, Georgiou G, Lamb C, Stone E, Puigserver P, Priolo C, Henske EP. Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11. Proc Natl Acad Sci U S A 2022;119:e2122840119. [DOI: 10.1073/pnas.2122840119] [Reference Citation Analysis]
554 Morin J, Peard L, Saltzman AF. Gonadal malignancy in patients with differences of sex development. Transl Androl Urol 2020;9:2408-15. [PMID: 33209714 DOI: 10.21037/tau-19-726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
555 Heinze A, Larcher A, Umari P, Fossati N, Piccolo J, De Groote R, Goossens M, De Coninck V, De Naeyer G, Mottrie A. Assessing perioperative, functional and oncological outcomes of patients with imperative versus elective indications for robot-assisted partial nephrectomy: Results from a high-volume center. Int J Urol 2018;25:826-31. [PMID: 30132976 DOI: 10.1111/iju.13754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
556 Xu W, Anwaier A, Ma C, Liu W, Tian X, Su J, Zhu W, Shi G, Wei S, Xu H, Qu Y, Ye D, Zhang H. Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment. Front Cell Dev Biol 2021;9:785410. [PMID: 34938737 DOI: 10.3389/fcell.2021.785410] [Reference Citation Analysis]
557 Walton-diaz A, Madariaga-venegas M, Aviles N, Roman JC, Gallegos I, Burotto M. Developing a National Center of Excellence for Prostate Imaging. Curr Urol Rep 2019;20. [DOI: 10.1007/s11934-019-0923-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
558 Erlmeier F, Sun N, Shen J, Feuchtinger A, Buck A, Prade VM, Kunzke T, Schraml P, Moch H, Autenrieth M, Weichert W, Hartmann A, Walch A. MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell Carcinomas. Cancers (Basel) 2022;14:1763. [PMID: 35406537 DOI: 10.3390/cancers14071763] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
559 Zhang KJ, Wilson GD, Kara S, Majeske A, Zhang PL, Hafron JM. Diagnostic role of kidney injury molecule-1 in renal cell carcinoma. Int Urol Nephrol 2019;51:1893-902. [DOI: 10.1007/s11255-019-02231-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
560 Luo J, Xie Y, Zheng Y, Wang C, Qi F, Hu J, Xu Y. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm. Cancer Med 2020;9:4310-23. [PMID: 32311223 DOI: 10.1002/cam4.2983] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
561 Wu P, Xiang T, Wang J, Lv R, Ma S, Yuan L, Wu G, Che X. Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis. BMC Med Genomics 2021;14:241. [PMID: 34620162 DOI: 10.1186/s12920-021-01092-w] [Reference Citation Analysis]
562 Xue J, Zhu S, Qi F, Zhu K, Cao P, Yang J, Wang Z. RUNX1/miR-582-5p Pathway Regulates the Tumor Progression in Clear Cell Renal Cell Carcinoma by Targeting COL5A1. Front Oncol 2021;11:610992. [PMID: 33937021 DOI: 10.3389/fonc.2021.610992] [Reference Citation Analysis]
563 Faes S, Demartines N, Dormond O. Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives. Front Cell Dev Biol 2021;9:636037. [PMID: 33791295 DOI: 10.3389/fcell.2021.636037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
564 Meng X, Xiong Z, Xiao W, Yuan C, Wang C, Huang Y, Tong J, Shi J, Chen Z, Liu C, Xie K, Xiong H, Chen K, Yang H, Zhang X. Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression. Ann Transl Med 2020;8:319. [PMID: 32355763 DOI: 10.21037/atm.2020.02.141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
565 Amin M, Trikalinos N, Chatterjee D. Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity. Hum Pathol 2021;114:36-43. [PMID: 33891968 DOI: 10.1016/j.humpath.2021.04.006] [Reference Citation Analysis]
566 Saiga K, Ohe C, Yoshida T, Ohsugi H, Ikeda J, Atsumi N, Noda Y, Yasukochi Y, Higasa K, Taniguchi H, Kinoshita H, Tsuta K. PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2022;14:1062. [PMID: 35205810 DOI: 10.3390/cancers14041062] [Reference Citation Analysis]
567 Ning Z, Pan W, Chen Y, Xiao Q, Zhang X, Luo J, Wang J, Zhang Y, Schwartz R. Integrative analysis of cross-modal features for the prognosis prediction of clear cell renal cell carcinoma. Bioinformatics 2020;36:2888-95. [DOI: 10.1093/bioinformatics/btaa056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
568 Lobo J, Jerónimo C, Henrique R. Targeting the Immune system and Epigenetic Landscape of Urological Tumors. Int J Mol Sci 2020;21:E829. [PMID: 32012885 DOI: 10.3390/ijms21030829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
569 Chen C, Yang RX, Zhang JX, Xu HG. Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte-associated genes. Cancer Med 2022. [PMID: 35373928 DOI: 10.1002/cam4.4733] [Reference Citation Analysis]
570 Chen YB, Gao L, Zhang JD, Guo J, You PH, Tang LY, Liu YW. Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma. Biomed Res Int 2021;2021:5589101. [PMID: 34222474 DOI: 10.1155/2021/5589101] [Reference Citation Analysis]
571 Fortarezza F, Trabucco SMR, De Luisi A, Resta N, Cimmino A, Marzullo A, Moschetta M, Lettini T, Serio G. Primary melanoma of the testis: myth. Ann Transl Med 2018;6:135. [PMID: 29955595 DOI: 10.21037/atm.2018.02.14] [Reference Citation Analysis]
572 Benešová M, Trejbalová K, Kučerová D, Vernerová Z, Hron T, Szabó A, Amouroux R, Klézl P, Hajkova P, Hejnar J. Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation. Mol Carcinog 2017;56:1837-50. [PMID: 28218476 DOI: 10.1002/mc.22638] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
573 Floranović MP, Veličković LJ. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma. Clin Genitourin Cancer 2020;18:e337-42. [PMID: 31882334 DOI: 10.1016/j.clgc.2019.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
574 Amar L, Pacak K, Steichen O, Akker SA, Aylwin SJB, Baudin E, Buffet A, Burnichon N, Clifton-Bligh RJ, Dahia PLM, Fassnacht M, Grossman AB, Herman P, Hicks RJ, Januszewicz A, Jimenez C, Kunst HPM, Lewis D, Mannelli M, Naruse M, Robledo M, Taïeb D, Taylor DR, Timmers HJLM, Treglia G, Tufton N, Young WF, Lenders JWM, Gimenez-Roqueplo AP, Lussey-Lepoutre C. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol 2021;17:435-44. [PMID: 34021277 DOI: 10.1038/s41574-021-00492-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 20.0] [Reference Citation Analysis]
575 Ofori EO, Bin Alhassan BA, Ayabilah EA, Maison POM, Asante-asamani A, Atawura H, Rahman GA, Akakpo PK, Imbeah EG, Ofori PW. An unusual outcome of papillary renal cell carcinoma with lung metastases: a case report and review of literature. Afr J Urol 2021;27. [DOI: 10.1186/s12301-020-00103-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
576 Ilijazi D, Shariat SF, Hassler MR, Lemberger U, Ertl IE. Epigenetic alterations of testicular germ cell tumours. Curr Opin Urol 2020;30:264-70. [PMID: 31905176 DOI: 10.1097/MOU.0000000000000724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
577 Liu Y, Cheng G, Song Z, Xu T, Ruan H, Cao Q, Wang K, Bao L, Liu J, Zhou L, Liu D, Yang H, Chen K, Zhang X. RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma. Int J Oncol 2019;55:645-56. [PMID: 31364727 DOI: 10.3892/ijo.2019.4849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
578 Gao S, Wang Z. Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma. J Healthc Eng 2021;2021:3533608. [PMID: 34221297 DOI: 10.1155/2021/3533608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
579 Palsgrove DN, Li Y, Pratilas CA, Lin MT, Pallavajjalla A, Gocke C, De Marzo AM, Matoso A, Netto GJ, Epstein JI, Argani P. Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum. Am J Surg Pathol 2018;42:1166-81. [PMID: 29975249 DOI: 10.1097/PAS.0000000000001111] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 12.7] [Reference Citation Analysis]
580 Iribe Y, Furuya M, Shibata Y, Yasui M, Funahashi M, Ota J, Iwashita H, Nagashima Y, Hasumi H, Hayashi N, Makiyama K, Kondo K, Tanaka R, Yao M, Nakaigawa N. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. Fam Cancer 2021;20:75-80. [PMID: 32666341 DOI: 10.1007/s10689-020-00195-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
581 Wyvekens N, Valtcheva N, Mischo A, Helmchen B, Hermanns T, Choschzick M, Hötker AM, Rauch A, Mühleisen B, Akhoundova D, Weber A, Moch H, Rupp NJ. Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Genes Chromosomes Cancer 2020;59:611-9. [PMID: 32537760 DOI: 10.1002/gcc.22878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
582 Bezhanova SD. Tumors of the kidney. The new 2016 WHO classification of tumors of the genitourinary system. Arkh patol 2017;79:48. [DOI: 10.17116/patol201779248-52] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
583 Dawoud MM, Aiad HA, Bahbah AMNH, Shaban MI. Comparative study of immunohistochemical expression of ERG and MAGI2 in prostatic carcinoma. Ann Diagn Pathol 2021;52:151727. [PMID: 33713943 DOI: 10.1016/j.anndiagpath.2021.151727] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
584 Chen C, Kang Q, Wei Q, Xu B, Ye H, Wang T, Lu Y, Lu J. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma. Abdom Radiol (NY) 2017;42:1464-71. [PMID: 27999886 DOI: 10.1007/s00261-016-1009-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
585 Xv Y, Lv F, Guo H, Zhou X, Tan H, Xiao M, Zheng Y. Machine learning-based CT radiomics approach for predicting WHO/ISUP nuclear grade of clear cell renal cell carcinoma: an exploratory and comparative study. Insights Imaging 2021;12:170. [PMID: 34800179 DOI: 10.1186/s13244-021-01107-1] [Reference Citation Analysis]
586 Lanciotti L, Cofini M, Leonardi A, Bertozzi M, Penta L, Esposito S. Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS). Int J Environ Res Public Health 2019;16:E1268. [PMID: 30970592 DOI: 10.3390/ijerph16071268] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
587 Kryst P, Poletajew S, Wyczałkowska-Tomasik A, Gonczar S, Wysocki M, Kapuścińska R, Krajewski W, Zgliczyński W, Pączek L. Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy. J Clin Med 2020;9:E3195. [PMID: 33023077 DOI: 10.3390/jcm9103195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
588 Lobo J, Gillis AJM, Jerónimo C, Henrique R, Looijenga LHJ. Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic. Int J Mol Sci 2019;20:E258. [PMID: 30634670 DOI: 10.3390/ijms20020258] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 17.7] [Reference Citation Analysis]
589 Pljesa-Ercegovac M, Savic-Radojevic A, Coric V, Radic T, Simic T. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma. Biofactors 2020;46:229-38. [PMID: 31483924 DOI: 10.1002/biof.1560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
590 Cimadamore A, Scarpelli M, Santoni M, Cheng L, Lopez-Beltran A, Montironi R. Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy. Expert Rev Mol Diagn 2018;18:1021-8. [PMID: 30452305 DOI: 10.1080/14737159.2018.1549490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
591 Liu X, Yang Z, Luo X, Luo J, Fu W, Fang Z, Xia D, Li L, Xu J. Calcium‐activated nucleotidase 1 silencing inhibits proliferation, migration, and invasion in human clear cell renal cell carcinoma. J Cell Physiol 2019;234:22635-47. [DOI: 10.1002/jcp.28829] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
592 Cattrini C, Cerbone L, Rubagotti A, Zinoli L, Latocca MM, Messina C, Zanardi E, Boccardo F. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study. Clinical Genitourinary Cancer 2019;17:e724-32. [DOI: 10.1016/j.clgc.2019.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
593 Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms. Urology 2019;133:145-50. [DOI: 10.1016/j.urology.2019.07.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
594 Norouzinia F, Abbasi F, Dindarian S, Mohammadi S, Meisami F, Bagheri M, Mohammadi H. Immunohistochemical study of C-kit expression in subtypes of renal cell carcinoma. Turk J Urol 2018;44:31-5. [PMID: 29484224 DOI: 10.5152/tud.2018.91455] [Reference Citation Analysis]
595 Agrawal V, Neyaz Z, Kapoor R. Thyroid-Like Follicular Carcinoma of the Kidney With Oncocytic Cells: A Case Report and Review of Metastatic and Non-metastatic Tumors. Int J Surg Pathol 2020;28:913-7. [PMID: 32484016 DOI: 10.1177/1066896920930283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
596 Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Nagashima Y, Tanabe K. Peritumoral pseudocapsule status according to pathological characteristics from robot‐assisted laparoscopic partial nephrectomy for localized renal cell carcinoma. Int J Urol 2019;26:446-50. [DOI: 10.1111/iju.13901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
597 Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients. Hum Pathol 2020;103:1-13. [PMID: 32681944 DOI: 10.1016/j.humpath.2020.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
598 Peyraud F, Allenet C, Gross-Goupil M, Domblides C, Lefort F, Daste A, Yacoub M, Haaser T, Ferretti L, Robert G, Ravaud A. Current management and future perspectives of penile cancer: An updated review. Cancer Treat Rev 2020;90:102087. [PMID: 32799062 DOI: 10.1016/j.ctrv.2020.102087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
599 Erlmeier F, Weichert W, Schrader AJ, Autenrieth M, Hartmann A, Steffens S, Ivanyi P. Prognostic impact of PD-1 and its ligands in renal cell carcinoma. Med Oncol 2017;34:99. [PMID: 28432616 DOI: 10.1007/s12032-017-0961-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
600 Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E, Wang PI, Nanjangud GJ, Redzematovic A, Nargund AM, Manley BJ, Arcila ME, Donin NM, Cheville JC, Thompson RH, Pantuck AJ, Russo P, Cheng EH, Lee W, Tickoo SK, Ostrovnaya I, Creighton CJ, Papaemmanuil E, Seshan VE, Hakimi AA, Hsieh JJ. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI Insight 2017;2:92688. [PMID: 28614790 DOI: 10.1172/jci.insight.92688] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 12.2] [Reference Citation Analysis]
601 Dong J, Chen JF, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng HR. Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Adv Mater 2020;32:e1903663. [PMID: 31566837 DOI: 10.1002/adma.201903663] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 19.5] [Reference Citation Analysis]
602 Wang D, Huang X, Bai L, Zhang X, Wei J, Zhou J. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography. Acta Radiol 2020;61:1562-9. [PMID: 32088966 DOI: 10.1177/0284185120903447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
603 Liu J, Yu X, Yu H, Liu B, Zhang Z, Kong C, Li Z. Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B. Cancer Med 2020;9:1183-95. [PMID: 31856414 DOI: 10.1002/cam4.2795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
604 Linehan WM, Ricketts CJ. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol 2019;16:539-52. [DOI: 10.1038/s41585-019-0211-5] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 29.0] [Reference Citation Analysis]
605 Lonati C, Baumeister P, Ornaghi PI, Di Trapani E, De Cobelli O, Rink M, Karnes RJ, Poyet C, Simone G, Afferi L, Necchi A, Briganti A, Montorsi F, Krajewski W, Antonelli A, Cerruto MA, Zamboni S, Simeone C, Mordasini L, Mattei A, Moschini M; EAU-YAU Urothelial Cancer Working Party. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy. Eur Urol Focus 2021:S2405-4569(21)00111-5. [PMID: 33867307 DOI: 10.1016/j.euf.2021.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
606 Alruwaii F, Grignon DJ, Idrees MT. Smooth muscle hyperplasia of the testicular adnexa: a clinicopathologic study of 12 cases. Hum Pathol 2020;99:27-35. [PMID: 32220606 DOI: 10.1016/j.humpath.2020.03.003] [Reference Citation Analysis]
607 Rodger FE, Brown K, Leung S, Coode‐bate J, Armitage J, Warren A, Hendry J, Stewart G, Laird A, Oades GM. Real world outcomes of biopsy‐proven oncocytic neoplasm of the kidney managed by surveillance. BJUI Compass. [DOI: 10.1002/bco2.141] [Reference Citation Analysis]
608 Vanthoor J, Vos G, Albersen M. Penile cancer: potential target for immunotherapy? World J Urol 2021;39:1405-11. [PMID: 33145666 DOI: 10.1007/s00345-020-03510-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
609 Barresi V. HOXB13 is not expressed in pleomorphic giant cell carcinoma of the bladder. Virchows Arch 2018;473:259-60. [PMID: 29926185 DOI: 10.1007/s00428-018-2394-1] [Reference Citation Analysis]
610 Che K, Han W, Zhang M, Niu H. Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma. Oncol Lett 2021;21:148. [PMID: 33552266 DOI: 10.3892/ol.2020.12409] [Reference Citation Analysis]
611 Banno T, Takagi T, Kondo T, Yoshida K, Iizuka J, Okumi M, Ishida H, Morita S, Nagashima Y, Tanabe K. Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma. Int Braz J Urol 2020;46:26-33. [PMID: 31851455 DOI: 10.1590/S1677-5538.IBJU.2018.0716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
612 Neves JB, Vanaclocha Saiz L, Abu-Ghanem Y, Marchetti M, Tran-Dang MA, El-Sheikh S, Barod R, Beisland C, Capitanio U, Cullen D, Klatte T, Ljungberg B, Mumtaz F, Patki P, Stewart GD, Dabestani S, Tran MGB, Bex A; RECUR consortium. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma. World J Urol 2021. [PMID: 33851271 DOI: 10.1007/s00345-021-03683-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
613 Elias R, Zhang Q, Brugarolas J. The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities. Cancer J 2020;26:390-8. [PMID: 32947307 DOI: 10.1097/PPO.0000000000000480] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
614 Sanders C, Hamad ASM, Ng S, Hosni R, Ellinger J, Klümper N, Ritter M, Stephan C, Jung K, Hölzel M, Kristiansen G, Hauser S, Toma MI. CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC. Cancers 2022;14:1541. [DOI: 10.3390/cancers14061541] [Reference Citation Analysis]
615 Razafinjatovo C, Bihr S, Mischo A, Vogl U, Schmidinger M, Moch H, Schraml P. Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer 2016;16:638. [PMID: 27530247 DOI: 10.1186/s12885-016-2688-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
616 Mele T, Reid A, Huddart R. Recent advances in testicular germ cell tumours. Fac Rev 2021;10:67. [PMID: 34557871 DOI: 10.12703/r/10-67] [Reference Citation Analysis]
617 Kravvas G, Ge L, Ng J, Shim TN, Doiron PR, Watchorn R, Kentley J, Panou E, Dinneen M, Freeman A, Jameson C, Haider A, Francis N, Minhas S, Alnajjar H, Muneer A, Bunker CB. The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature. Journal of Dermatological Treatment. [DOI: 10.1080/09546634.2020.1800574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
618 Qian X, Wan J, Qian C, Zhang J. Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma. Int J Gen Med 2021;14:7523-31. [PMID: 34754225 DOI: 10.2147/IJGM.S340569] [Reference Citation Analysis]
619 Koparal MY, Polat F, Çetin S, Bulut EC, Sözen TS. Prognostic role of preoperative albumin to globulin ratio in predicting survival of clear cell renal cell carcinoma. Int Braz J Urol 2018;44:933-46. [PMID: 29757575 DOI: 10.1590/S1677-5538.IBJU.2018.0012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
620 Morshid A, Duran ES, Choi WJ, Duran C. A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma. Cureus 2021;13:e13231. [PMID: 33728180 DOI: 10.7759/cureus.13231] [Reference Citation Analysis]
621 Erman M, Benekli M, Basaran M, Bavbek S, Buyukberber S, Coskun U, Demir G, Karabulut B, Oksuzoglu B, Ozkan M, Sevinc A, Yalcin S. Renal cell cancer: overview of the current therapeutic landscape. Expert Review of Anticancer Therapy 2016;16:955-68. [DOI: 10.1080/14737140.2016.1222908] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
622 Giulietti M, Cecati M, Sabanovic B, Scirè A, Cimadamore A, Santoni M, Montironi R, Piva F. The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors. Diagnostics (Basel) 2021;11:206. [PMID: 33573278 DOI: 10.3390/diagnostics11020206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
623 Packiam VT, Tyson Ii MD, Tsivian M, Lohse CM, Boorjian SA, Cheville JC, Costello BA, Leibovich BC, Thompson RH. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. Urologic Oncology: Seminars and Original Investigations 2020;38:41.e19-27. [DOI: 10.1016/j.urolonc.2019.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
624 Frydenlund N, Zakharia Y, Garje R, Dahmoush L, O'Donnell MA. Non-Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible. J Investig Med High Impact Case Rep 2018;6:2324709618806332. [PMID: 30349834 DOI: 10.1177/2324709618806332] [Reference Citation Analysis]
625 Rüschoff JH, Ferraro DA, Muehlematter UJ, Laudicella R, Hermanns T, Rodewald AK, Moch H, Eberli D, Burger IA, Rupp NJ. What's behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns. Eur J Nucl Med Mol Imaging 2021. [PMID: 34386839 DOI: 10.1007/s00259-021-05501-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
626 Elst L, Albersen M. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions? Seminars in Oncology Nursing 2022. [DOI: 10.1016/j.soncn.2022.151284] [Reference Citation Analysis]
627 Rini BI, Battle D, Figlin RA, George DJ, Hammers H, Hutson T, Jonasch E, Joseph RW, McDermott DF, Motzer RJ, Pal SK, Pantuck AJ, Quinn DI, Seery V, Voss MH, Wood CG, Wood LS, Atkins MB. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC). J Immunother Cancer 2019;7:354. [PMID: 31856918 DOI: 10.1186/s40425-019-0813-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 23.3] [Reference Citation Analysis]
628 Huang R, Zhang C, Wang X, Zou X, Xiang Z, Wang Z, Gui B, Lin T, Hu H. Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC. Cancer Med 2022. [PMID: 35322581 DOI: 10.1002/cam4.4716] [Reference Citation Analysis]
629 Iida N, Takemura K, Ito M, Funata N, Yonese I, Suzuki H, Tsuzuki T, Koga F. Primary Testicular Neuroendocrine Tumor Coexisting With Seminoma Sharing Germ Cell Origin. Int J Surg Pathol. [DOI: 10.1177/10668969211008980] [Reference Citation Analysis]
630 Ronchi A, Pagliuca F, Franco R. Testicular germ cell tumors: the changing role of the pathologist. Ann Transl Med 2019;7:S204. [PMID: 31656783 DOI: 10.21037/atm.2019.07.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
631 Shi B, Xue K, Yin Y, Xu Q, Shi B, Wu D, Ye J. Grading of clear cell renal cell carcinoma using diffusion MRI with a fractional order calculus model. Acta Radiol 2022;:2841851211072482. [PMID: 35040361 DOI: 10.1177/02841851211072482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
632 Martínez I Cózar V, Bauza ME, Blanco Máñez R, Vera-Sempere FJ, Ramos-Soler D. [Tubulocystic renal cell carcinoma. A rare entity in neoplastic renal pathology]. Rev Esp Patol 2019;52:57-61. [PMID: 30583834 DOI: 10.1016/j.patol.2018.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
633 Mueller-peltzer K, Negrao de Figueiredo G, Graf T, Rübenthaler J, Clevert D, Jung F, Fornal M. Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) – A diagnostic performance study. CH 2019;71:159-64. [DOI: 10.3233/ch-189406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
634 Fichtner A, Bohnenberger H, Elakad O, Richter A, Lenz C, Oing C, Ströbel P, Kueffer S, Nettersheim D, Bremmer F. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry. World J Urol 2022. [PMID: 35084545 DOI: 10.1007/s00345-022-03936-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Freund JE, Buijs M, Savci-heijink CD, de Bruin DM, de la Rosette JJMCH, van Leeuwen TG, Laguna MP. Optical Coherence Tomography in Urologic Oncology: a Comprehensive Review. SN Compr Clin Med 2019;1:67-84. [DOI: 10.1007/s42399-018-0016-5] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
636 Fankhauser CD, Roth L, Grossmann NC, Kranzbühler B, Eberli D, Sulser T, Moch H, Bode PK, Beyer J, Hermanns T. CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors. BMC Cancer 2019;19:802. [PMID: 31412792 DOI: 10.1186/s12885-019-5961-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
637 Nicu A, Medar C, Chifiriuc MC, Gradisteanu Pircalabioru G, Burlibasa L. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care. Front Cell Dev Biol 2022;10:861995. [DOI: 10.3389/fcell.2022.861995] [Reference Citation Analysis]
638 Lotan TL, Kaur HB, Alharbi AM, Pritchard CC, Epstein JI. DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features. Histopathology 2019;74:836-43. [PMID: 30636012 DOI: 10.1111/his.13806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
639 Gu W, Zhang P, Zhang G, Zhou J, Ding X, Wang Q, Wang B, Wei Y, Jin S, Ye D, Zhu Y. Importance of HPV in Chinese Penile Cancer: A Contemporary Multicenter Study. Front Oncol 2020;10:1521. [PMID: 33014796 DOI: 10.3389/fonc.2020.01521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
640 Wu J, Wei Y, Miao C, Wang S, Wang X, Wang Z, Wang J. Essential m6A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-29. [DOI: 10.1155/2022/9411692] [Reference Citation Analysis]
641 Johnson M, Nowlan S, Sahin G, Barnett DA, Joy AP, Touaibia M, Cuperlovic-Culf M, Zofija Avizonis D, Turcotte S. Decrease of Intracellular Glutamine by STF-62247 Results in the Accumulation of Lipid Droplets in von Hippel-Lindau Deficient Cells. Front Oncol 2022;12:841054. [PMID: 35223522 DOI: 10.3389/fonc.2022.841054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
642 Hu X, Wang YH, Lia T, Yang ZQ, Shao YX, Yang WX, Li X. Prognostic value of preoperative prognostic nutritional index in patients with renal cell carcinoma after nephrectomy. Clin Chim Acta 2020;509:210-6. [PMID: 32562664 DOI: 10.1016/j.cca.2020.06.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Sivagnanasithiyar T, Okafor L, Faust G, Mudhar HS, Sii S, Knapp C, Sampath R. Metastatic testicular choriocarcinoma presenting as eyelid swelling and ptosis. Orbit 2021;:1-4. [PMID: 33632056 DOI: 10.1080/01676830.2021.1890134] [Reference Citation Analysis]
644 Han D, Yu Y, Yu N, Dang S, Wu H, Jialiang R, He T. Prediction models for clear cell renal cell carcinoma ISUP/WHO grade: comparison between CT radiomics and conventional contrast-enhanced CT. Br J Radiol 2020;93:20200131. [PMID: 32706977 DOI: 10.1259/bjr.20200131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
645 Al-Maghrabi B, Gomaa W, Abdelwahed M, Al-Maghrabi J. Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis. Anal Cell Pathol (Amst) 2019;2019:5026939. [PMID: 31179232 DOI: 10.1155/2019/5026939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
646 Wang N, Yuan J, Liu F, Wei J, Liu Y, Xue M, Dong R. NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription. PeerJ 2021;9:e10848. [PMID: 33981484 DOI: 10.7717/peerj.10848] [Reference Citation Analysis]
647 Luo M, Zhu Y, Chen S, Huang Q, Zhang W, Ma M, Wei Y. Multi-Phase Multiple Detector Computed Tomography (MDCT) Enhancement Patterns and Morphological Features of Chromophobe Renal Cell Carcinoma: An Analysis of 67 Cases. Med Sci Monit 2021;27:e929287. [PMID: 33907175 DOI: 10.12659/MSM.929287] [Reference Citation Analysis]
648 Pierpont TM, Lyndaker AM, Anderson CM, Jin Q, Moore ES, Roden JL, Braxton A, Bagepalli L, Kataria N, Hu HZ, Garness J, Cook MS, Capel B, Schlafer DH, Southard T, Weiss RS. Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer. Cell Rep 2017;21:1896-909. [PMID: 29141221 DOI: 10.1016/j.celrep.2017.10.078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
649 Yip SM, Ruiz Morales JM, Donskov F, Fraccon A, Basso U, Rini BI, Lee JL, Bjarnason GA, Sim HW, Beuselinck B, Kanesvaran R, Brugarolas J, Koutsoukos K, Fu SYF, Yuasa T, Davis I, Alva A, Kollmannsberger C, Choueiri TK, Heng DYC. Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC). Kidney Cancer 2017;1:41-7. [PMID: 30334003 DOI: 10.3233/KCA-160002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
650 Gulati S, Vogelzang NJ. Biomarkers in renal cell carcinoma: Are we there yet? Asian J Urol 2021;8:362-75. [PMID: 34765444 DOI: 10.1016/j.ajur.2021.05.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
651 Xu N, Xiao W, Meng X, Li W, Wang X, Zhang X, Yang H. Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT. Cell Death Discov 2022;8:351. [PMID: 35927229 DOI: 10.1038/s41420-022-01145-8] [Reference Citation Analysis]
652 Li F, Hu W, Zhang W, Li G, Guo Y. A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma. Dis Markers 2020;2020:8352809. [PMID: 32184905 DOI: 10.1155/2020/8352809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
653 Liu N, Gan W, Qu F, Wang Z, Zhuang W, Agizamhan S, Xu L, Yin J, Guo H, Li D. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study. Am J Pathol 2018;188:929-36. [PMID: 29571325 DOI: 10.1016/j.ajpath.2017.12.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
654 Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, Linehan WM, Maher ER, Merino MJ, Offit K, Reuter VE, Shuch B, Coleman JA. Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights. Eur Urol. 2019;76:754-764. [PMID: 31326218 DOI: 10.1016/j.eururo.2019.06.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
655 Guerreiro Í, Ferreira-pêgo C, Carregosa D, Santos CN, Menezes R, Fernandes AS, Costa JG. Polyphenols and Their Metabolites in Renal Diseases: An Overview. Foods 2022;11:1060. [DOI: 10.3390/foods11071060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
656 González Ibáñez MV, Ruiz Cabezas L, Moreno Ontalba A, Rubio Fernández A, Mayoral Guisado C, Flores Barranquero M, Díaz Delgado M. [Hereditary leiomyomatosis syndrome associated with renal cell carcinoma. A case report]. Rev Esp Patol 2021;54:193-6. [PMID: 34175032 DOI: 10.1016/j.patol.2019.07.001] [Reference Citation Analysis]
657 Cao C, Bi X, Liang J, Li L, Zhang H, Xiao Z, Xiao Z, Tian J, Wang D, Guan K, Li C, Ma J, Zheng S, Shou J. Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. BMC Cancer 2019;19:144. [PMID: 30760245 DOI: 10.1186/s12885-019-5359-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
658 Erdogan F, Radu TB, Orlova A, Qadree AK, de Araujo ED, Israelian J, Valent P, Mustjoki SM, Herling M, Moriggl R, Gunning PT. JAK-STAT core cancer pathway: An integrative cancer interactome analysis. J Cell Mol Med 2022. [PMID: 35229974 DOI: 10.1111/jcmm.17228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
659 Liu Y, Li J, Song M, Qi G, Meng L, Ye X. High-Concentration Metformin Reduces Oxidative Stress Injury and Inhibits the Growth and Migration of Clear Cell Renal Cell Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/1466991] [Reference Citation Analysis]
660 Lee KS, Yun S, Lee K, Moon S, Choe G. Clinicopathological implications of the expression of vascular endothelial growth factor and programmed death ligand 1 in clear-cell renal cell carcinoma. Hum Pathol 2020;99:88-97. [PMID: 32246989 DOI: 10.1016/j.humpath.2020.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
661 Chang HY, Hang JF, Wu CY, Lin TP, Chung HJ, Chang YH, Pan CC. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue. Histopathology 2021;78:1019-31. [PMID: 33351968 DOI: 10.1111/his.14320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
662 Rouprêt M, Xylinas E, Colin P, Houédé N, Compérat E, Audenet F, Larré S, Masson-Lecomte A, Pignot G, Brunelle S, Roumiguié M, Neuzillet Y, Méjean A. [French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma]. Prog Urol 2018;28 Suppl 1:R34-47. [PMID: 31610873 DOI: 10.1016/j.purol.2019.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
663 Rocher L, Criton A, Gennisson J, Creze M, Albiges L, Ferlicot S, Bellin M, Izard V, Correas J. Characterization of Testicular Masses in Adults: Performance of Combined Quantitative Shear Wave Elastography and Conventional Ultrasound. Ultrasound in Medicine & Biology 2019;45:720-31. [DOI: 10.1016/j.ultrasmedbio.2018.10.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
664 Gu D, Dong K, Jiang A, Jiang S, Fu Z, Bao Y, Huang F, Yang C, Wang L. PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2'-Deoxycytidine. Front Oncol 2022;12:870229. [PMID: 35719970 DOI: 10.3389/fonc.2022.870229] [Reference Citation Analysis]
665 Ghasemi H, Amini MA, Pegah A, Azizi E, Tayebinia H, Khanverdilou S, Mousavibahar SH, Alizamir A. Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer. Mol Biol Rep 2020;47:6497-505. [PMID: 32770525 DOI: 10.1007/s11033-020-05702-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
666 Asgharzadeh F, Hashemzehi M, Moradi-Marjaneh R, Hassanian SM, Ferns GA, Khazaei M, Avan A. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis. Life Sci 2020;242:117181. [PMID: 31863771 DOI: 10.1016/j.lfs.2019.117181] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
667 Ferrari M, Cartolari R, Barizzi J, Pereira Mestre R, D'Antonio E, Renard J. Percutaneous biopsy of small renal mass: can diagnostic accuracy be affected by hospital volume? Cent European J Urol 2021;74:334-40. [PMID: 34729222 DOI: 10.5173/ceju.2021.3.0104] [Reference Citation Analysis]
668 Al-Obaidy KI, Cheng L. Renal oncocytoma with adverse pathologic features: a clinical and pathologic study of 50 cases. Mod Pathol 2021. [PMID: 34103666 DOI: 10.1038/s41379-021-00849-z] [Reference Citation Analysis]
669 Yang B, Xia H, Xu C, Lu M, Zhang S, Wang G, Ma L. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically. BMC Urol 2020;20:14. [PMID: 32070319 DOI: 10.1186/s12894-020-0584-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
670 Kyriazoglou A, Dimitriadis I, Bamias A. Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease. Forum of Clinical Oncology 2017;8:15-21. [DOI: 10.1515/fco-2015-0025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
671 Compérat E, Moguelet P. [The malignant epithelial carcinomas of the penis: A review of the different histological types]. Ann Pathol 2021:S0242-6498(21)00089-4. [PMID: 34872795 DOI: 10.1016/j.annpat.2021.03.014] [Reference Citation Analysis]
672 van Oostenbrugge TJ, Fütterer JJ, Mulders PFA. Diagnostic Imaging for Solid Renal Tumors: A Pictorial Review. Kidney Cancer 2018;2:79-93. [PMID: 30740580 DOI: 10.3233/KCA-180028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
673 Pan L, Su Z, Song J, Xu W, Liu X, Zhang L, Li S; multidisciplinary collaboration team of DSD management at Shenzhen Children’s Hospital. Growth data and tumour risk of 32 Chinese children and adolescents with 45,X/46,XY mosaicism. BMC Pediatr 2019;19:143. [PMID: 31060547 DOI: 10.1186/s12887-019-1520-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
674 Zhai TY, Luo BJ, Jia ZK, Zhang ZG, Li X, Li H, Yang JJ. Organ-associated pseudosarcomatous myofibroblastic proliferation with ossification in the lower pole of the kidney mimicking renal pelvic carcinoma: A case report. World J Clin Cases 2019; 7(17): 2605-2610 [PMID: 31559299 DOI: 10.12998/wjcc.v7.i17.2605] [Reference Citation Analysis]
675 Ren W, Xue B, Qu J, Liu L, Li C, Zu X. Localized chromophobe renal cell carcinoma: preoperative imaging judgment and laparoscopic simple enucleation for treatment. Int Braz J Urol 2018;44:922-32. [PMID: 29757571 DOI: 10.1590/S1677-5538.IBJU.2017.0519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
676 Wang X, Ou H, Zhou L, Liu H, Liu X, Zhang H. Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis. Exp Ther Med 2021;22:754. [PMID: 34035851 DOI: 10.3892/etm.2021.10186] [Reference Citation Analysis]
677 Yang K, Lu XF, Luo PC, Zhang J. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma. Biomed Res Int 2018;2018:9303486. [PMID: 30406146 DOI: 10.1155/2018/9303486] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
678 Skowron MA, Vermeulen M, Winkelhausen A, Becker TK, Bremmer F, Petzsch P, Schönberger S, Calaminus G, Köhrer K, Albers P, Nettersheim D. CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms. Br J Cancer 2020;123:378-91. [PMID: 32418994 DOI: 10.1038/s41416-020-0891-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
679 Ayoubian H, Heinzelmann J, Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Heinzelbecker J, Lohse S, Geppert C, Loertzer H, Wunderlich H, Bohle RM, Stöckle M, Matveev VB, Hartmann A, Junker K. miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma. Cancers (Basel) 2021;13:1480. [PMID: 33807023 DOI: 10.3390/cancers13061480] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
680 Moch H, Ohashi R, Gandhi JS, Amin MB. Morphological clues to the appropriate recognition of hereditary renal neoplasms. Semin Diagn Pathol 2018;35:184-92. [PMID: 29454577 DOI: 10.1053/j.semdp.2018.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
681 Letkovska K, Babal P, Cierna Z, Schmidtova S, Liskova V, Kalavska K, Miskovska V, Horak S, Rejlekova K, Chovanec M, Mardiak J, Janega P, Mego M. Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors. Cancers (Basel) 2021;13:776. [PMID: 33668443 DOI: 10.3390/cancers13040776] [Reference Citation Analysis]
682 Michalova K, Tretiakova M, Pivovarcikova K, Alaghehbandan R, Perez Montiel D, Ulamec M, Osunkoya A, Trpkov K, Yuan G, Grossmann P, Sperga M, Ferak I, Rogala J, Mareckova J, Pitra T, Kolar J, Michal M, Hes O. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture. Ann Diagn Pathol 2020;44:151448. [PMID: 31918172 DOI: 10.1016/j.anndiagpath.2019.151448] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
683 Hu X, Shao YX, Yang ZQ, Dou WC, Xiong SC, Li X. Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis. Cancer Cell Int 2020;20:222. [PMID: 32523427 DOI: 10.1186/s12935-020-01320-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
684 García M, Palma MB, Verine J, Miriuka S, Inda AM, Errecalde AL, Desgrandchamps F, Carosella ED, Tronik-Le Roux D. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma. BMC Cancer 2020;20:624. [PMID: 32620162 DOI: 10.1186/s12885-020-07113-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
685 Montes-mojarro IA, Hassas S, Staehle S, Sander P, Harland N, Serna-higuita LM, Bonzheim I, Bösmüller H, Stenzl A, Fend F. Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification. IJMS 2022;23:8133. [DOI: 10.3390/ijms23158133] [Reference Citation Analysis]
686 Hires M, Jane E, Mego M, Chovanec M, Kasak P, Tkac J. Glycan Analysis as Biomarkers for Testicular Cancer. Diagnostics (Basel) 2019;9:E156. [PMID: 31652641 DOI: 10.3390/diagnostics9040156] [Reference Citation Analysis]
687 Koshkin VS, Barata PC, Zhang T, George DJ, Atkins MB, Kelly WJ, Vogelzang NJ, Pal SK, Hsu J, Appleman LJ, Ornstein MC, Gilligan T, Grivas P, Garcia JA, Rini BI. Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma. J Immunother Cancer 2018;6:9. [PMID: 29378660 DOI: 10.1186/s40425-018-0319-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 20.8] [Reference Citation Analysis]
688 Boudaouara O, Kallel R, Dhieb D, Smaoui W, Ayed HB, Keskes L, Sellami Boudawara T. Renal angiomyolipoma: Clinico-pathologic study of 17 cases with emphasis on the epithelioid histology and p53 gene abnormalities. Ann Diagn Pathol 2020;47:151538. [PMID: 32574890 DOI: 10.1016/j.anndiagpath.2020.151538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
689 Falzarano SM, Feely MM. How can biomarkers assist the prognosis of urologic malignancies? Expert Review of Molecular Diagnostics 2020;20:131-3. [DOI: 10.1080/14737159.2019.1665506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
690 Prudhomme T, Maulat C, Péré G, Mokrane FZ, Soulié M, Muscari F. Are gastric metastases of renal cell carcinoma really rare? A case report and systematic review of the literature. Int J Surg Case Rep 2021;82:105867. [PMID: 33839629 DOI: 10.1016/j.ijscr.2021.105867] [Reference Citation Analysis]
691 da Costa WH, Fares AF, Bezerra SM, Morini MA, de Toledo Benigno LA, Clavijo DA, Fornazieri L, Rocha MM, da Cunha IW, de Cassio Zequi S. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. Urol Oncol 2019;37:78-85. [PMID: 30446457 DOI: 10.1016/j.urolonc.2018.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
692 Jorge S, Capelo JL, LaFramboise W, Satturwar S, Korentzelos D, Bastacky S, Quiroga-Garza G, Dhir R, Wiśniewski JR, Lodeiro C, Santos HM. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms. BMC Med 2021;19:196. [PMID: 34482820 DOI: 10.1186/s12916-021-02071-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
693 Karabulut YY, Köse EÇ, Bozlu M, Tuncel F, Yüksek GE, Etit D, Toru HS, Akkaya B, Çelik ZE, Öznur M, Temel GÖ, Akbay E. The role of COL6A1and PD-1 expressions in renal cell carcinoma. Turk J Urol 2020. [PMID: 32479254 DOI: 10.5152/tud.2020.20062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
694 López-Cortés R, Vázquez-Estévez S, Fernández JÁ, Núñez C. Proteomics as a Complementary Technique to Characterize Bladder Cancer. Cancers (Basel) 2021;13:5537. [PMID: 34771699 DOI: 10.3390/cancers13215537] [Reference Citation Analysis]
695 Kleibert M, Majka M, Łakomska K, Czystowska-kuźmicz M. Extracellular Vesicles—A New Potential Player in the Immunology of Renal Cell Carcinoma. JPM 2022;12:772. [DOI: 10.3390/jpm12050772] [Reference Citation Analysis]
696 Castillo RP, Santoscoy JF, Pisani L, Madrazo BL, Casillas VJ. Imaging of Unusual Renal Tumors. Curr Urol Rep 2019;20:5. [PMID: 30663008 DOI: 10.1007/s11934-019-0867-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
697 Zhu W, Wang JZ, Wei JF, Lu C. Role of m6A methyltransferase component VIRMA in multiple human cancers (Review). Cancer Cell Int 2021;21:172. [PMID: 33731118 DOI: 10.1186/s12935-021-01868-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
698 Wu Y, Wei X, Feng H, Hu B, Liu B, Luan Y, Ruan Y, Liu X, Liu Z, Liu J, Wang T. Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma. Oxid Med Cell Longev 2021;2021:6648093. [PMID: 33968297 DOI: 10.1155/2021/6648093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
699 Li QK, Pavlovich CP, Zhang H, Kinsinger CR, Chan DW. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers. Semin Cancer Biol 2019;55:8-15. [PMID: 30055950 DOI: 10.1016/j.semcancer.2018.06.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
700 Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades. Journal of Proteomics 2019;191:38-47. [DOI: 10.1016/j.jprot.2018.04.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
701 Li Y, Liu X, Duan CF, Zhuang XH, Ge W, Song XF. Imaging manifestations of congenital mesoblastic nephroma. Clin Imaging 2021;72:91-6. [PMID: 33217676 DOI: 10.1016/j.clinimag.2020.10.040] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
702 Barthélémy P, Rioux-Leclercq N, Thibault C, Saldana C, Borchiellini D, Chevreau C, Desmoulins I, Gobert A, Hilgers W, Khalil A, Lemoine N, Schlürmann-Constans F, Négrier S. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data. Cancer Treat Rev 2021;97:102191. [PMID: 34015728 DOI: 10.1016/j.ctrv.2021.102191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
703 Chahoud J, Msaouel P, Campbell MT, Bathala T, Xiao L, Gao J, Zurita AJ, Shah AY, Jonasch E, Sharma P, Tannir NM. Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis. Oncologist. 2020;25:252-258. [PMID: 32162795 DOI: 10.1634/theoncologist.2019-0372] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
704 Bang AK, Busch AS, Almstrup K, Gromoll J, Kliesch S, Rajpert-de Meyts E, Skakkebaek NE, Juul A, Tüttelmann F, Jørgensen N. Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer? Andrology 2018;6:176-83. [DOI: 10.1111/andr.12440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
705 Agrawal S, Haas NB, Bagheri M, Lane BR, Coleman J, Hammers H, Bratslavsky G, Chauhan C, Kim L, Krishnasamy VP, Marko J, Maher VE, Ibrahim A, Cross F Jr, Liu K, Beaver JA, Pazdur R, Blumenthal GM, Singh H, Plimack ER, Choueiri TK, Uzzo R, Apolo AB. Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer. JAMA Oncol 2020;6:133-41. [PMID: 31750870 DOI: 10.1001/jamaoncol.2019.4117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
706 Fernando A. Time to Focus on the Rare-Encouraging Progress in the Management of Non-clear Cell Renal Cell Carcinoma. Eur Urol 2017;72:984-5. [PMID: 28822585 DOI: 10.1016/j.eururo.2017.07.028] [Reference Citation Analysis]
707 Pitra T, Pivovarcikova K, Tupy R, Alaghehbandan R, Barakova T, Travnicek I, Prochazkova K, Klatte T, Chlosta P, Hes O, Hora M. Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study. World J Urol 2018;36:905-11. [PMID: 29383479 DOI: 10.1007/s00345-018-2176-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
708 Carnahan MB, Kunzelman J, Kawashima A, Patel BN, Menias CO, Fananapazir G. Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution. Abdom Radiol (NY) 2022;47:2858-66. [PMID: 35674787 DOI: 10.1007/s00261-022-03566-6] [Reference Citation Analysis]
709 Introini C, Di Domenico A, Ennas M, Campodonico F, Brusasco C, Benelli A. Functional and oncological outcomes of 3D clampless sutureless laparoscopic partial nephrectomy for renal tumors with low nephrometry score. Minerva Urol Nefrol 2020;72:723-8. [PMID: 32748622 DOI: 10.23736/S0393-2249.20.04005-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
710 Li M, Wang Y, Cheng L, Niu W, Zhao G, Raju JK, Huo J, Wu B, Yin B, Song Y, Bu R. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications. Oncotarget 2017;8:48424-35. [PMID: 28467794 DOI: 10.18632/oncotarget.17053] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
711 Lin TF, Lin WR, Chen M, Dai SH, Sun FJ, Tsai WK, Chiu AW. Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC. Open Med (Wars) 2019;14:336-42. [PMID: 31032425 DOI: 10.1515/med-2019-0032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
712 Franca RA, Crocetto F, Pandolfo SD, Ponsiglione A, Franzese CA, Imbriaco M, Imbimbo C, Insabato L. Cystadenoma of the seminal vesicle – Potential diagnostic pitfall: A case report and literature review. Journal of Clinical Urology. [DOI: 10.1177/20514158211059059] [Reference Citation Analysis]
713 Agarwala V, Ramaswamy A, Joshi A, Patil VM, Noronha V, Menon S, Popat BP, Sable N, Prabhash K. Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysis. South Asian J Cancer 2018;7:226-30. [PMID: 30430089 DOI: 10.4103/sajc.sajc_22_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
714 Hu D, Zhou M, Zhu X. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer. Biomed Res Int 2019;2019:2506843. [PMID: 31886185 DOI: 10.1155/2019/2506843] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
715 Zuo T, Zheng Y, He L, Chen T, Zheng B, Zheng S, You J, Li X, Liu R, Bai J, Si S, Wang Y, Zhang S, Wang L, Chen J. Automated Classification of Papillary Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma Based on a Small Computed Tomography Imaging Dataset Using Deep Learning. Front Oncol 2021;11:746750. [PMID: 34868946 DOI: 10.3389/fonc.2021.746750] [Reference Citation Analysis]
716 Martins-lima C, Miranda-gonçalves V, Lobo J, Constâncio V, Leite-silva P, Guimarães-teixeira C, Monteiro-reis S, Sequeira JP, Cantante M, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression. Cell Oncol . [DOI: 10.1007/s13402-021-00657-2] [Reference Citation Analysis]
717 Rudzinska M, Czarnecka-Chrebelska KH, Kuznetsova EB, Maryanchik SV, Parodi A, Korolev DO, Potoldykova N, Svetikova Y, Vinarov AZ, Nemtsova MV, Zamyatnin AA Jr. Long Non-Coding PROX1-AS1 Expression Correlates with Renal Cell Carcinoma Metastasis and Aggressiveness. Noncoding RNA 2021;7:25. [PMID: 33920185 DOI: 10.3390/ncrna7020025] [Reference Citation Analysis]
718 Shen H, Shih J, Hollern DP, Wang L, Bowlby R, Tickoo SK, Thorsson V, Mungall AJ, Newton Y, Hegde AM, Armenia J, Sánchez-Vega F, Pluta J, Pyle LC, Mehra R, Reuter VE, Godoy G, Jones J, Shelley CS, Feldman DR, Vidal DO, Lessel D, Kulis T, Cárcano FM, Leraas KM, Lichtenberg TM, Brooks D, Cherniack AD, Cho J, Heiman DI, Kasaian K, Liu M, Noble MS, Xi L, Zhang H, Zhou W, ZenKlusen JC, Hutter CM, Felau I, Zhang J, Schultz N, Getz G, Meyerson M, Stuart JM, Akbani R, Wheeler DA, Laird PW, Nathanson KL, Cortessis VK, Hoadley KA; Cancer Genome Atlas Research Network. Integrated Molecular Characterization of Testicular Germ Cell Tumors. Cell Rep 2018;23:3392-406. [PMID: 29898407 DOI: 10.1016/j.celrep.2018.05.039] [Cited by in Crossref: 158] [Cited by in F6Publishing: 147] [Article Influence: 52.7] [Reference Citation Analysis]
719 Feldman DR, Ged Y, Lee CH, Knezevic A, Molina AM, Chen YB, Chaim J, Coskey DT, Murray S, Tickoo SK, Reuter VE, Patil S, Xiao H, Aghalar J, Apollo AJ, Carlo MI, Motzer RJ, Voss MH. Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. Cancer 2020;126:5247-55. [PMID: 32975815 DOI: 10.1002/cncr.33148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
720 Narayanasamy S, Krishna S, Prasad Shanbhogue AK, Flood TA, Sadoughi N, Sathiadoss P, Schieda N. Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management. Clin Radiol 2019;74:83-94. [PMID: 30314810 DOI: 10.1016/j.crad.2018.09.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
721 Casuscelli J, Vano YA, Fridman WH, Hsieh JJ. Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice. Kidney Cancer. 2017;1:3-13. [PMID: 30334000 DOI: 10.3233/kca-170008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
722 Yan X, Zhou L, Li S, Wu X, Cui C, Chi Z, Si L, kong Y, Tang B, Li C, Mao L, Wang X, Lian B, Bai X, Dai J, Guo J, Sheng X. Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma. Clinical Genitourinary Cancer 2022. [DOI: 10.1016/j.clgc.2022.03.005] [Reference Citation Analysis]
723 Aravind S, Nayanar SK, Varadharajaperumal R, Satheeshbabu TV, Balasubramanian S. High Grade Serous Cystadenocarcinoma of Testis-Case Report of a Rare Ovarian Epithelial Type Tumour. J Clin Diagn Res 2017;11:ED13-5. [PMID: 28764180 DOI: 10.7860/JCDR/2017/27743.10097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
724 Miyai K, Yonekura Y, Ito K, Matsukuma S, Tsuda H. Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors. Virchows Arch 2021. [PMID: 34347114 DOI: 10.1007/s00428-021-03168-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
725 Flippot R, Damarla V, McGregor BA. Management of Metastatic Renal Cell Carcinoma with Variant Histologies. Urol Clin North Am 2020;47:319-27. [PMID: 32600534 DOI: 10.1016/j.ucl.2020.04.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
726 Fuchizawa H, Kijima T, Takada-Owada A, Nagashima Y, Okazaki A, Yokoyama M, Nishihara D, Ishida K, Kamai T. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab. IJU Case Rep 2021;4:333-7. [PMID: 34497997 DOI: 10.1002/iju5.12342] [Reference Citation Analysis]
727 Herlemann A, Horst D, D'Anastasi M, Kretschmer A, Stief CG, Gratzke C. [Primary prostatic sarcoma - a rare malignancy]. Urologe A 2017;56:857-60. [PMID: 28349187 DOI: 10.1007/s00120-017-0370-z] [Reference Citation Analysis]
728 Ameli F, Panahi P, Soleimani V. Burned-out Post Pubertal Teratoma Presenting as a Liver Metastases in a 34-Year-Old Male. Iran J Pathol 2021;16:232-6. [PMID: 33936236 DOI: 10.30699/IJP.2020.128407.2402] [Reference Citation Analysis]
729 Steinberg RL, Rasmussen RG, Johnson BA, Ghandour R, De Leon AD, Xi Y, Yokoo T, Kim S, Kapur P, Cadeddu JA, Pedrosa I. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol 2021;31:314-24. [PMID: 32770377 DOI: 10.1007/s00330-020-07093-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
730 Leuthold P, Schaeffeler E, Winter S, Büttner F, Hofmann U, Mürdter TE, Rausch S, Sonntag D, Wahrheit J, Fend F, Hennenlotter J, Bedke J, Schwab M, Haag M. Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison. J Proteome Res 2017;16:933-44. [DOI: 10.1021/acs.jproteome.6b00875] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
731 Gao Y, Wang X, Wang S, Miao Y, Zhu C, Li C, Huang G, Jiang Y, Li J, Zhao X, Wu X. Differential Diagnosis of Type 1 and Type 2 Papillary Renal Cell Carcinoma Based on Enhanced CT Radiomics Nomogram. Front Oncol 2022;12:854979. [PMID: 35719928 DOI: 10.3389/fonc.2022.854979] [Reference Citation Analysis]
732 Yu Y, Zheng M, Zhu W, Zhao F, Guan B, Shen Q, Yang F, He Q, Li X. Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature. Urol Oncol 2021;39:791.e9-791.e16. [PMID: 34462205 DOI: 10.1016/j.urolonc.2021.07.026] [Reference Citation Analysis]
733 Suárez C, Díaz-mejía N, Morales-barrera R, González M, Mateo J, Carles J. Metastatic nonclear renal cell carcinoma current review in evolving treatment strategies. Current Opinion in Urology 2021;31:242-8. [DOI: 10.1097/mou.0000000000000869] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
734 Fukuda H, Takagi T, Kondo T, Yoshida K, Shimizu S, Nagashima Y, Tanabe K. Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy. Int J Clin Oncol 2018;23:539-46. [DOI: 10.1007/s10147-017-1221-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
735 Kang MA, Lee J, Lee CM, Park HS, Jang KY, Park SH. IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway. J Pers Med 2021;11:284. [PMID: 33917914 DOI: 10.3390/jpm11040284] [Reference Citation Analysis]
736 Danjou AMN, Pérol O, Coste A, Faure E, Béranger R, Boyle H, Belladame E, Grassot L, Dubuis M, Spinosi J, Bouaoun L, Fléchon A, Bujan L, Drouineaud V, Eustache F, Berthaut I, Perrin J, Brugnon F, Charbotel B, Schüz J, Fervers B; TESTIS study group. Domestic use of pesticides during early periods of development and risk of testicular germ cell tumors in adulthood: a French nationwide case-control study. Environ Health 2021;20:111. [PMID: 34706722 DOI: 10.1186/s12940-021-00795-y] [Reference Citation Analysis]
737 Liu J, Zhang C, Hu J, Tian Q, Wang X, Gu H, Zhang S, Zhao D, Fan R. Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis. Oncotarget 2018;9:12400-7. [PMID: 29552320 DOI: 10.18632/oncotarget.24249] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
738 Ahrens M, Scheich S, Hartmann A, Bergmann L; IAG-N Interdisciplinary Working Group Kidney Cancer of the German Cancer Society. Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options. Oncol Res Treat 2019;42:128-35. [DOI: 10.1159/000495366] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
739 Zou Y, Lu Q, Yao Q, Dong D, Chen B. Identification of novel prognostic biomarkers in renal cell carcinoma. Aging (Albany NY) 2020;12:25304-18. [PMID: 33234734 DOI: 10.18632/aging.104131] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
740 Lindner AK, Tulchiner G, Seeber A, Siska PJ, Thurnher M, Pichler R. Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma. Front Oncol 2022;12:906014. [DOI: 10.3389/fonc.2022.906014] [Reference Citation Analysis]
741 da Cunha IW, da Costa WH, Morini MA, Bezerra SM, Carraro DM, Torrezan GT, Formiga MNC, Guimaraes GC, Zequi SC, Soares FA. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation. Virchows Arch 2018;473:775-9. [DOI: 10.1007/s00428-018-2420-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
742 Omiyale AO, Carton J. Renal oncocytoma with vascular and perinephric fat invasion. Ther Adv Urol 2019;11:1756287219884857. [PMID: 31700546 DOI: 10.1177/1756287219884857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
743 Brown JR, Calaway A, Castle E, Garcia J, Barata PC. Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma. KCA 2022. [DOI: 10.3233/kca-210005] [Reference Citation Analysis]
744 Akgul M, Williamson SR, Ertoy D, Argani P, Gupta S, Caliò A, Reuter V, Tickoo S, Al-Ahmadie HA, Netto GJ, Hes O, Hirsch MS, Delahunt B, Mehra R, Skala S, Osunkoya AO, Harik L, Rao P, Sangoi AR, Nourieh M, Zynger DL, Smith SC, Nazeer T, Gumuskaya B, Kulac I, Khani F, Tretiakova MS, Vakar-Lopez F, Barkan G, Molinié V, Verkarre V, Rao Q, Kis L, Panizo A, Farzaneh T, Magers MJ, Sanfrancesco J, Perrino C, Gondim D, Araneta R, So JS, Ro JY, Wasco M, Hameed O, Lopez-Beltran A, Samaratunga H, Wobker SE, Melamed J, Cheng L, Idrees MT. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. J Clin Pathol 2021;74:291-9. [PMID: 33514585 DOI: 10.1136/jclinpath-2020-207372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
745 Bianconi M, Cimadamore A, Faloppi L, Scartozzi M, Santoni M, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R. Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter. Ther Adv Urol 2019;11:1756287218815372. [PMID: 30671136 DOI: 10.1177/1756287218815372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
746 Takahashi H, Vikram R, Jimenez RE, Bolan CW, Kawashima A, Karam JA, Takahashi N. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma. Abdom Radiol (NY) 2021;46:5250-9. [PMID: 34338814 DOI: 10.1007/s00261-021-03227-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
747 Cao Q, Bai P. Role of Autophagy in Renal Cancer. J Cancer 2019;10:2501-9. [PMID: 31258756 DOI: 10.7150/jca.29285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
748 Jacob A, Shook J, Hutson TE. Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma. Future Oncol 2020;16:2147-64. [PMID: 32692256 DOI: 10.2217/fon-2020-0443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
749 Giles RH, Choueiri TK, Heng DY, Albiges L, Hsieh JJ, Linehan WM, Pal S, Maskens D, Paseman B, Jonasch E, Malouf G, Molina AM, Pickering L, Shuch B, Srinivas S, Srinivasan R, Tannir NM, Bex A. Recommendations for the Management of Rare Kidney Cancers. European Urology 2017;72:974-83. [DOI: 10.1016/j.eururo.2017.06.040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
750 Hsieh JJ, Manley BJ, Khan N, Gao J, Carlo MI, Cheng EH. Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer. Semin Cell Dev Biol 2017;64:98-106. [PMID: 27615548 DOI: 10.1016/j.semcdb.2016.09.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
751 Manzi M, Riquelme G, Zabalegui N, Monge ME. Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics. J Pharm Biomed Anal 2020;178:112905. [PMID: 31707200 DOI: 10.1016/j.jpba.2019.112905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
752 Berney DM, Lu Y, Shamash J, Idrees M. Postchemotherapy changes in testicular germ cell tumours: biology and morphology. Histopathology 2017;70:26-39. [DOI: 10.1111/his.13078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
753 Ribera-Cortada I, Guerrero-Pineda J, Trias I, Veloza L, Garcia A, Marimon L, Diaz-Mercedes S, Alamo JR, Rodrigo-Calvo MT, Vega N, López Del Campo R, Parra-Medina R, Ajami T, Martínez A, Reig O, Ribal MJ, Corral-Molina JM, Jares P, Ordi J, Rakislova N. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review. Int J Mol Sci 2021;23:251. [PMID: 35008677 DOI: 10.3390/ijms23010251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
754 Scheri KC, Leonetti E, Laino L, Gigantino V, Gesualdi L, Grammatico P, Bizzari M, Franco R, Oosterhuis JW, Stoop H, Looijenga LHJ, Ricci G, Catizone A. c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors. Oncotarget 2018;9:31842-60. [PMID: 30159127 DOI: 10.18632/oncotarget.25867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
755 Shimbori M, Osaka K, Kawahara T, Kasahara R, Kawabata S, Makiyama K, Kondo K, Nakaigawa N, Yamanaka S, Yao M. Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report. J Med Case Rep 2017;11:297. [PMID: 29052535 DOI: 10.1186/s13256-017-1460-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
756 Bedke J, Heide J, Ribback S, Rausch S, de Martino M, Scharpf M, Haitel A, Zimmermann U, Pechoel M, Alkhayyat H, Shariat SF, Dombrowski F, Stenzl A, Burchardt M, Klatte T, Kroeger N. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. BJU Int 2018;121:84-92. [PMID: 28803448 DOI: 10.1111/bju.13984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
757 Li Z, Zhao S, Zhu S, Fan Y. MicroRNA-153-5p promotes the proliferation and metastasis of renal cell carcinoma via direct targeting of AGO1. Cell Death Dis 2021;12:33. [PMID: 33414440 DOI: 10.1038/s41419-020-03306-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
758 Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon Tan P, Tickoo SK, Tsuzuki T, Turajlic S, Cree I, Netto GJ. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol 2022:S0302-2838(22)02467-8. [PMID: 35853783 DOI: 10.1016/j.eururo.2022.06.016] [Reference Citation Analysis]
759 Deng T, He Z, Duan X, Gu D, Cai C, Wu W, Liu Y, Zeng G. STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion. Front Oncol 2021;11:611081. [PMID: 33959493 DOI: 10.3389/fonc.2021.611081] [Reference Citation Analysis]
760 Dagher J, Kammerer-Jacquet SF, Dugay F, Beaumont M, Lespagnol A, Cornevin L, Verhoest G, Bensalah K, Rioux-Leclercq N, Belaud-Rotureau MA. Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases. Virchows Arch 2017;471:107-15. [PMID: 28488172 DOI: 10.1007/s00428-017-2124-0] [Cited by in Crossref: 10]